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ABSTRACT 
Demyelination is a pathological process which causes profound changes in the physiology 
of axons. Post mortem evidence suggests that mitochondrial content is increased in 
demyelinated axons which has led to the widely accepted theory that loss of myelin causes 
an increase in axonal energy demand which in turn can be satisfied by a larger number 
of mitochondria. However, demyelinated axons are known to undergo a series of changes 
from conduction block early on in demyelination to altered modes of conduction and 
finally remyelination and return of normal conduction. Little is known about how these 
different states influence axonal mitochondria. 
 
In this thesis, mitochondrial function and dynamics were investigated throughout the 
time course of lysolecithin-mediated de- and remyelination in the saphenous nerve in 
vivo. First, the time course of anatomical and electrophysiological changes after 
application of lysolecithin was mapped out using semi-thin resin sections and recordings 
of compound action potentials. Then, mitochondrial dynamics and membrane potential 
were measured at various time points during the onset and resolution of demyelination. 
Mitochondrial transport was significantly reduced during the first week of demyelination, 
preceding the accumulation of stationary mitochondria in the axon. At the same time, 
mitochondrial membrane potential was significantly increased, particularly at the earliest 
time points investigated (days 2 and 4). Interestingly, all changes including the above-
mentioned accumulation of mitochondria took place before the return of conduction and 
putative increase in energy demand. 
 
In order to understand better the processes underlying these changes, the role of two 
known modifiers of mitochondrial dynamics were investigated: action potential 
conduction and intra-axonal calcium. A 6h conduction block was induced using 
bupivacaine and confirmed using electrophysiological stimulation but did not lead to any 
of the changes seen in the early phases of demyelination. On the other hand, calcium 
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imaging using the genetically encoded calcium sensor Tn-XXL revealed a slight but 
consistent increase in intra-axonal calcium in demyelinated axons, both at the time point 
with the highest increase in mitochondrial membrane potential (day 2) and at the time 
point with the highest mitochondrial density (day 8). 
 
Taken together, these findings point to impaired axonal calcium homeostasis, rather than 
changes in energy demand, as the main driving force behind mitochondrial changes in 
demyelination. The fact that mitochondrial transport remained impaired until later in 
the remyelination process may have implications for the long term survival of chronically 
demyelinated axons. 
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CHAPTER 1: INTRODUCTION 
STUDYING MITOCHONDRIA IN VIVO 
In the introduction to his 2005 book Power, Sex, Suicide – Mitochondria and the Meaning 
of Life, Nick Lane describes mitochondria as a badly kept secret: more and more people 
have heard of them, yet many details of their origin and life cycle are only partially 
understood. Whilst this certainly still holds true in 2016, considerable efforts are being 
undertaken to study these fascinating organelles. A quick pubmed search for 
‘mitochondria’ brings up more than 26,000 hits in the last three years alone (Figure 1.1). 
 
 
Figure 1.1: PubMed search results for “mitochondria” by year. The dashed line 
shows results with the addition of “in vivo”. 
 
It is interesting to view the evolution of mitochondrial research from a techniques 
perspective (Ernster & Schatz 1981). The classic image of a mitochondrion as an oval 
shaped, striped organelle, for example was a result of the invention of the electron 
micrograph in the early 1950s. Our understanding of the function of these organelles was 
made possible by the development of cell fractionation techniques a few years earlier 
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(Hogeboom et al. 1948). Interest in mitochondria peaked in late 1960s and early 1970s, 
beginning with the reconstruction of the mitochondrial respiratory chain (Keilin & King 
1958; Hatefi et al. 1962). Finally, it was advances in cell culturing which provided the 
basis for understanding how mitochondria interact with their surroundings, and how they 
shape, and are shaped by, their host cell’s physiology. This tightly controlled environment 
made it possible to block the expression of proteins or alter mitochondrial function 
through the precise application of drugs, revealing the function of the mitochondrial 
machinery piece by piece. The vast majority of what we know about mitochondrial 
function, dynamics, and life cycle is based on decades of important in vitro research. 
However, despites their success, cell culture studies have clear limitations. Perhaps the 
most obvious factors are space and time. Axons in the human sciatic nerve, for example, 
can extend to a length of over one meter and have to be maintained for decades. In 
contrast, cultured neurons are typically young and have axons which are still growing. 
This difference is important as growing and regenerating axons are believed to have 
significantly increased mitochondrial transport (Misgeld et al. 2007; Mar et al. 2014; 
Lewis et al. 2016) and fission and fusion compared with mature, resting axons (Jendrach 
et al. 2005; Arnold et al. 2011; Figge et al. 2012). Similar limitations exist with respect 
to energy supply and demand. The concentration of key factors such as oxygen or glucose 
in the body varies significantly and dynamically in a way which is difficult to simulate 
in culture (Chisholm et al. 2016). The same holds for energy demand which in vivo 
changes constantly depending, for example, on an animal’s behaviour. Finally, many 
physiological and pathophysiological processes which influence mitochondria involve a 
multitude of cell types and signalling cascades which cannot always be accurately 
recreated in vitro. Inflammation, for example, is a complex interaction of many different 
cells which has been shown to affect both mitochondrial membrane potential and 
transport (Nikić et al. 2011; Sorbara et al. 2014). 
In order to understand the role of mitochondria in such scenarios, it is necessary to study 
them in the living animal. Fortunately, the last decades have seen significant advances 
in microscope technology (Chisholm et al. 2016), leading to a small but increasing number 
of publications on mitochondrial function in vivo (see dashed line in Figure 1.1).  This 
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thesis deals with a number of topics such as changes in energy demand, calcium 
homeostasis, and destruction and regeneration of the myelin sheath, all of which I believe 
are best studied in vivo. 
 
MITOCHONDRIA AS SUPPLIERS OF NEURONAL ENERGY 
The famous description of mitochondria as “powerhouse[s] of the cell” was popularised in 
an article in Scientific American in 1957 (Siekevitz 1957), almost a decade after Kennedy 
and Lehninger first discovered that mitochondria are the site of oxidative phosphorylation 
(Kennedy & Lehninger 1949). The title is particularly apt in neurons which rely on them 
for an estimated 95% of their ATP supply (Ames 2000) and largely lack the ability to 
up-regulate glycolysis (Erecińska & Dagani 1990; Erecińska et al. 1993; Bolaños et al. 
2010), which means that any increase in energy demand can only be counteracted by 
increasing mitochondrial ATP supply. 
Given the above it is hardly surprising that damage to mitochondria has devastating 
consequences for nerve cells in general and axons in particular. Blocking mitochondrial 
complexes using either nitric oxide (NO) donors (Smith et al. 2001; Nikić et al. 2011) or 
the mitochondrial poison rotenone (Persson et al. 2013) has been shown to provoke rapid 
swelling of axons followed by degeneration. The underlying mechanism appears to be 
that mitochondrial dysfunction quickly leads to a local ATP deficit which prevents the 
Na+/K+ ATPase from operating properly. This, especially in combination with neuronal 
activity (Smith et al. 2001; Persson et al. 2013) leads to the accumulation of sodium in 
the axoplasm. Once a critical concentration is reached, the Na+ / Ca2+ exchanger begins 
to work in reverse mode, shuttling Na+ out of the axoplasm and in turn increasing the 
concentration of Ca2+ (Lehning et al. 1996; Waxman 2008; Witte et al. 2013). Excessive 
intracellular calcium is a cell death signal which leads, among other things, to the 
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activation of the axonal protease calpain, and the dissolving of axonal proteins (George 
et al. 1995).1 
Mitochondria produce ATP via a process known as oxidative phosphorylation. Briefly, 
substrates are transported through the inner membrane of the mitochondrion and 
converted into acetyl CoA which is subsequently fed into the citric acid cycle. In a chain 
of 8 chemical reactions, the carbon from acetyl CoA is reduced to CO2 and the electrons 
gained in the process are stored in the form of NADH, which subsequently interacts with 
complex I of the respiratory chain (RC), and FADH2, which is part of complex II. The 
RC is a series of more than 20 different electron carriers organised in four major 
complexes which are linked by the molecules ubiquinone and cytochrome c. The protein 
complexes and linkage proteins along the RC have an ascending affinity for electrons 
which enables mitochondria to pass on electrons from NADH and FADH2 along the RC 
and onto the strong electron acceptor O2 (Alberts et al. 2008). The energy which is 
released in the process powers proton pumps located in complexes I, III, and IV which 
transport H+ ions from the inside of the inner membrane to the outside. This leads to 
the build-up of both a proton gradient (commonly denoted Δψm)  and a pH gradient 
over the inner membrane, resulting in a proton-motive force of approximately 200mV 
(Nicholls & Ferguson 2013). Not unlike a battery, this gradient serves as an energy 
storage mechanism. If ATP/ADP levels in the mitochondrial matrix fall below a certain 
level, the protons flow back into the mitochondrion through a protein called the ATP 
synthase or FoF1 ATPase (Walker 2012). This remarkable protein is closely related to 
bacterial flagella motors and one of only very few examples of rotary mechanisms found 
in nature (Nicholls & Ferguson 2013). It consists of two molecular rotary motors: Fo 
which is embedded in the inner membrane, and F1 which resides within the matrix 
(Okuno et al. 2011). In isolation, F1 acts as an ATP consuming motor. It consists of a 
                                         
1 Whilst both NO and rotenone block the mitochondrial transport chain, they may not damage 
the axon via precisely the same pathway: As opposed to rotenone, NO is also involved in the 
opening of the mitochondrial transition permeability pore and may cause degeneration via the 
release of cytochrome C from mitochondria in the presence of Ca2+(see e.g. Martin et al. 2011). 
NO has many effects, including impairing the function of the sodium pump and making sodium 
channels open for longer, both of which also promote intracellular Na. Nevertheless, ATP 
deficiency and Ca2+ influx are important steps involved in both mechanisms. 
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pole-like γ-subunit that is surrounded by a cylinder made of 3 α and 3 β subunits. Upon 
binding of ATP to the β-subunits and its subsequent cleaving by interaction with H2O, 
these undergo a conformational change that translates into a counterclockwise rotation 
of a γ-pole (Masaike et al. 2008). However, this ATP consuming process is reversible. 
Forced clockwise rotation of γ-unit using magnetic beads has been shown to be sufficient 
to generate ATP from ADP and Phosphate (Itoh et al. 2004; Rondelez et al. 2005). In 
the mitochondrion, this forced rotation of γ is realized through the F0 motor. This outer 
part of the protein consists of a ring of c subunits as well as an ab2 strator. While the 
strator connects to the α3β3-cylinder of the F1 unit and keeps it in place, the c ring forms 
an ion channel that connects to the F1 γ-subunit. As H+ ions pass through the channel 
into the matrix, the c ring and the connected γ-pole turn clockwise (Okuno et al. 2011). 
This way FoF1 acts as an ATP synthase as long as it is driven by the proton-motive 
force2. 
In addition to ADP-ATP conversion, other essential mitochondrial processes are driven 
by Δψm, too. Pyruvate and inorganic phosphate, for example, need to be co-transported 
into the matrix along with H+ (Alberts 2008). Similarly, the exchange of ADP and ATP 
utilizes the voltage difference across the membrane. Here, a protein called adenine 
nucleotide translocase shuttles ATP into the cytosol and ADP into the matrix. 
All this makes the mitochondrial membrane potential the basis of neuronal energy 
production and thus neuronal survival. However, there are downsides to this way of 
producing and storing energy: as they build up a protonmotive force  over their inner 
membrane, mitochondria produce superoxide (O2-), a reactive species of oxygen (Murphy 
2009). Most superoxide is quickly turned into hydrogen peroxide, both spontaneously and 
                                         
2 Interestingly, F1 retains its ability to act as an ATPase persists even in connection with 
Fo. If the voltage difference over the IM drops below a certain reversal potential, FoF1  
reverses its function and consumes ATP while pumping cations out of the matrix 
(Chinopoulos 2011). ADP/ATP and pyruvate transport are also reversible. It follows 
that strongly depolarized mitochondria do not only cease to produce ATP but start to 
actually take it up from the cytosol and consume it (Chinopoulos et al. 2010; Chinopoulos 
2011). 
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through the protective enzyme superoxide dismutase (Bedard & Krause 2007). However, 
due to its proximity to mitochondrial proteins and genome (see below) some oxidative 
damage is unavoidable. Furthermore, NO and superoxide can combine to the very 
powerful oxidizing agent peroxynitrite (ONOO-) which is believed to cause significant 
damage in inflammatory conditions such as multiple sclerosis (Cross et al. 1998). 
In isolated mitochondria and permeabilised cells, both the rate of ATP production and 
the production of reactive oxygen species raise exponentially with the increase in 
membrane potential (Starkov & Fiskum 2003; Chinopoulos et al. 2009; Kawamata et al. 
2010). Furthermore, O2- production has been shown to increase if ATP levels are high 
and mitochondria sit idle (Murphy 2009). This trade-off between ATP produced by 
mitochondria and damaged caused in the process together with the high complexity of 
mitochondria (and therefore high cost of producing and maintaining them, see below) 
likely explains why mitochondria are not found in superabundance but rather constantly 
relocated to where they are most needed (MacAskill et al. 2010; Sajic et al. 2013). 
 
MITOCHONDRIAL MAINTENANCE 
Mitochondria are very complex organelles containing an estimated 1500 different proteins 
(Calvo et al. 2006), as well as copies of their own genome (mtDNA), all of which are 
stored in a very small space. mtDNA only encodes a small set of proteins (13 polypeptides 
out of a total of 37 genes) which fulfil essential functions in the respiratory chain 
(Chinnery & Hudson 2013). These 13 proteins are only encoded in mtDNA while all other 
mitochondrial proteins are encoded in nuclear DNA. This puts mitochondria in a special 
position: In order to maintain their function, they are dependent on two distinct sets of 
DNA stored in different locations. As a result, mitochondria have evolved a set of ‘on 
board’ repair mechanisms which are able to ameliorate some of the damage caused by 
reactive oxygen species (Kazak et al. 2012).  However, this does not fully prevent the 
accumulation of damage over time which is believed to eventually lead to a reduction in 
mitochondrial function. In addition to the damage accumulated by single mitochondria, 
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the health of the mitochondrial population as a whole has also come into focus. This is 
driven by evidence from live cell imaging showing that mitochondria in the same cell 
exchange proteins and DNA through fission and fusion (Legros et al. 2002; Malka et al. 
2005; Ma & O’Farrell 2015). This can lead to damage to mtDNA (usually in the form of 
deletions) being  spread throughout the mitochondrial population of a cell, ultimately 
rendering the host cell respiratory deficient (Krishnan et al. 2008; de Grey 2009; Fukui 
& Moraes 2009). Hence, maintenance of a healthy population of mitochondria is only 
possible through continuous rejuvenation of the mitochondrial population by creating 
new mitochondria (mitochondrial biogenesis) and removing old specimens (mitophagy) 
(Liesa & Shirihai 2013). In axons and dendrites, mitochondria are known to exist in two 
different states: The majority of them are elongated and stationary, while a smaller 
number of shorter mitochondria can be seen moving in either direction (Misgeld et al. 
2007; Sajic et al. 2013; Sorbara et al. 2014). Computer simulations suggest that the 
stationary population needs to undergo repeated selective fusion with new, healthy 
organelles followed by fission to keep the spread of damaged mtDNA under control and 
that small drops in the rate of such exchanges can significantly increase the chance of a 
cell becoming respiratory deficient  (Elson et al. 2001; Twig et al. 2008; Mouli et al. 
2009)3. 
As mentioned previously, the vast majority of mitochondrial proteins are encoded by the 
nuclear genome. There is some controversy about whether it follows that synthesis of 
said proteins is therefore restricted to the proximity of the nucleus. Some evidence 
suggests that axonal synthesis of mitochondrial proteins occurs and is of functional 
importance (Amiri & Hollenbeck 2008; Kaplan et al. 2009). However, there is a disconnect 
                                         
3 Computer simulation of the spread of ΔmtDNA through random drift is a fascinating tool for 
understanding the consequences of mtDNA damage. It is my belief, however, that current 
simulations do not accurately reflect the consequences of mtDNA deletions in neurons: to the best 
of my knowledge, all publications to date employ a simplified model of mtDNA exchange in which 
every mitochondrion within a cell can fuse with every other one. This is far from the reality in a 
highly polarized cell such as a neuron where mitochondria at the axon terminal and near the 
nucleus can be as much as a meter apart. Since decreasing the total amount of exchangeable 
mtDNA in a cell has been shown to accelerate the spread of ΔmtDNA (Payne et al. 2011), 
modifying the existing models to incorporate neuronal cell architecture might result in (locally) 
higher estimates of ΔmtDNA. 
 23 
between findings in vitro, where evidence of axonal translation is abundant and in vivo, 
particularly in adult animals, where the importance of such mechanisms is less clear 
(Jung et al. 2012).  A similar picture emerges with respect to mitochondrial DNA: while 
a study of cultured sensory neurons of chick embryos suggested that mtDNA does 
replicate in axons, even if they are separated from their nucleus (Amiri & Hollenbeck 
2008), research carried out in our lab using a similar technique failed to show the same 
effect in adult mice in vivo, indicating instead that mitochondrial biogenesis is largely, if 
not exclusively, confined to the soma (Radha Desai, unpublished research). Finally, it 
has been argued that degradation of mitochondria (mitophagy) through fusion of the 
organelles with lysosomes is largely confined to the cell body (Cai et al. 2012). 
Taken together, these findings indicate that providing new mitochondria within axons or 
removing old ones requires transporting them to and from the soma respectively. The 
importance of this process is clearly demonstrated in conditions of impaired mitochondrial 
transport. Most prominently, Charcot–Marie–Tooth type 2A is an inherited form of 
peripheral neuropathy caused by mutations of the mitochondrial motor protein KIF1B β 
(type 2A1) (Zhao et al. 2001) or of the mitochondrial fusion protein MFN2 (type 2A2) 
(Baloh et al. 2007; Misko et al. 2010), both of which cause significant impairment of 
mitochondrial movement. Beginning in early adulthood, this impairment leads to the 
degeneration of peripheral nerves, starting with the longest axons. Similarly, impairment 
of mitochondrial dynamics has been shown in animal models of amyotrophic lateral 
sclerosis (ALS) which, in humans, is characterized by the degeneration of motor neurons 
(De Vos et al. 2007; Bilsland et al. 2010). 
While these examples show that mitochondrial transport is critical to guarantee the 
survival of neurons over their decades-long lifetimes, it also comes with a cost. Diana 
Zala and colleagues elegantly demonstrate that an ATP decrease of approximately 20% 
within the axons of cultured neurons is sufficient to bring axonal transport of 
mitochondria to a near-complete stop (Zala et al. 2013). Mitochondrial transport may 
also compromise ATP production as mitochondria appear to be most energetically 
efficient when they are (hyper-) fused to form a single, long organelle (Liesa & Shirihai 
2013; Rolland et al. 2013), whereas transported mitochondria are generally much smaller 
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in size (e.g. Sajic et al. 2013) and preventing the fission of large mitochondria leads to a 
breakdown of transport (Li et al. 2004). Neurons thus need to balance the risk of a 
temporary energy failure against the cost of maintaining a larger pool of mitochondria. 
In summary, two opposing forces shape the number and distribution of mitochondria in 
cells in general and neurons with long processes in particular: the need to guarantee 
adequate, local supply of ATP at all times and the complicated process of maintaining a 
healthy mitochondrial population. In the next section, I will look at the mechanisms 
behind mitochondrial transport in more detail before coming back to axonal energy 
demand and its connection to myelination. 
 
MECHANISMS AND CONTROL OF MITOCHONDRIAL 
TRANSPORT 
Most mitochondrial movement is carried out along microtubules which, in axons, are 
arranged with their (+) ends facing towards axon terminals and (-) ends towards the 
soma (Baas et al. 1989). As seen in other kinds of axonal transport, anterograde 
movement of mitochondria along these structures is driven by kinesin, whereas retrograde 
transport is controlled by dynein. However, a significant amount of complexity is 
introduced by different adaptor proteins connecting the motors with the mitochondrial 
membrane (Saxton & Hollenbeck 2012). The best understood mitochondrial transport 
complex is the one which appears to account for most of the anterograde movement of 
mitochondria: here, the mitochondria outer membrane receptor Miro (MacAskill et al. 
2009; Chen & Sheng 2013) is coupled to the adaptor protein Trak1 (Koutsopoulos et al. 
2010; Brickley & Stephenson 2011) which, in turn, binds to kinesin (more precisely, 
kinesin-1, or KIF5B) (Tanaka et al. 1998). However, alternative adaptor proteins have 
also been proposed. Syntabulin appears to be able to link the mitochondrial outer 
membrane directly to the kinesin motor (Cai et al. 2005), as do the proteins FEZ1 and 
RANBP2 (Fujita et al. 2007; Cho et al. 2007). The retrograde transport machine is 
somewhat less understood but a recent study showed that dynein, together with its 
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auxiliary complex dynactin, can also be linked to mitochondria via the Trak isoforms 1 
and 2 (van Spronsen et al. 2013). It is thus possible that mitochondria simultaneously 
bind motor proteins for both anterograde and retrograde movement. In fact, such a setup 
is supported by experiments carried out in Drosophila which demonstrate that disturbing 
the function of either kinesin or dynactin impedes transport in both directions, suggesting 
an interaction between the two motor complexes (Pilling et al. 2006; Haghnia et al. 2007). 
What is not yet well understood is precisely how mitochondrial transport is controlled. 
Some factors have been identified which are involved in the arrest of mitochondrial 
movement. An early report suggested that increases in local ADP attract and arrest 
mitochondria (Mironov 2007) but a mechanism explaining how the transport machinery 
might sense this increase was never found (Lovas & Wang 2013). Instead, calcium has 
emerged as potentially the most important stop signal for mitochondria. While 
mitochondrial movement is commonly seen in axons at baseline Ca2+, increasing its 
concentration using calcium ionophores arrests mitochondrial movement in primary 
neuron cultures (Saotome et al. 2008) and excised frog nerves (Zhang et al. 2010). 
Conversely, using calcium chelators or calcium free media has been shown to increase 
mitochondrial movement in neurites (Zhang et al. 2010; Ohno et al. 2011). 
Two different aspects of Ca2+ dependent mitochondrial arrest in axons have been 
described and likely act together to stop mitochondria in what has been called ‘engine 
switch and break’ (Sheng 2014). The mitochondrial membrane protein Miro contains 
calcium binding sites. As these are activated, Miro undergoes a conformation change and 
appears to bind directly to kinesin, dissociating it from microtubules (Wang & Schwarz 
2009). In addition to this ‘stepping off the gas pedal’, mitochondria also become anchored 
to microtubules by a protein called syntaphilin. Syntaphilin is likely  present in the axon 
independently of mitochondria (Kang et al. 2008; Sheng 2014) but can be translocated 
to mitochondria where, in the presence of calcium, it disrupts the Trak-kinesin complex, 
binds KIF5 and inhibits the molecular motor’s ATPase (Chen & Sheng 2013; Sheng 
2014). Importantly, syntaphilin was found to arrest mitochondrial movement 
independently of the direction of movement, thus representing a mechanism by which 
calcium can lead to a complete arrest of axonal mitochondria. 
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In neurons, sites with high calcium influx are also often the sites with the highest energy 
demand. Chemical synapses, for example, have been estimated to account for nearly half 
of a grey matter neuron’s ATP demand (Howarth et al. 2012, see also below) and because 
vesicle release is driven by calcium influx, Ca2+ serves as a good indicator of activity and 
thus energy demand. Of course this doesn’t exclude the possibility that mitochondria can 
directly sense and accumulate in areas of high energy demand. But to our current 
knowledge, calcium signalling may be both necessary and sufficient to control local energy 
supply in neuronal processes (Macaskill et al. 2009; MacAskill et al. 2010). However, in 
addition to being controlled by it, mitochondria also actively influence the cell’s calcium 
household by ingesting, buffering and releasing calcium. This process is discussed below. 
 
MITOCHONDRIAL CALCIUM BUFFERING 
Mitochondria have been shown to store impressive calcium concentrations of up to 1000 
nmol per mg mitochondrial protein (Nicholls 2005). Like so many other mitochondrial 
processes, the influx of calcium is largely driven by the membrane potential which moves 
Ca2+ anions through the membrane into the inner matrix. Interestingly, even though 
mitochondria have been known for over 50 years to accumulate calcium (Deluca & 
Engstrom 1961; Vasington & Murphy 1962), it was not until 2011 that the molecular 
identity of the main inward bound calcium channel, the mitochondrial calcium uniporter 
(MCU), was revealed (De Stefani et al. 2011; Baughman et al. 2011). Efflux of Ca2+ 
happens in exchange for Na+ through the Ca2+Na+ exchanger molecule NCLX (Palty et 
al. 2010)4. It is driven both by free Ca2+ and a low concentration of Na+ in the inner 
                                         
4 In addition to NCLX, a non-specific channel named the mitochondrial permeability transition 
pore (MPTP) can facilitate rapid release of mitochondrial calcium (Haworth & Hunter 1979). This 
appears to happen mainly upon mitochondrial depolarisation or extreme calcium overload, and 
under conditions of oxidative stress  (Hunter & Haworth 1979; Halestrap et al. 1997; Martin et 
al. 2011) and has been shown to play an important role in cardiac reperfusion injury (Nakagawa 
et al. 2005). Because mice lacking the protein cyclophilin D which is necessary for MPTP opening 
develop normally (Baines et al. 2005; Nakagawa et al. 2005), MTPT opening is generally seen as 
a catastrophic event, although a role in normal physiology cannot be excluded (see e.g. Barsukova 
et al. 2011). 
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mitochondrial matrix which in turn is a consequence of sodium leaving the mitochondrion 
in exchange for H+ pumped out by the respiratory chain. On the surface, this seems like 
an expensive and fairly circular system. However, as Nichols et al showed in an important 
series of experiments on isolated mitochondria (summarised in Nicholls 2005), it makes 
perfect sense when considering the different changes in kinetics of influx and efflux in 
reaction to changing external calcium concentrations. The MCU is highly specific for 
Ca2+ and has a relatively low affinity at low external Ca2+ concentrations, but its 
throughput increases significantly as [Ca2+]e increases (Nicholls suggests an increase as a 
3.5 power function of [Ca2+]e in brain mitochondria). Calcium efflux, on the other hand, 
is remarkably stable over a wide range of [Ca2+]e, both due to the rate limit of the Na+ 
Ca2+ exchanger and because much of the Ca2+ in the mitochondrial matrix is buffered 
by phosphate, keeping the concentration of free calcium stable and relatively independent 
of the extra-mitochondrial concentration. These “scale-able” calcium dynamics enable 
mitochondria to clamp the intracellular calcium in their surroundings to a relatively 
stable level. The effect is strong enough so that in pancreatic acinar cells and perhaps 
also in neurons mitochondria are able to form “belts” around areas of high calcium influx 
which stop Ca2+ waves from spreading through the cell (Tinel et al. 1999; reviewed in 
Rizzuto et al. 2012). 
Some discussion remains about the speed at which mitochondria take up calcium. Some 
have argued that the low affinity prohibits mitochondria from influencing fast, calcium-
driven cellular processes (Williams et al. 2013), while others have pointed out that local 
levels of Ca2+, for example in synapses or near the ER / SR can get extremely high 
compared with the average level of intracellular calcium, thus driving the Vmax of 
mitochondrial calcium intake to levels significantly above even what is seen in isolated 
mitochondria in vitro (Nicholls 2005; Rizzuto et al. 2012). But irrespective of whether 
mitochondrial calcium buffering can influence the fastest of calcium driven events there 
is experimental evidence that suggests that it does influence the host cell’s calcium 
signalling. In neurons, mitochondria have been shown to aid the recovery from high 
frequency stimulation-based synaptic depression (Billups & Forsythe 2002); knocking out 
syntaphilin and thus reducing the number of stationary mitochondria in post-synaptic 
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boutons was reported to change the synaptic response to high frequency stimulation by 
causing short-term facilitation (Kang et al. 2008); and inhibiting mitochondrial calcium 
uptake was shown to narrow the dynamic response of olfactory sensory neurons during 
odour stimulation (Fluegge et al. 2012). All of this suggests that mitochondrial calcium 
buffering plays a role in normal neuronal, and particularly synaptic, function5.  
 
NEURONAL ENERGY DEMAND AND MYELINATION 
It is widely agreed that brains as a whole and neurons in particular have a high energy 
demand compared with other cell types (Rolfe & Brown 1997). However, relating this 
demand to different cellular processes is a challenging task. Broadly speaking, neuronal 
energy demand can be broken down into an active and a passive component. Passive 
(that is, activity independent) energy demand is cause by general housekeeping activity 
such as protein turnover, cellular transport, and the upkeep of the cell’s membrane 
potential. Active demand, on the other hand, is cause by the firing of action potentials 
as well as synaptic transmission and depends directly on the cell’s signalling activity. The 
balance between these factors differs significantly between white and grey matter regions 
of the brain. Using extensive simulations of cerebellar neurons, Attwell, Laughlin, 
Howarth, and Gleeson estimated that in the grey matter passive processes account for 
about 40% of a neuron’s total ATP demand (25% for non-signalling related activity and 
15% for the upkeep of membrane potentials), action potentials make up 16%, and at 44% 
synaptic transmission consumes the biggest chunk of energy (Attwell & Laughlin 2001; 
Howarth et al. 2012). The white matter presents a different distribution of energy 
demand. Here, only very few synapses can be found, reducing the proportion of total 
energy demand due to synaptic transmission almost to zero. The proportion of 
                                         
5 It is worth pointing out, however, that MCU knockouts are nonetheless viable and, apart from 
weaknesses during prolonged physical activity, appear relatively normal (Pan et al. 2013) which 
suggests that at least under physiological conditions neurons may be able to compensate for 
reduced mitochondrial calcium buffering. 
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housekeeping and maintenance of the cell’s membrane potential, in turn, are increased 
to 56% and 44% of the local energy demand (Harris & Attwell 2012). 
Perhaps surprisingly, the relative cost of action potential conduction in the mature white 
matter is estimated to be very low (< 1%). This is largely due to myelination. In 
myelinated axons (as in demyelinated ones) the action potential itself is actually “free” 
as it is powered by the potential and concentration gradient already established across 
the cell membrane. ATP consumption only occurs after the action potential as the 
gradient is restored by pumping Na+ out of the cell and K+ in (Debanne et al. 2011). 
This is done by the Na+/K+ exchanger at a rate of 1 ATP per 3 Na+ and 2 K+. The 
ATP cost per action potential is therefore proportional to the amount of sodium which 
enters the cell. Myelin, whether produced centrally by oligodendrocytes or peripherally 
by Schwann cells, significantly reduces the capacitance of the axon membrane. Instead 
of a widespread exchange of K+ and Na+ along a leaky axon membrane, ion channels are 
arranged such that Na+ and K+ exchange is restricted to the centre of the node of Ranvier 
and the juxta-paranode, respectively, while the internodes are comparatively 
impenetrable for both ions. This setup significantly lowers the amount of sodium influx 
necessary for action potential propagation and consequently the amount of ATP 
necessary to restore the membrane potential. 
The reduction in capacitance, and therefore reduction in energy demand depends on the 
thickness of the myelin sheath and the total axonal surface area. Both are often combined 
into the so-called g-ratio, that is the axonal diameter to the total outer diameter including 
myelin (an increase in this ratio therefore means a relative decrease in myelin thickness). 
In adult mammals, the g-ratio was found to be fairly constant for axons of the same type 
and has been shown to be close to the theoretical optimum for high speed conduction 
(Rushton 1951; Chomiak & Hu 2009). Assuming a g-ratio of 0.81 (a common value in 
the CNS) Harris and Attwell estimate that myelination reduces the cost of every single 
AP (or rather every restoration of the membrane potential) by about two orders of 
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magnitude compared with unmyelinated grey matter (Harris & Attwell 2012)6. This 
difference is likely even higher in the PNS, where g-ratios are lower (Arbuthnott et al. 
1980). 
The mammalian optic nerve provides a well-known real-world example of this difference. 
Fibres in the adult optic nerve head contain both myelinated and unmyelinated regions 
which are subjected to the same levels of activity. Intriguingly, multiple lines of evidence 
suggesting that the energy demand due to neuronal activity is indeed higher in the 
unmyelinated parts of the nerve. Compared with the myelinated sections, it is surrounded 
by a denser network of capillaries and astrocytic processes and it is more vulnerable to 
ischaemia (Balaratnasingam et al. 2010; Chan et al. 2012). Furthermore, there is 
histochemical and immunochemical evidence of stronger activity of cytochrome c oxidase 
(Yu et al. 2013). Finally, and perhaps most importantly, mitochondrial density was found 
to be significantly larger in the unmyelinated part relative to the myelinated part of the 
axons (Barron et al. 2004) which, in agreement with the theory laid out above, correlated 
with a larger number of sodium channels.  
The optic nerve also demonstrates another important quality of axonal bioenergetics: 
energy supply and demand are highly local. ATP is a very unstable molecule and its 
diffusion through the dense intracellular environment is believed to be limited (Clegg 
1984; Jones 1986; Ames 2000). Therefore, energy needs to be supplied very close to where 
it is consumed, a fact that is also demonstrated by the high density of mitochondria at 
synapses (which are areas of high energy demand, as discussed above) (MacAskill et al. 
2010). 
This leads to the interesting question of how an adult neuron can cope with the focal loss 
of myelin. Based on the above, if the cell is active, this should lead to an increase in local 
energy demand which requires a local increase in energy supply. On the other hand, 
                                         
6 Interestingly, it does not follow that myelination conserves energy overall. While AP propagation 
is made significantly cheaper, this is likely outweighed by the energy needed to maintain the 
myelinating cells (Harris & Attwell 2012). Instead, it is factors such as speed of conduction and 
the axon diameter necessary to guarantee it or reliability of action potentials which explain the 
evolutionary advantage of myelination (Faisal & Laughlin 2007; Hartline & Colman 2007; 
Neishabouri & Faisal 2014). 
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neurons which do not fire may undergo a (small) decrease in energy demand. Since axons 
in the spinal cord or the peripheral nervous system can grow to a length of more than a 
metre, any adaptation needs to happen far from the cell body and possibly without 
orchestration. 
 
THE PATHOLOGY OF DEMYELINATION AND ITS CONNECTION 
TO MITOCHONDRIA 
Demyelination is a hallmark of multiple debilitating neurological diseases including 
multiple sclerosis (MS), optic neuritis, Guillain–Barré syndrome, inherited 
leukodystrophies, and most forms of Charcot–Marie–Tooth disease (CTM). All of these 
conditions cause disability, which is highly correlated with axonal loss (Davie et al. 1995; 
De Stefano et al. 1998; Rudick et al. 1999; Garbern et al. 2002; Pareyson et al. 2006). 
This has led to considerable interest in the link between demyelination and axonal 
degeneration. 
Acute demyelination is usually not a catastrophic event. Despite the aggressive nature of 
its relapses, demyelinated but intact axons are commonly found in both active (inflamed) 
and inactive lesions in multiple sclerosis (e.g. Lassmann et al. 2012). Similarly, in animal 
models of transitory demyelination induced by toxins such as lysolecithin (Hall & Gregson 
1971), ethidium bromide (Blakemore 1982), or cuprizone (Blakemore 1973), most axons 
survive the demyelinating event and regain function. Instead, demyelination appears to 
cause a vulnerability which leads to axonal loss over time even in the absence of 
inflammation. Irvine and Blakemore demonstrated that delaying remyelination in 
cuprizone-treated mice through radiation (Irvine & Blakemore 2008) or simply increased 
age of the animal (Irvine & Blakemore 2006) leads to increased axonal loss after 16 weeks. 
The effect can also be observed in human pathology studies of MS where axons in 
chronically demyelinated, inactive lesions show significantly more signs of degeneration 
compared to those in remyelinated lesions (Trapp et al. 1998; Kornek et al. 2000). It is 
also not clear, whether remyelination can fully stop the degeneration. In the above-
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mentioned paper by Kornek et al., remyelinated axons were still 1.4x as likely to show 
βAPP-positivity (a common marker of axonal degeneration) as normal white matter. 
Similarly, Manrique-Hoyos et al. describe a second wave of motor axon degeneration six 
months after cuprizone-induced demyelination, following an initial recovery (Manrique-
Hoyos et al. 2012). 
Over the last decades, a number of theories have been proposed which link demyelination 
to axonal decline. Demyelinated axons undergo a number of changes in their physiology 
and composition of ion channels which are believed to increase their energy demand (see 
below as well as the introduction to chapter 4 for details). If this increased demand 
cannot be met with sufficient supply, the cell is believed to enter a state termed “virtual 
hypoxia” (Trapp & Stys 2009). As described above, a lack of ATP needed to drive the 
Na+/K+ exchanger leads to the accumulation of sodium in the axoplasm which leaves 
the cell in exchange for Ca2+ through reverse-operation of the Na+/Ca2+ exchanger, 
ultimately causing Ca2+ triggered cell death. This process is likely exasperated in 
inflammatory environments, where healthy myelin acts as a protective barrier against 
damaging molecules such as nitric oxide (NO) (Redford et al. 1997), which can lead to 
the degeneration of electrically active axons (Smith et al. 2001; Kapoor et al. 2003). 
Finally, studies in mice (Griffiths et al. 1998) and humans (Garbern et al. 2002) with 
genetic defects that produce oligodendrocytes which lack proteolipid protein 1 but 
nevertheless form compact myelin have shown that myelinating cells supply not just the 
myelin itself but also trophic support in the form of neurotrophic factors. Subsequent 
experiments have revealed a list of such factors supplied by oligodendrocytes, including 
IGF-1 (Wilkins et al. 2001), and GDNF (Wilkins et al. 2003; Nave 2010 for a review). 
Intriguingly, the first two mechanisms are directly connected to the axon’s pool of 
mitochondria. As laid out above, mitochondria supply virtually all ATP of a neuron and 
buffer its calcium. Furthermore, high concentrations of NO disturb mitochondrial ATP 
production by interfering with electron transfer at cytochrome oxidase (Brookes et al. 
1999; Pacher et al. 2007) and increase the formation of peroxynitrate, which causes lasting 
damage to mitochondrial proteins and DNA (Campbell et al. 2011). 
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One particularly interesting indication of a link between demyelination, axonal 
degeneration, and mitochondria can be found in the different forms of Charcot–Marie–
Tooth disease (CMT). CMT is an inheritable neuropathy characterised by the 
degeneration of long peripheral axons with minimal inflammation and which leads to the 
progressive loss of muscle mass and sensation (Vallat et al. 2013). Most subtypes of CMT 
affect Schwann cells and cause demyelination (Bouhy & Timmerman 2013). However, 
one particular sub-family of the disease, type 2A, leads to axonal loss by impairing the 
transport of axonal mitochondria through a defect in the motor protein KIF1B β (Zhao 
et al. 2001) or the mitochondrial fusion protein MFN2 (Baloh et al. 2007). Intriguingly, 
the clinical outcome – progressive loss of peripheral axons starting with the longest – is 
remarkably similar in both cases (Krajewski et al. 2000; Vallat et al. 2013). This similarity 
could be explained if demyelination lead to a decrease in mitochondrial transport. 
Studying the role of mitochondria in demyelination, therefore, can lead to a better 
understanding of the “slow burning” degeneration of chronically demyelinated axons in 
CMT and other diseases. 
 
DEMYELINATION AND MITOCHONDRIA: PREVIOUS WORK AND 
OPEN QUESTIONS 
Both the physiology of demyelinated axons, and the relationship between demyelination 
and mitochondrial density have been studied in some detail. Much of our understanding 
of the physiology of demyelinated axon stems from a series of experiments by Smith, 
Bostock, Hall et al. in the early 1980s. Using toxin-induced demyelination in the rat and 
mouse saphenous nerve, and later the spinal cord, the authors showed that following 
acute loss of myelin, axons undergo a phase of conduction-block and complete loss of 
excitability, which persists for a few days (Felts et al. 1997; Smith & Hall 1980). After 
this initial period, axons regain the ability to be excited and propagate currents over 
small distances, albeit in a very different manner to normal conduction: in the case of 
lysolecithin (LPC)-mediated demyelination (see chapter 2), conduction was shown to 
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return in a micro-saltatory fashion with novel foci of inward currents at short intervals 
found along the still naked axon (Smith et al. 1982). At a similar time point, axons 
demyelinated using diphtheria toxin were shown to conduct in a continuous fashion 
(Bostock & Sears 1978). Robust propagation of action potentials did not occur until later 
when axons were again surrounded by a thin sheet of myelin. Even then, however, action 
potentials were found to be elongated, slower, and with significantly prolonged refractory 
periods (Smith & Hall 1980). At this point in the demyelination – remyelination cycle, 
demyelination of the saphenous nerve has also been reported to lead to spontaneous 
action potential firing (Smith & McDonald 1980; Kapoor et al. 1997; Wallace et al. 2003). 
Normal conduction returned only much later after the myelin sheaths surrounding axons 
had returned to their maximal remyelinated thickness (Smith et al. 1979; Smith & Hall 
1980). Others soon contributed potential cellular correlates of these effects: both sodium 
(Shrager 1989; Black et al. 1991; Novakovic et al. 1996; Craner et al. 2003) and potassium 
(Rasband et al. 1998) channels, which are usually confined to the nodes of Ranvier were 
found to be redistributed along demyelinated axon. Additionally, accumulation of calcium 
channel subunits (Kornek et al. 2001) and acid sensing calcium channels (Vergo et al. 
2011) have been reported in inflammatory demyelination, suggesting potential changes 
in axonal calcium homeostasis. In fact, increased axoplasmic Ca2+ is widely regarded as 
a consequence of demyelination (Waxman 2006; Trapp & Nave 2008), although to my 
knowledge this has never been experimentally confirmed. 
These alterations in axonal physiology, particularly in the phase of returning micro-
saltatory conduction, could be predicted to have an effect on axonal energy consumption 
and therefore mitochondria. And, indeed, there have been a number of investigations 
corroborating this theory. Post mortem studies of both animal models of demyelination 
(Mutsaers & Carroll 1998; Hogan et al. 2009) and brains of patients with the 
demyelinating disease multiple sclerosis (Zambonin et al. 2011; Campbell & Mahad 2011) 
have consistently shown an increase in both the size and number of mitochondria in the 
region of demyelination. Similarly, mitochondrial activity (measured via cytochrome c 
histochemistry) was found to be significantly increased in mice carrying the 
dysmyelinating shiverer mutation (Andrews 2006). These findings have had a strong 
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influence on theories of axon degeneration in chronic demyelination (Trapp & Nave 2008; 
Lassmann & van Horssen 2011; Campbell et al. 2012) where the observed accumulation 
of mitochondria is commonly interpreted as a physiological (and healthy) reaction which 
ultimately preserves the axon. 
Mitochondrial dynamics and function in demyelination have been investigated to a lesser 
extent. Most of what we know about mitochondrial transport in demyelinated axons 
stems a series of in vitro experiments from Bruce Trapp’s lab. Using co-cultures of DRG 
neurons and Schwann cells, the authors report significantly increased mitochondrial 
transport 48h after LPC induced demyelination which returns to baseline levels after 
remyelination 15 days later (Kiryu-Seo et al. 2010). They demonstrate that this change 
is not caused by LPC itself and they suggest the neuronal transcription factor ATF3, 
which is known to play a role in regeneration, is required for the observed increase of 
transport. Though a later study involving the same authors and using the same method 
failed to show the same effect (Zambonin et al. 2011), it was recently replicated 
successfully in cultured slices (Ohno et al. 2014) which were treated with LPC for 26h 
and imaged after another 24h. These studies suggest that the cell might compensate for 
the putative increase in energy demand by increasing the production and trafficking of 
mitochondria which, given the constraints above, seems like an appropriate reaction. 
There are, however, some caveats which make it hard to extrapolate these findings to 
the living animal. The studies are restricted to early time points at which, at least in 
vivo, the axon could be expected to experience conduction block (Smith & Hall 1980). 
One could therefore argue that the reported increase in transport is in line with findings 
of increased axonal transport in axons blocked with TTX (Ohno et al. 2011; Obashi & 
Okabe 2013). If the increase in transport is indeed a direct effect of conduction block, it 
would be interesting to observe whether a return of conduction in a more energetically 
expensive, micro-saltatory fashion has the opposite effect (although this might be difficult 
to achieve in vitro). Activity aside it is interesting to speculate what effect such a lesion 
might have if it was focal and far enough removed from the cell body. In vitro 
demyelination is spread across the whole culture with the same dose of LPC reaching the 
somata as reaches the axons. Since LPC interacts with both G-protein coupled receptors 
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and MAP kinase pathways (Bassa et al. 1999; Jing et al. 2000; Xu 2002) this kind of 
application is likely to have significant effects on the soma. If demyelination occurred 
away from the cell body, might it cause the same kind of increased transport but without 
the increased supply from the soma, thereby draining mitochondria from the axon and 
leaving it exposed to the increase in energy demand after remyelination? 
Another observation with potential effects on mitochondrial trafficking is that the 
diameters of demyelinated axons both after treatment with LPC and in experimental 
autoimmune encephalitis were reported to be smaller than those of myelinated ones 
(Raine et al. 1969; Hall & Gregson 1971). The changes were found to correspond well 
with the time course of demyelination and were largely reversed by remyelination (Hall 
& Gregson 1971). Furthermore, it was found that the axonal cytoskeleton undergoes 
reversible changes in LPC demyelination and that these changes are likely secondary to 
the demyelination rather than a direct effect of the LPC (Jean et al. 2002). Both changes 
may be highly relevant for mitochondrial transport as axons are spatially very restricted 
environments (Wortman et al. 2014), particularly given the high density of stationary 
mitochondria in demyelinated axons. Experiments in Drosophila have suggested that 
accumulation of mitochondria can impose enough of a spatial constraint to impair axonal 
trafficking (Narayanareddy et al. 2014) and cell culture experiments suggest that axonal 
transport slows down in the vicinity of stationary organelles (Che et al. 2016). It is 
therefore at least conceivable that an increase in mitochondrial density, particularly 
combined with a decrease in intra-axonal volume could lead to further impairment of 
mitochondrial trafficking. 
 
Finally, there is the question of mitochondrial function / activity. Kiryu-Seo et al. 
convincingly demonstrate that knockout of the mitochondrial anchoring protein 
syntaphilin in combination with demyelinating treatments leads to axonal death both in 
vivo and in vitro (Kiryu-Seo et al. 2010). This strongly suggests that the increased 
mitochondrial content in demyelinated axons is necessary for axonal survival. However, 
it is not entirely clear what function the additional mitochondria fulfil. The early time 
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point indicates that their main function is not to balance out increased energy demand. 
However, the other common explanation, that they might buffer increased intracellular 
calcium, seems at odds with the observed increase in transport (compare e.g. Saotome et 
al. 2008; Zhang et al. 2010). 
In summary, whilst a link between demyelination and mitochondria is well established, 
many of the details are still unknown. In particular, it would be desirable to understand 
mitochondrial function and dynamics at different time points during de- and 
remyelination as these are characterised by vastly different activity patterns of the axon. 
 
STRUCTURE, AIMS AND OBJECTIVES 
 
 
Figure 1.2: Potential influences on mitochondrial function and dynamics in 
demyelination. Factors include changes in energy demand (both increasing and 
decreasing), calcium homeostasis, and spatial constraints. See text for details. 
 
The aim of this PhD project is to investigate changes in mitochondrial dynamics in 
demyelinated axons under conditions of realistic energy demand in vivo. Chapter 2 begins 
with a pilot study during which the well-established lysolecithin model of demyelination 
is replicated in the saphenous nerve and mitochondrial dynamics in myelinated and 
demyelinated axons are assessed at a single time point. Chapter 3 describes the methods 
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for quantifying mitochondrial function and dynamics in more detail and contains my 
findings about mitochondria in the saphenous nerve of naïve animals. In Chapter 4, the 
same methods are applied to quantify mitochondrial membrane potential and trafficking 
throughout the whole time course of de- and remyelination, capturing states of 
conduction block, early micro-saltatory conduction, and return to normal conduction. In 
order to embed the finding in the context of earlier work, the time course of de- and 
remyelination in the saphenous nerve is mapped out both anatomically using semi-thin 
resin sections and functionally via electrophysiological recordings of evoked compound 
action potentials. Chapters 5 and 6 investigate potential mechanisms underlying the 
findings in chapter 4: the effects of drug-induced conduction block are measured and 
intra-axonal calcium is quantified and compared between myelinated and demyelinated 
axons. Chapter 7 concludes with a general discussion of all findings.  
It is my hope that taken together, these experiments help tease apart and better 
understand the different aspects of demyelination and their effects on mitochondria. 
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CHAPTER 2: PILOT STUDY - MITOCHONDRIAL 
DYNAMICS IN LYSOLECITHIN-MEDIATED 
DEMYELINATION ON DAY 7 
INTRODUCTION 
I began the investigation of mitochondrial dynamics in demyelination by conducting a 
pilot study. The goal of this preliminary investigation was to establish a demyelination 
protocol, develop an initial version of the tools needed to quantify mitochondrial 
trafficking, and investigate mitochondrial dynamics at a single time point during 
demyelination to establish whether it was affected by demyelination at all. Many aspects 
of this pilot study were improved and elaborated upon later (see especially chapters 3 
and 4). Where this is the case I will limit myself to a short description here and refer to 
later chapters for more detail. 
 
CHOICE OF DEMYELINATING AGENT 
The first step in any study of demyelination is to choose an appropriate method of 
demyelination. Broadly, there are three ways of inducing demyelination: inflammation, 
genetic manipulations which cause demyelination and the application of demyelinating 
agents. 
Inflammation-induced demyelination plays an important role in diseases such as multiple 
sclerosis or Guillain-Barré syndrome. However, inflammation is a complex process with 
wide-ranging effects from changes in local blood flow and oxygen supply (e.g. Andrew L 
Davies et al. 2013) to the release of cytokines and reactive oxygen species (Cross et al. 
1998) by immune cells. The latter have been shown to have a direct effect on 
mitochondrial function (Nikić et al. 2011) and trafficking (Rintoul et al. 2006; Sorbara et 
al. 2014), as well at axonal integrity (Kapoor et al. 2003). This makes it hard to untangle 
inflammation-mediated mitochondrial changes from those caused by demyelination. 
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Genetic methods can be used to specifically mimic human diseases (see e.g. Fledrich et 
al. 2012 for an overview of the many available mouse models of the demyelinating form 
of Charcot-Marie-Tooth) or to very specifically target a single cell type. Two examples 
of the latter are the expression of the diphtheria toxin receptor in oligodendrocytes 
followed by the injection of small doses of the toxin (Buch et al. 2005; Locatelli et al. 
2012) and even the direct expression of the diphtheria toxin A subunit controlled by 
tamoxifen injection (Traka et al. 2010; Traka et al. 2016). These approaches enable 
“clean” demyelination with little damage to other cell types and have been successfully 
used to study e.g. the effect of myelin debris on the acquired immune system. However, 
they are also expensive and difficult to combine with other genetic tools such as labelling 
of mitochondria or calcium indicators. 
Alternatively, there is a collection of toxins which have been used to induce 
demyelination. Examples include the copper chelator cuprizone (Matsushima & Morell 
2001), ethidium bromide (Black et al. 2006), anti-galactocerebroside antibody and 
complement (Mutsaers & Carroll 1998), the calcium ionophore ionomycin (Smith & Hall 
1988), and lysolecithin (Hall & Gregson 1971). Of these, ethidium bromide and 
lysolecithin seem most appropriate for the purposes of this study, as they can both be 
topically applied to nerves and can cause reliable demyelination without overt damage 
to axons (Woodruff & Franklin 1999). 
Ethidium bromide (EB) is a DNA chelator which binds to both DNA and RNA and 
thereby disrupts protein synthesis. It has been used extensively in studies of 
demyelination where it was reported to cause less axonal damage than LPC (Blakemore 
1982; Woodruff & Franklin 1999). However, very early on the were reports of 
mitochondria abnormalities in the affected cells (Yajima & Suzuki 1979; Blakemore 
1982). Since then, EB has been shown to reduce drastically the content of mitochondrial 
DNA in cells (Leibowitz 1971; Desjardins et al. 1985) and interfere with oxidative 
phosphorylation (Hayashi et al. 1990), which complicates any subsequent measurements 
of mitochondrial function. 
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Lysolecithin (LPC) is a lipid with detergent properties which has been used extensively 
both in vivo (Hall & Gregson 1971; Smith & Hall 1980; Bieber et al. 2002) and in vitro 
(Birgbauer et al. 2004). The exact mechanism by which LPC induces demyelination is 
not known. It has been suggested that it damages myelin as well as other lipid membranes 
because of its detergent properties (Hall & Gregson 1971; Birgbauer et al. 2004), however 
stronger detergents were found to cause no demyelination (Low et al. 1983). Instead, the 
effects of LPC on myelin may be more specific, for example through binding to myelin 
basic protein (Hughes et al. 1982; Smith 1982) which would also explain why axons and 
Schwann cell somata in LPC lesions do not to take up the tracer ferritin and are therefore 
believed to have an intact cell membrane (Hall & Gregson 1971). Alternatively, it has 
been suggested that lysolecithin and its conversion product lysophosphatidic acid activate 
G-protein coupled receptors (Xu 2002) and MAP kinase pathways (Bassa et al. 1999; 
Jing et al. 2000) and thereby induce apoptosis. However, this theory is at odds with 
multiple findings of low doses of LPC destroying the myelin surrounding axons while 
leaving cell bodies - including those of the myelinating cells - intact (Hall & Gregson 
1971; Griffin et al. 1990; Woodruff & Franklin 1999). Cell bodies might also be protected 
from excessive damage because of their ability to break down LPC via the enzymes 
lysophospholipase and LPC-acyltransferase (Low et al. 1983). This theory is also 
supported by findings by Hall and Gregson showing that inhibition of the oxidative 
metabolism through cyanide and therefore cessation of enzymatic activity including (but 
obviously not limited to) acylation of LPC leads to widespread damage of Schwann cells 
and axons by LPC which is not seen in the absence of cyanide (Gregson & Hall 1973). 
Because of these enzymatic reactions, the biological half-life of LPC in vivo is believed to 
be very short. 
Due to the interference of EB with mitochondrial function, LPC was chosen as the 
demyelinating agent for most experiments in this thesis, with the exception of an EB 
control experiment (see Appendix C). 
Axonal damage in LPC mediated demyelination was repeatedly found to be low (Hall & 
Gregson 1971; Smith & Hall 1980; Woodruff & Franklin 1999; Wallace et al. 2003) but 
increasing with concentration. At the same time, the length of the demyelinated section 
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increases with higher concentrations. Hence, an appropriate dose was established in the 
pilot study. 
In order to avoid injecting LPC solution into the small saphenous nerve, the agent was 
applied topically as described previously (Griffin et al. 1990; Wallace et al. 2003). The 
resulting demyelination was assessed in two different ways: firstly, by using the lipophilic 
fluorescent dye FluoroMyelin (Monsma & Brown 2012) for its ease of use and in the hope 
that it might be applicable later during in vivo imaging, and secondly in a more 
traditional fashion using toluidine-blue stained semi-thin resin sections. 
 
DEMYELINATION AND AXON PHYSIOLOGY ON DAY 7 
The cycle of de- and remyelination after lysolecithin application in the peripheral nervous 
system is quite fast with remyelination of virtually every affected axon after three weeks 
(Hall & Gregson 1971; Smith & Hall 1980). Along with the changes in myelination, axons 
in LPC lesions undergo changes in physiology from (in order of time) conduction block 
to abnormal, micro-saltatory conduction, to restored near-normal conduction (Smith et 
al. 1979; Smith & Hall 1980; Smith et al. 1982). For the pilot study, day 7 after the 
surgery to induce demyelination was chosen since at this time point demyelination is well 
established and the myelin debris has been largely cleared (Hall & Gregson 1971), but 
axons are still in the phase of conduction block (Smith & Hall 1980). For a detailed 
discussion of the time course of demyelination, see Chapter 4. 
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MATERIALS AND METHODS 
 
ANIMALS 
Ex vivo assessment of demyelination was carried out using male C57Bl/6J wildtype mice. 
The animals were acquired from Charles River at an age of 6 to 8 weeks and left to 
acclimatise to their new environments for at least 7 days after arrival. 
Mice used for mitochondrial imaging were male, heterozygous, Thy1-CFP-S positive 
(main study) or Thy1-CFP-S positive and negative (pilot study) littermates (Jackson 
laboratories strain designation: B6.Cg-Tg(Thy1-CFP/COX8A)S2Lich/J) (Mito-S). Mice 
were bred in-house and had been back-crossed to C57Bl/6J for at least three generations. 
Mito-S mice selectively express cyan fluorescent protein (CFP) under the mouse thymus 
cell antigen 1, theta (Thy1) promotor which is localized to the mitochondrial inner 
membrane by a human cytochrome c oxidase subunit 8A targeting signal (Misgeld et al. 
2007). Mitochondrial physiology and morphology were reported to be normal in 
heterozygous animals (Misgeld et al. 2007 ) which has led to a widespread use of this 
mouse line in mitochondrial research (e.g. Bilsland et al. 2010; Nikić et al. 2011; Sajic et 
al. 2013; Sorbara et al. 2014). However, it should be noted that some homozygotes 
develop a tremor in adult life (Misgeld et al. 2007, supplementary). We found that CFP 
is expressed in approximately 30-50% of all myelinated saphenous nerve axons where it 
can be detected with roughly equal intensity in all mitochondria. Unmyelinated C-fibres, 
in contrast, do not appear to express CFP. 
The age of all mice commonly ranged from 8 to 12 weeks, never exceeding 16, and care 
was taken to ensure that treatment and control groups were age-matched and wherever 
possible litter mates. 
All animal experiments were carried out according to the 1986 Animals (Scientific 
Procedures) Act, UK, and were approved by the institutional ethics committee. 
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DEMYELINATION PROCEDURE 
Animals were anaesthetized using isoflurane (5% induction, 1-2% during surgery) and 
placed on a heating mat connected to a temperature control unit. At the beginning of 
the surgery they were injected with 10μl Vetergesic s.c. (0.3mg/ml, Alstoe Animal Health) 
to ensure adequate analgesia after recovery. Subsequently, the hair was removed from 
the inside of the leg using clippers and hair removal cream, and the skin was sterilized 
with iodine and sterile ethanol wipes. An incision was made at the thigh, exposing 
approximately 1 cm of the saphenous nerve. Connective tissue and fat were carefully 
removed from the top of the nerve without damaging the perineurium. Lysolecithin 
(L4129, Sigma) was diluted in sterile physiological saline (0.5%, 1%, 2% for dose 
assessment, 1% or pure saline for all subsequent experiments), vortexed for at least 20 
minutes, and applied topically to the nerve, using the surrounding skin as a well. It was 
held in place for 20 minutes and topped up if necessary to keep the tissue from drying 
(usually one top-up of 1-2 drops, never more than two top-ups). For control animals, the 
same procedure was conducted with sterile saline instead of LPC. After 20 min, the 
opening was washed thoroughly with saline and the skin sutured shut with 2-4 sutures 
of 6-0 polypropylene thread (Ethicon). Animals were observed for at least 1h post-surgery 
and daily afterwards. The surgery was well tolerated and complete recovery was seen 
within a couple of hours. Where necessary, sutures were removed after seven days. 
SEMI-THIN RESIN SECTIONS 
At the desired time points after treatment, animals were anaesthetized using isoflurane 
(3%) and euthanized via cardiac perfusion with heparinised buffered saline followed by a 
mixture of 4% paraformaldehyde (PFA) and 2% glutaraldehyde in phosphate buffered 
saline (PBS). Approximately 5mm of each nerve (two per animal) was harvested and 
post fixed overnight in 4% glutaraldehyde. Afterwards, the tissue was washed (3x10 min; 
0.1 M PO4 buffer; pH 7.4), post-fixed in osmium tetroxide (1.5%) for 1h, washed again 
(3x10 min; 0.1 M PO4 buffer; pH 7.4), dehydrated in an ascending series of ethanol (30%, 
50%, 70%, 90%, 3x100%; 20min each) and passed via propylene oxide into resin (TAAB 
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Laboratories, Aldermaston, UK) where it was left overnight. Subsequently, the nerve 
fragments were embedded in coffin moulds in fresh resin and heated at 60ºC for 48 hours. 
0.7μm thick transverse sections were cut from the middle part of each specimen using an 
ultramicrotome (Reichert Ultracut S, Leica), stained with toluidine blue and examined 
and photographed using a Zeiss Axiophot microscope equipped with a Nikon D300 
camera (Nikon, USA). 
Images were processed using Fiji/ImageJ Version 1.48. Photographs of resin sections were 
converted to grayscale and contrast was optimised for each image such that the image’s 
histogram covered the whole range of grey levels. 
 
ASSESSMENT OF DEMYELINATION 
Animals and treatments per experiment were as follows: first, mice (n=2 per group, n=8 
total) were treated with 0.5%, 1%, or 2% LPC or saline applied to the saphenous nerve 
of their left leg and prepared for imaging as described below 7 days later. The lipophilic 
fluorescent dye FluoroMyelin Green (FlM, life technologies) was diluted 1:25 in 
physiological saline and applied to the desheathed nerve either on its own for 30 min or 
in combination with 0.5µM TMRM for 45 min. Residual dye was washed off. A well 
made of petroleum jelly was formed around the surgical opening, and the opening was 
covered with a glass coverslip. Imaging was performed using an LSM Pascal 5.0 confocal 
microscope (Zeiss) and a Zeiss Appochromat Plan 63x oil objective (NA 1.4).  
Subsequently, 4 animals (n=2 per group) were treated with either 1% or 2% LPC applied 
to their left saphenous nerve, with saline applied to the right nerve as a control. The 
animals were perfused and nerves were harvested after 7 days and processed into resin 
as described above. 
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IN VIVO MICROSCOPY 
 
Figure 2.1: Sketch of the imaging setup. Animal placed in supine position and 
viewed from above. 
 
Mito-S mice underwent demyelination or control treatment (n=4 sham surgery, n=5 LPC 
treatment) and after 7 days were prepared for imaging as described above. In addition, 
another n=4 naïve animals were imaged without any treatment.  
Animals were injected with 2g/kg urethane (Sigma, diluted 20% w/v in sterile saline) 
and, 10 minutes later, with a small dose of 20mg/kg ketamine (Ketaset, Fort Dodge, 
diluted to 10mg/ml). This anaesthetic combination enabled stable, long term anaesthesia 
with a significantly accelerated onset compared with urethane alone (see also: 
Klausberger et al. 2003; Moldestad et al. 2009; Molden et al. 2013). Toe pinch reflexes 
were checked regularly and, if necessary, additional urethane was added. Surgical depth 
of anaesthesia was reached after about 15 minutes at which point the hair was removed 
from the inside of the leg using clippers and hair removal cream. Mice were placed in a 
supine position on a heating mat connected to a temperature control unit and mounted 
on a customized stage. Additional heating was provided via an electrically grounded 
heating lamp. 
The left leg was immobilized using a dental impression polymer (Examix NDS Monophase 
Purple, GC America) (Misgeld et al. 2007; Haney et al. 2008). An incision was made at 
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the thigh, exposing approximately 1 cm of the saphenous nerve. Connective tissue and 
fat were carefully removed from the top of the nerve. Using a tungsten needle, a small 
hole was produced in the perineurium, following which the nerve was desheathed carefully 
using Vannas scissors. In order to keep the tissue from drying, sterile saline was applied 
whenever necessary. After the surgery was completed, TMRM was applied at a 
concentration of 0.5µM in sterile saline for 45 minutes after which the residual dye was 
washed off (Sajic et al. 2013). Subsequently, a well made of petroleum jelly was formed 
around the surgical opening, fresh saline was applied, and the leg was covered with a 
glass coverslip. The animal was transferred to the custom made stage of an LSM Pascal 
5.0 confocal microscope (Zeiss). Images were taken using either a Zeiss Appochromat 10x 
objective (NA 0.3; overview tiles only) or a Zeiss Appochromat Plan 63x oil objective 
(NA 1.4). 
A pixel size of 0.16µm was chosen to satisfy the Nyquist sampling criterion for small 
particles (Petty 2007) and to improve segmentation performance (Jaqaman & Danuser 
2009). The pinhole size was set to 1.2 AU and time lapses were recorded at 1 frame/sec 
for 65 seconds. Successive dual colour CFP / TMRM images were taken to help 
distinguish axonal mitochondria from mitochondria found in other cells. However, time 
lapses were based on the TMRM signal alone because of its superior contrast and 
prohibitive bleaching caused by repeated CFP imaging. 
FluoroMyelin, while useful to assess demyelination in LPC dose calibration, was found 
to have a very broad emission spectrum which overlapped with both CFP and TMRM 
and which rendered it unsuitable for use in mitochondrial imaging. For time lapse 
recordings, myelination was thus assessed via the presence or absence of a red ‘border’ 
around axons caused by TMRM in the myelin layers. 
 
IMAGE ANALYSIS AND STATISTICS 
Recordings of mitochondrial movement were originally analysed using an early version of 
the methods described in chapter 3. For consistency, and because the latest version of 
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the analysis scripts has been more stringently tested, results presented here have been 
re-analysed using the same methods as described in chapter 3. Briefly, videos were 
segmented frame by frame using the Squassh algorithm (Rizk et al. 2014) in combination 
with point spread functions acquired using the same settings as during recording. 
Particles were then split and classified as either static or moving using custom made 
Matlab scripts, and tracked using the Matlab package uTrack 2.1.3 (Jaqaman et al. 2008) 
with custom cost matrices. Note that in contrast to all subsequent experiments, CFP 
fluorescence was not recorded and thus no relative TMRM intensity was measured. 
Similarly, statistical analysis, which was originally done using a naïve approach (see 
Appendix A) was re-done using a nested approach. Where possible, conditions were 
compared on an axon-by-axon basis. Using the nlme package for R, a two-level linear 
model with a fixed slope and random intercepts was fitted to the data. The variable of 
interest (e.g. average speed of mitochondria) per axon was used as the response variable, 
treatment/day as a fixed effect, and animal ID as a random effect. Multiple comparisons 
were corrected using Tukey correction. Probability density estimates were calculated 
using Matlab’s ksdensity function with a normal kernel. Corresponding confidence 
intervals were estimated via Bootstrapping using 10,000 repeated draws of the same 
sample size as the original distribution. The 95% confidence interval for cumulative 
distribution functions was estimated using Greenwood’s Formula. 
RESULTS 
LYSOLECITHIN DOSE ASSESSMENT 
The use of FluoroMyelin green resulted in crisp images of myelinated axons with the 
nodes of Ranvier clearly visible. The pathology appeared comparable to pictures taken 
using incident light microscopy (for comparison, see e.g. Hall & Gregson 1971 figures 
2,3), and the quality approached that of longitudinal resin sections. 
 
 49 
 
Figure 2.2: Comparison of incident light microscopy and confocal imaging 
using FluoroMyelin Green in vivo. A: Incident light images taken 6 days after 
injection of 1% LPC into the mouse sciatic nerve (Hall & Gregson 1971 figures 2,3) B: 
Saphenous nerve stained with FluoroMyelin Green and imaged on a confocal microscope 
7 days after topical application of 2% LPC. 
 
In saline-treated animals, axons lay in parallel and they were close to each other. A few 
severed axons could be seen, but they were found mostly where the perineurium was first 
opened, suggesting damage during the imaging surgery rather than during treatment. 
Where TMRM was used, mitochondria were found to be restricted largely to the 
axoplasm with some TMRM positive particles found in the myelin close to the nodes. 
Overall, the nerve fibres took up the vast majority of space and only remarkably few 
other cells were visible in any given field of view (Figure 2.3). Rarely, this included mobile 
macrophages which were usually clearly identifiable in experiments involving TMRM due 
to their cell shape, bright mitochondria and movement patterns, but were usually absent 
from preparations, including those with clear signs of demyelination. 
Nerves treated with LPC reliably showed signs of myelin disturbance which increased in 
a dose-dependent manner (Figure 2.4). In the case of 0.5% LPC the disturbance was 
largely restricted to a less-smooth appearance of the sheath. Axons still lay in parallel 
and in close proximity to one another. Nerves treated with 1% or 2% LPC showed much 
stronger signs of myelin damage with fewer axons visible per field of view. Instead, long, 
oval fields of debris very similar to the ones described by Hall and Gregson using incident 
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light microscopy could be seen between axons (Figure 2.2). The fluorescent signal 
appeared less crisp, individual axons were harder to make out, and nodes of Ranvier were 
rarely, if ever, seen. Importantly, where demyelination was visible it appeared to extend 
deeper into the nerve than was possible to image using the available confocal setup, 
suggesting that doses higher than 2% or a treatment for longer than 20min were not 
necessary for in vivo imaging. Based on these observations 1% and 2% LPC were selected 
as doses for a more detailed investigation using transverse resin sections. 
 
Figure 2.3: Dual colour in vivo imaging of FluoroMyelin (green) and TMRM 
in a saline treated animal. Top: Mitochondria indicated by TMRM. Middle: 
FluoroMyelin Green signal. Bottom: Merged. Note the accumulation of non-axonal 
mitochondria near the nodes (arrows). 
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Figure 2.4: Examples of FluoroMyelin imaging after application of LPC. Left 
side: Saphenous nerve imaged from above 7 days after topical application of different 
doses of LPC. Right side: Corresponding transverse sections recreated from Z stacks. 
Arrows indicate nodes of Ranvier. 
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The first important histological finding was that sham procedures did not cause any signs 
of demyelination or damage to the axons (Figure 2.5). Application of LPC produced signs 
of demyelination in three out of four nerves (2x 1%, 1x 2%). In all cases, axons could be 
found near the top of the nerve which appeared to be surrounded by very little or no 
myelin. Many of them were associated with cells. Very rarely, dystrophic axons 
(characterized by dark, granular appearing axoplasm) could be spotted. The area in 
which these changes could be observed covered approximately 10%-30% of the nerve’s 
cross section. While the previous set of FluoroMyelin experiments suggested increased 
demyelination in 2% LPC treated animals compared with 1% LPC treated animals, this 
relationship was not replicated histologically. The two nerves treated with 1% LPC 
showed at least as many signs of demyelination as the first animal treated with 2% LPC. 
No demyelination was found in the second nerve treated with 2% LPC. However, the 
corresponding control nerve was damaged during processing, and it is possible that the 
two pieces of tissue were swapped. Given that the experiment revealed no obvious reason 
to favour 2% LPC over 1% LPC, I decided to use the lower concentration for all 
subsequent experiments. 
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Figure 2.5: Semi-thin transverse resin sections of the saphenous nerve on d7 
after topical application of 1% LPC, 2% LPC or saline. Scale bars on the left 
indicate 20μM; orange rectangles indicate the original locations of the magnification seen 
on the right. Arrows indicate demyelinated axons, often with associated cells. See text 
for details and Figure 4.2 for comparison. 
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MITOCHONDRIAL DYNAMICS IN MYELINATED AND DEMYELINATED 
AXONS 
Myelinated and demyelinated axons could be clearly distinguished even though 
FluoroMyelin was not used in this series of experiments because of bleed-through into 
the TMRM signal. While myelinated axons were surrounded by thin, visible borders 
(likely due to some TMRM uptake into the myelin), the only visible part of demyelinated 
fibres was often a string of mitochondria. The genetically encoded CFP signal was helpful 
in revealing axonal damage which appeared more widespread than suggested by the 
transverse resin sections: about one in ten axons on the nerve surface presented with 
TMRM negative mitochondria, indicating a lack of Δψm and/or Δψp (Figure 2.6). Such 
damage was very rarely seen in naïve or sham operated animals. Mitochondrial 
polarisation appeared uniform within axons, that is either all or none of the mitochondria 
of a given axon seemed to be polarised. No movement of CFP-positive, TMRM-negative 
mitochondria was observed and axons with depolarised mitochondria were discarded from 
further analysis. 
As reported above, few cells could be seen between the axons in naïve and sham-treated 
animals. In LPC preparations, non-neuronal cells associated with axons could be seen as 
well as large, debris-laden cells in between nerve fibres. Here, the CFP signal was useful 
for telling axonal and non-axonal mitochondria apart. Mobile macrophages were virtually 
absent from all preparations. 
Of all data collected during the pilot study, 270 recordings of individual axons were found 
to be stable enough for analysis: 84 axons from naive animals, 119 axons from sham 
treated nerves and 67 demyelinated axons. 
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Figure 2.6: Examples of mitochondria in saphenous nerve axons, imaged in 
vivo: Genetically encoded CFP is shown in cyan, TMRM signal in red. Signal overlap 
appears white. A: Myelinated axons. Note the node of Ranvier in the top image and the 
red outline of the axons indicating the presence of myelin. B: Demyelinated axons 7 days 
after LPC treatment. Note the lack of a myelin border around the axons and the high 
density of mitochondria. Bars indicate 10µm. 
 
 
Axon width was estimated as the width of the smallest rectangle around the straightened 
axon that could contain 98% of all mitochondrial pixels. Surprisingly, by this definition, 
demyelinated axons were found to be significantly wider than both naïve and sham 
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treated axons (mean width of naïve axons: 3.99µm ± 0.174µm SE; sham treated axons: 
4.11µm ± 0.29µm, n.s.; demyelinated axons: 4.80µm ± 0.30µm, p<0.01 for both 
comparisons). Visual inspection showed that this was not caused by axonal swelling or 
beading; the demyelinated axons in question appeared straight and with a constant 
diameter. Nevertheless, mitochondrial density measured as percentage of the axoplasm 
slice covered by mitochondria was significantly increased from 11.25% ± 0.52% and 
11.22% ± 0.87% for naives and sham treated animals, respectively to 17.39% ± 0.91% in 
demyelinated axons (p<0.001). This increase could be explained by both a larger number 
of stationary particles and a significantly increased size (see Figure 2.7 C). In contrast, 
moving particles were found to have comparable sizes in all three conditions (Figure 2.7 
D). There was no difference in the size of anterogradely and retrogradely moving 
particles. 
The main objective of the pilot study was to establish whether demyelination would cause 
a change in mitochondrial dynamics. Total transport was calculated as the average sum 
of all particle speeds in either direction. In order to account for differences in the number 
of frames (e.g. due to removal of frames where focus on the axon was lost) and length of 
the recorded axon, this value was normalised to an axon length of 100µm and a recording 
of 60 frames (= 60 seconds). Demyelinated axons showed a significant decrease in 
mitochondrial transport in both anterograde and retrograde direction. Anterograde 
transport fell by 74.0% (± 16.2% SE) compared with naives and 74.3% (± 16.0%) 
compared with sham treated animals (p < 0.001 for both). Retrograde transport was 
reduced by 68.4% ± 26.0% (p < 0.05) and 76.7% ± 19.2% (p < 0.001), respectively 
(Figure 2.8 A). A more detailed analysis revealed that this decrease in transport was due 
to both a lower speed of moving mitochondria (Figure 2.8 B), and a smaller number of 
mitochondria being transported (anterograde: on average 3.97 ± 0.43 tracks per frame 
vs 3.880 ± 0.711 tracks in saline treated axons and 1.30 ± 0.75 tracks per frame in 
demyelinated axons; retrograde: 0.52 ± 0.09 tracks per frame in naïve axons vs 0.71 ± 
0.15 in saline treated axons and 0.17 ± 0.16 in demyelinated axons). Moving 
mitochondria were detected in all but 10 axons, nine of which were demyelinated, and 
one of which had undergone control treatment. 
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An interesting observation was that in all three conditions, retrograde transport was 
significantly lower than anterograde transport. In untreated axons, for example, 
anterograde transport on average accounted for 79% of all mitochondrial movement, 
which seemed to be largely due to a lower number of moving particles (see next chapter 
for a more detailed discussion of this phenomenon). 
 
 
Figure 2.7: Anatomical changes in demyelinated axons and their 
mitochondria. A: Demyelinated axons were significantly wider. Grey dots indicate 
individual axons, lines indicate population means, and circles show the means of different 
animals. B: Mitochondrial density was significantly increased in demyelinated axons. C: 
Cumulative frequency plots of mitochondrial sizes. Both graphs show the largest 25% of 
all particles and their 95% confidence intervals. 
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Figure 2.8: Mitochondrial dynamics in demyelinated axons on day 7. A: Total 
transport - average particle speed in either direction normalised to an axon of 100µm 
length and 60 seconds. Demyelinated axons present significantly decreased transport in 
both directions. Note the difference between anterograde and retrograde transport. Grey 
dots indicate individual axons, lines indicate population means, and circles show the 
means of different animals. B: Distribution of transport speeds for anterogradely and 
retrogradely moving mitochondria. Distributions for naïve and control treatment are 
nearly identical; mitochondria in demyelinated axons have reduced transport speeds. C: 
Average number of simultaneous tracks in either direction normalised to 100µm axon 
length. Fewer moving mitochondria are observed in demyelinated axons. 
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DISCUSSION 
This pilot study yielded interesting results, encouraging further investigation of 
mitochondrial dynamics in demyelination.  
A model of saphenous nerve demyelination by topical application of lysolecithin was 
successfully established and characterized. Care was taken to use the lowest LPC 
concentration possible in order to minimize axonal damage. I found that the application 
of 1% LPC for 20 minutes was sufficient for the purposes of this study, creating 
demyelination of the uppermost axons. This dose is slightly lower than doses used for 
topical application by other groups (Griffin et al. 1990; Wallace et al. 2003) but results 
appear similar. Wallace and colleagues, for example, describe demyelination of a 
maximum of 40% of axons in the saphenous nerve 13 days after topical application of 
1.5% LPC (Wallace et al. 2003). Note that the efficacy of this method of demyelination 
significantly improved with practise, leading to a much larger number of demyelinated 
fibres (see chapter 4). 
The naïve saphenous nerve contains a mixture of myelinated A fibres and unmyelinated 
C fibres with unmyelinated fibres outnumbering myelinated ones at a ratio of 
approximately 4:1 (Carter & Lisney 1987) which raises the question whether some of the 
observations may have been confounded by naturally unmyelinated fibres. However, I 
believe that this is unlikely for several reasons. The diameters of C fibres tend to be 
smaller than the diameter of A fibres by about an order of magnitude (Stucky et al. 2002) 
which makes it impossible to make out individual C fibre axoplasms in vivo. Furthermore, 
whilst myelinated fibres are evenly spaced across the nerve, C fibres are held closely 
together in so-called Remak bundles of usually >20 axons (Murinson & Griffin 2004) 
which branch and recombine regularly and contain large cell bodies between the 
individual axons. This gives them a foamy appearance in resin section as well as very 
distinct look in vivo (see Figure 2.9). Most importantly, C fibres do not seem to express 
the mitochondrially targeted CFP and were thus not selected for analysis. 
 
 60 
 
Figure 2.9: C-Fibre bundles imaged in vivo. Bars indicate 10µm. See text for 
details. 
 
In agreement with earlier reports of LPC-treated nerves (Hall & Gregson 1971) and 
demyelinating EAE (Raine et al. 1969), demyelinated axons appeared rounder and with 
a seemingly smaller diameter when looking at resin sections. However, this finding could 
not be replicated in vivo where, instead, axon diameter seemed significantly increased. 
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Whilst it is possible that this result was exacerbated by the way I estimated axon width 
in vivo (in naïve axons there is usually some space between mitochondria and the 
surrounding myelin which might get filled up with additional mitochondria in 
demyelinated axons) it nevertheless seems incompatible with the notion of a smaller 
diameter. This suggests that the decreased diameter reported previously might be a 
fixation artefact. 
Using live imaging and semi-automated quantification of movement the consequences of 
demyelination on mitochondrial transport were successfully investigated. In agreement 
with earlier studies (Mutsaers & Carroll 1998; Hogan et al. 2009), a significant increase 
in mitochondrial density was found. While a direct comparison with the two studies is 
complicated (both authors look at nerve cross-sections using electron microscopy), the 
1.55-fold increase in density found here lies slightly below the density increases found by 
Hogan et al. (1.7x) and Mutsaers & Carroll (2.36x). However, this discrepancy might be 
explained by two factors. Firstly, when looking at the axon in vivo, distinct mitochondria 
may overlap, making their cumulative area seam smaller than is really appropriate. 
Secondly, since measurements in the pilot study were performed based on TMRM images, 
it is possible that some of the mitochondria identified in untreated axons were in fact 
located in the myelin sheath (see also Gonzalez et al. 2015 in which only mitochondria 
in the myelin sheaths surrounding the saphenous nerve are visualised). This could have 
led to an overestimation of mitochondrial density in myelinated axons and hence an 
underestimation of the change compared with demyelinated axons. However, the increase 
in mitochondrial density measured in the time series experiments described in chapter 4 
which was calculated using CFP images was found to be almost exactly the same (1.60x 
on day 8), making this an unlikely explanation. While overall there were significantly 
more large mitochondria in demyelinated axons it should be noted that about 75% of all 
static particles in demyelinated axons were no bigger than those in myelinated axons, 
and well within the size range of moving mitochondria. An increase in size therefore does 
not appear to be the main cause of reduced mitochondrial transport. 
Compared with a related study of mitochondrial dynamics in the saphenous nerve 
previously conducted in the lab (Sajic et al. 2013), the velocities found in the pilot study 
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were slightly higher (e.g. 0.53µm/s vs 0.30µm/s for anterograde movement in axons of 
naïve animals). Furthermore, the average size of moving particles was found to be slightly 
smaller. Since the study at hand used a 50% higher spatial resolution and a 100% higher 
time resolution, it is possible that more small and fast particles were detected, thus 
explaining the discrepancy. This explanation is also supported by the fact that the 
average number of tracks identified here was 19 over 60 seconds, in contrast to an average 
of 3 tracks over 98.5s found previously (Sajic et al. 2013) (both in naïve animals and 
spanning 6 or more frames). 
An interesting phenomenon which is not related to demyelination per se is the significant 
difference between anterograde and retrograde mitochondrial transport observed in all 
groups. This phenomenon, although not fully understood, is well-described in the in vivo 
literature (Andrews et al. 2010; Zhang et al. 2010; Kiryu-Seo et al. 2010; Bilsland et al. 
2010; Sajic et al. 2013) and I was able to successfully replicated it using the improved 
methodology described in chapter 3. It is discussed in more detail there. 
Most importantly, I detected a highly significant decrease in mitochondrial transport due 
to demyelination. This finding is particularly interesting because it stands in obvious 
contrast to findings of demyelination causing increased mitochondrial transport in vitro 
(Kiryu-Seo et al. 2010; Ohno et al. 2014). As laid out in chapter 1, it could also be of 
clinical significance since mitochondrial transport is believed to be essential for 
mitochondrial maintenance. When writing up the findings of the pilot study, I speculated 
that whilst likely helpful in the short term (see Ohno et al. 2014), the local accumulation 
of mitochondria might be harmful for the long-term survival of the axon if it meant a 
decrease in mitochondrial transport and exchange of material. I was thus particularly 
intrigued by a recent paper by Joshi and colleagues showing that the knockout of the 
mitochondrial anchoring protein syntaphilin in dysmyelinating shiverer mice was in fact 
protective and prolonged the animal’s survival (Joshi et al. 2015). The study is discussed 
in more detail in chapter 7. 
At this point it was not clear what the cause of the decrease of transport might be. 
Previous studies suggested that in the majority of axons conduction should not have 
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returned by day 7, but given the slightly different methodology used here it was 
conceivable that the time courses might be different and the increase in mitochondrial 
density was indeed a reaction to heightened ATP demand. To investigate this possibility, 
I decided to map the whole time course of de- and remyelination in anatomical and 
electrophysiological terms and determine mitochondrial dynamics and function at 
multiple time points throughout. The results are described in chapter 4.  
The decrease in mitochondrial trafficking found in this study has one potential caveat: 
in situations of high mitochondrial density it is more challenging to track moving 
mitochondria accurately than in axons with fewer stationary particles. This particular 
problem is addressed in chapter 3, which explains my general approach to particle 
tracking in more detail and investigates the connection between mitochondrial density 
and observed transport in naïve animals, as well as in chapter 4 which contains analyses 
on mitochondrial transport for various densities of stationary mitochondria. 
As a result of this study, I also introduced several methodological changes. Firstly, instead 
of using sterile saline to surround the desheathed nerve during surgery and imaging, I 
decided to use artificial cerebrospinal fluid. I introduced this change because of the well-
known influence which calcium has on mitochondrial trafficking and because of studies 
showing significant effects on mitochondrial transport caused by using calcium free media 
in vitro (Zhang et al. 2010). Secondly, thanks to a microscope upgrade, I was able to 
record mitochondrial trafficking using simultaneous CFP and TMRM imaging. This 
development had two major advantages: it enabled me to separate clearly axonal 
mitochondria from Schwann cell mitochondria (compare Gonzalez et al. 2015) and it 
formed the basis for measuring TMRM intensity. 
In conclusion, the study of mitochondrial dynamics in demyelinated axons on day 7 after 
the application of LPC confirmed previous findings of a higher density of stationary 
mitochondria, and furthermore it revealed a highly significant decrease in mitochondrial 
trafficking. The result motivated me to investigate further the relationship between 
demyelination and mitochondria. 
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CHAPTER 3: MEASURING MITOCHONDRIAL 
TRANSPORT AND FUNCTION IN VIVO 
INTRODUCTION 
Mitochondrial dynamics are increasingly prevalent in the mitochondrial literature. 
However, whilst they have been investigated extensively both in vivo (Bilsland et al. 
2010; Sajic et al. 2013; Sorbara et al. 2014) and in vitro (Kiryu-Seo et al. 2010; Zhang et 
al. 2010; Obashi & Okabe 2013), the properties of the image acquisition and the modes 
of analysis vary significantly across studies. Recently, efforts have been made to compare 
and rank different tracking approaches (Chenouard et al. 2014; Bros et al. 2015), but to 
this day no generally agreed on solution has emerged. Similarly, TMRM is a common 
tool in mitochondrial research, but even in vitro its use has largely been restricted to  
hole cell analyses and examples of TMRM measurements at mitochondrial resolution are 
rare (Breckwoldt et al. 2014). 
Early during the course of this work I thus set out to develop an analysis pipeline which 
allowed me to quantify reliably both mitochondrial transport and function in vivo. The 
requirements for this were: 
a) Single organelle resolution: Estimates of shape, movement, and membrane 
potential should be extracted for each individual mitochondrion. 
b) Verification: Tracking of mitochondria should be correspond well with manual 
analysis, and TMRM analysis should be able to detect drug-induced increases and 
decreases in mitochondrial membrane potential.  
c) Minimal manual interaction: Manual steps should be reduced to conducting 
the actual experiment and outlining the axons of interest guaranteeing 
reproducibility and reducing bias 
As I was unable to find a solution that worked “out of the box”, I devised a combination 
of pre-existing and novel methods. 
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This chapter describes my final approach analysing mitochondrial dynamics and function 
in vivo, and experiments to verify the methods, as well as insights about mitochondrial 
transport and function in the saphenous nerve of untreated animals. 
 
AXONAL MITOCHONDRIAL TRANSPORT AND FUNCTION – PREVIOUS 
FINDINGS AND OPEN QUESTIONS 
It is widely accepted that mitochondrial transport and fission / fusion are essential for a 
neuron’s long term survival: mutations in kinesin and dynein have been shown to cause 
axonal swellings followed by degeneration (Pilling et al. 2006), loss of the mitochondria 
fusion proteins Mfn1 and Mfn2 is incompatible with embryonal development (Chen et al. 
2003; Lee et al. 2012), and disruption of mitochondrial transport is implicated in a 
growing number of neurological diseases (see Burté et al. 2014  for a review). This has 
led to the theory that axonal mitochondria need to be regularly supplied with new, 
undamaged proteins and mtDNA through fusion with younger mitochondria travelling 
down from the nucleus, whilst old material needs to be transported back to the nucleus 
to be destroyed through mitophagy. However, details of this machinery are not well 
understood. It is, for example, not fully known which factors decide whether and how 
two mitochondria will fuse. There generally appear to be two different versions of fusion: 
full fusion and a much faster exchange of material named “kiss and run fusion” (Liu et 
al. 2009; Wang et al. 2012). Full fusion, which is the complete merging of two particles 
into one, is enabled by the fusion protein optic atrophy-1 (OPA1) which is ingested and 
degraded at low membrane potentials (Legros et al. 2002; Song et al. 2007). Kiss-and-
run is a much faster exchange (on the scale of a few seconds) which can happen between 
mitochondria associated with different microtubules, and from which both particles 
emerge with the same shape they had before the encounter. In contrast to full fusion it 
appears to be independent of OPA1 (Liu et al. 2009). Intriguingly, mitochondria in b 
cells have been shown to regularly break into fragments with uneven membrane 
potentials, depending on which they were either more likely to fuse again or to be 
degraded without further fusion (Twig et al. 2008). This leads to the intriguing theory 
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that mitochondria shed their damaged proteins through fission and the particle 
containing the larger number of damaged proteins is kept from fusing again because of 
its lower Δψm and lack of OPA1. Computer simulations suggest that if such exchange 
happens at a sufficiently high rate, it provides a strong safety mechanism against the 
accumulation of damage (Mouli et al. 2009). What is not entirely sure is whether a similar 
mechanism can be found in neurons. A 2004 paper seems to corroborate this idea: Based 
on cultured chicken DRG neurons, Miller and Sheetz reported that highly polarised 
mitochondria in cultured neurons predominantly move toward the growth cone whilst 
mitochondria with low polarisation predominantly move back towards the nucleus (Miller 
& Sheetz 2004). However, they were not able to record fusion and fission behaviour due 
to technical limitations and, to my knowledge, their findings, although regularly cited, 
have yet to be replicated. 
The exchange of proteins and mtDNA is not the only function of mitochondrial fission 
and fusion. Particularly, hyperfusion, that is the formation of large, connected 
mitochondrial networks can be seen in a number of physiological and pathological 
conditions. Hoitzing et al provide an interesting theoretical discussion of the potential 
benefits of mitochondrial fusion (Hoitzing et al. 2015), two of which are important in the 
context of this thesis. The first suggestion is that mitochondrial fusion may lead to 
increased ATP production efficiency. Experimental evidence for this comes from fasting 
or other forms of starvation in which mitochondria present decreased fission rates and 
fuse to fewer, larger organelles (e.g. Gomes et al. 2011; reviewed in Liesa & Shirihai 2013), 
or decreases in complex IV activity which was shown to be compensated for by 
hyperfusion (Rolland et al. 2013). The authors list multiple potential mechanisms, one of 
which involves a nonlinear increase in membrane potential such that the membrane 
potential of the fused mitochondrion is higher than the average membrane potential of 
the smaller, individual mitochondria. The second interesting potential of hyperfusion is 
that it may be useful in high-calcium situations as free calcium diffusion within the large 
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mitochondrion is a better way to ensure optimal calcium buffering than would be possible 
with multiple, smaller particles7. 
In addition to the open questions about the details of mitochondrial fission and fusion, it 
is not entirely clear whether, and to what extent, old mitochondria need to be transported 
back to the nucleus at all. While some evidence suggests that mitophagy is largely 
confined to the cell body (Cai et al. 2012), other groups report significant local mitophagy 
in axons (Ashrafi et al. 2014). Recently, Davis et al described a particularly interesting 
mechanism whereby retinal ganglion cells at the optic nerve head, and potentially also 
cerebral neurons in mice, shed mitochondria by forming axonal evulsions which are taken 
up by astrocytes and digested in astrocytic lysosomes (Davis et al. 2014). While it is not 
known how frequently this happens or whether there is an equivalent mechanism in the 
PNS, it raises the question of whether a cell necessarily has to go through the expensive 
process of transporting old mitochondria back to the soma and, if not, what the function 
of retrogradely moving mitochondria might be. 
In the chapter at hand I attempt to shed a light on some of these questions. While the 
focus is largely on developing the necessary tools to quantify mitochondrial transport and 
membrane potential I also use these tools to try and answer a set of basic questions about 
mitochondria in naïve animals, such as: how much mitochondrial trafficking can be seen 
in the axons and in which direction? Are anterograde and retrograde transport balanced 
or not and are they correlated with the number of stationary mitochondria seen in the 
axon (as one might expect if the main purpose of motile mitochondria was to replenish 
the pool of stationary ones)? Can we observe fission and full fusion? What happens to 
moving mitochondria as they get close to stationary mitochondria? Do they slow down 
(which could be a sign of kiss-and-run exchange and / or potentially have implications 
for mitochondrial transport in more crowded environments, see introduction or last 
chapter’s discussion)? Finally, is there any evidence that retrogradely moving 
mitochondria actually have a lower membrane potential than anterogradely moving ones? 
                                         
7 Hoitzing et al actually construct their argument around mitochondrial calcium signalling and 
argue that hyperfused organelles are better at avoiding saturation of calcium detecting enzymes. 
However, their line of reasoning applies fully to calcium buffering. 
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And is there any suggestion of increased effectiveness of larger mitochondria such as a 
higher membrane potential? 
Before going into these questions, however, I will discuss the approaches to quantifying 
mitochondrial movement and membrane potential in more detail. 
 
EXISTING SOLUTIONS FOR THE QUANTIFICATION OF 
MITOCHONDRIAL MOVEMENT 
Perhaps the most common means of quantifying mitochondrial movement, particularly 
in vitro, are kymographs (e.g. Miller & Sheetz 2004; Kang et al. 2008; Bilsland et al. 
2010; Zhang et al. 2010; Ohno et al. 2011; Zambonin et al. 2011; Zala et al. 2013; Obashi 
& Okabe 2013). In these representations, the axon is straightened and condensed to a 
single row of pixels for every frame. When aligning the condensed frames on top of each 
other, vertical and diagonal lines appear, representing stationary and motile 
mitochondria, respectively. Kymographs take advantage of the fact that in perfectly 
straightened axons mitochondria travel along a straight line and provide an easy to 
quantify, and visually striking, representation of movement. Arguably, they are the best 
way to detect and compare stopping and direction changes and a variety of methods 
exists to quantify them automatically (Chenouard et al. 2010; Mukherjee et al. 2011; 
Chetta & Shah 2011; Zhang et al. 2011). However, due to the compression of the whole 
axon width into a single pixel, the link between particle movement and the actual position 
of the particle is lost, meaning that it is difficult to combine information about, for 
example, movement and shape or movement and membrane potential of a given 
mitochondrion (Pereira & Maiato 2010 suggests the use of colour to encode a particles 
horizontal position but do not provide a way to retrive it from the kymograph). 
Furthermore, while kymographs produced from the thin axons and dendrites of cultured 
neurons tend to be fairly clean, the higher density of stationary mitochondria and much 
greater number of mitochondria moving close to each other, in peripheral nerves renders 
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them very cluttered and hard to read (see, e.g., the kymographs in (Bilsland et al. 2010) 
versus those in (Kiryu-Seo et al. 2010) as well as Figure 3.1). 
 
Figure 3.1: Kymographs. Genetically labelled mitochondria in cyan. A: Node of 
Ranvier of an untreated axon. B: Lysolecithin-treated axon on day 8.  Orange arrows 
indicate anterogradely moving mitochondria, arrow heads show retrogradely moving 
mitochondria. Both kymographs are dominated by static mitochondria. Automatic 
tracking of the two time lapse recordings revealed 38 and 20 particle tracks, respectively. 
 
Other studies rely on manual tracking for the quantification of mitochondrial movement 
(Sorbara et al. 2014; Bros et al. 2015). While precise, this method is immensely labour 
intensive and does not allow for blinded analysis if differences between treatment groups 
(such as the absence of the myelin sheath, see Figure 2.6) are obvious in the time lapse 
videos. 
Finally, over the last years multiple fully automated particle tracking solutions – both 
commercial and free – have been published (see Chenouard et al. 2014 for an overview 
and comparison). Fully automated solutions promise speed, convenience, and high 
reproducibility. However, few software packages have been optimised to capture axonal 
transport and a recent comparison showed poor correlation between manual and 
automated quantification of mitochondrial movement (Bros et al. 2015). One noteworthy 
particle tracking solution developed specifically for the quantification of mitochondrial 
movement is the Difference Tracker plugin (DT) (Andrews et al. 2010). Freely available 
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and the highest scoring algorithm in the abovementioned comparison study, DT has been 
used both in our lab (Sajic et al. 2013) and by others (Milde et al. 2015). The principle 
behind DT is to extract only the moving particles from a time lapse recording, thereby 
reducing the number of possible connections in particle tracking. In a second step, these 
particles are then assigned to tracks using a simple nearest neighbour search with motion 
propagation according to the last observed speed of a particle. Unfortunately, in my 
hands, tracking results obtained with DT did not show a satisfying correlation with 
manually obtained results (see results). Furthermore, since DT’s segmentation step is 
performed on a per-pixel basis, the resulting moving particles are only fragments of the 
underlying mitochondrion, preventing any further analysis of mitochondrial shape and 
size. 
Given these limitations I decided to adapt an existing, fully automated particle tracking 
framework for the quantification of mitochondrial movement whilst also building on the 
idea of separating motile particles from stationary ones. In doing so I aimed to get a full 
set of data (size, shape, position, movement, membrane potential) for every 
mitochondrion in a single run with minimal manual interaction. 
 
AUTOMATED SEPARATION OF STATIONARY AND MOTILE 
MITOCHONDRIA 
Linking particles across frames is an optimisation problem, the complexity of which grows 
exponentially with the number of candidate particles (Jaqaman & Danuser 2009). 
Arguably, the strength of the DT algorithm lies in its ability to reduce the number of 
candidate particles by removing those which are not moving. This is achieved by 
comparing intensities of each pixel between two frames and including only those pixels 
in the linking step which decrease in brightness by more than a given threshold value 
(Andrews et al. 2010 section 3.1). Here, I extended this principle in several ways: Firstly, 
instead of classifying pixels as either stationary or moving, a measure of stability (stat 
score) is calculated. The stat score is the number of subsequent frames in the segmented 
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video in which a specific pixel (e.g. at position (13, 35)) is classified as belonging to a 
particle (see Figure 3.2 B). Neighbouring pixels belonging to the same mitochondrion can 
be expected to change at a similar rate and thus have similar stat scores. Therefore, 
particles can be reconstructed from stat scores by setting a maximum stat score difference 
Δss. Using a simple flood fill, neighbouring pixels with a difference in stat score <Δss 
can be identified as belonging to the same particle. This yields a set of putative particles 
(sets of neighbouring pixels) with a known size and a fairly uniform stat score. In a final 
step, each particle is classified as either stationary or moving by combining information 
about their size and median stat score with a predefined minimum speed. If, for example, 
the threshold for considering a particle as stationary is set to 0.5px per frame (or 1px 
every two frames) and the length of a given particle is 5px, then this particle is classified 
as stationary if it has a median stat score >10. 
Using this simple algorithm, it is possible to separate reliably moving particles from 
stationary ones even before tracking, which significantly reduces the complexity of 
particle linking. Furthermore, the algorithm improves video segmentation by breaking 
up clusters of moving and stationary particles which are close together and thus have 
not been successfully separated in the segmentation step. This is important since optical 
fusion of nearby particles is both a weakness of segmentation algorithms without a shape 
prior (such as Squassh) and a common problem in particle tracking (Jaqaman & Danuser 
2009). 
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Figure 3.2: Demonstration of the particle classification algorithm. Numbers 
denote frame numbers. A: 5 frames of Squassh-segmented particles spanning 13 frames 
 73 
/ seconds. B: Corresponding pixel stat scores. For demonstration purposes, background 
is shown in grey. Note that individual particles have homogeneous stat scores, thus 
making it possible to break up clusters of particles. C: Particle separation before tracking. 
By comparing a particle’s median stat score to its length, it is possible to classify the 
particle as stationary (red) or potentially moving (green). Only potentially moving 
particles are used in particle tracking. D: After particle tracking. Multiple moving 
mitochondria were successfully tracked including some which initially appeared fused to 
static particles and were hard to spot even by eye. Putatively moving particles (green in 
C) which could not be assigned to a track are allocated to a neighbouring static particle 
where possible or otherwise ignored in the subsequent analysis (shown in grey). 
 
PARTICLE TRACKING: SPECIAL CONSIDERATIONS FOR 
MITOCHONDRIAL MOVEMENT 
Once particles have been extracted from raw data through segmentation, they can be 
linked over time to form trajectories and extract movement statistics. This is a non-
trivial task because in most cases a given particle could be assigned to multiple different 
tracks. An optimal strategy to construct tracks from a given set of particles is Multiple 
Hypothesis Tracking (MHT) (Reid 1979; Blackman 2004). In MHT, given a set of tracks 
and a set of new particles, likelihoods are assigned to every possible link between a 
particle and a track, as well as the case of a particle starting a new, independent track.  
In cases where multiple alternative solutions exist, all possible solutions are simply carried 
forward. The expected trajectories of particles are calculated for every scenario and 
combined with the next set of particles from the next frame, yielding an extended set of 
connections and their likelihoods. After all available information has been incorporated, 
an optimal ensemble of non-conflicting track assignments can be selected according to 
the highest global likelihood. This combination of assignments is the best possible solution 
to the particle linking problem given the data (Blackman 2004; Jaqaman & Danuser 
2009). Unfortunately, MHT is often not feasible in practise because the enormous number 
of possible solutions even for relatively small particle linking problems (Jaqaman et al. 
2008). Over the last few years, different ways have been developed to reduce the 
computational burden while retaining some of the benefits of MHT. One such solution 
was published in 2008 by Jaqaman and colleagues (Jaqaman et al. 2008). Similar to 
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MHT, their algorithm assigns a cost to all possible links between particles in two 
subsequent frames but instead of carrying forward all possible solutions, a locally optimal 
solution is calculated. This way, a set of track fragments is created which, in a second 
step, can be linked together globally to form the final tracks. This approach is not only 
computationally feasible but also adds the advantage of being able to deal with the 
temporary disappearance of particles due to movement artefacts, which is a common 
problem in in vivo applications. Since its publication, Jaqaman’s algorithm has been used 
in various publications (Jaqaman et al. 2011; Chang et al. 2012; Reuter et al. 2014; Wu 
et al. 2014; Senning & Gordon 2015; Liu et al. 2015; Plebanek et al. 2015) and formed 
the backbone of the popular TrackMate plugin for ImageJ (http://fiji.sc/TrackMate). 
Furthermore, it has been made available in form of the Matlab particle tracking solution 
uTrack (http://lccb.hms.harvard.edu/software.html) which allows for easy extension 
using custom written cost functions. All particle tracking in this study is done using 
uTrack 2.1.3 with the custom written cost functions explained below. 
Since mitochondria are transported through axons along microtubules they can only move 
in parallel with the axon’s central axis. In straightened axons (as analysed here), 
mitochondrial movement should thus be largely horizontal. This fact can be exploited to 
reduce the number of false connections between particles. Furthermore, while 
mitochondria mostly move along a straight line with relatively constant speed, they can 
also stop and reverse direction (e.g. Sorbara et al. 2014). The cost function used in this 
study reflects these unique properties of mitochondrial transport in several ways. Firstly, 
it allows for two modes of motion propagation: forwards / backwards movement and 
stopping. During forward movement, only connections which deviate from the last 
direction of the particle by less than a given angle αvel are allowed. The new position of 
the particle is estimated using a Kalman filter and the cost of linking depends on the 
squared distance between a candidate particle and this propagated position. Furthermore, 
penalties can be imposed for connecting particles of different sizes. Particles for which 
there is no movement history or which move so slowly as to be considered stopping can 
be linked to all particles within a small radius to account for drifts. Beyond this radius 
their links are limited to particles within αvel from a horizontal line in either direction. 
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Lastly, a maximum vertical distance from the horizontal line can be defined regardless 
of the particle’s previous movement. Figure 3.3 demonstrates all these restrictions. 
 
Figure 3.3: Custom restrictions to particle linking. A custom set of cost functions 
for uTrack was developed in order to improve performance when tracking mitochondria. 
A: Particles without a known trajectory, or slowly moving particles, can connect to 
particles on both sides within a maximum displacement (dashed line, arrow) and a given 
angle α from the horizontal line. B: Particles which are moving with a known velocity 
can only connect to new particles close to their current position (stopping) or within α 
relative to their current velocity. 
 
MEASURING MITOCHONDRIAL MEMBRANE POTENTIAL USING 
TMRM 
As discussed previously, mitochondrial membrane potential (Δψm) is essential for 
mitochondrial function. Several indicators have been developed to assess Δψm, of which 
TMRM (tetramethylrhodamine methyl ester) and TMRE (tetramethylrhodamine ethyl 
ester) are the most common ones. A red-orange fluorescent, lipophilic, cationic dye, 
TMRM is rapidly taken up into axons and mitochondria due to their membrane potential. 
Thus, the final concentration of dye in mitochondria depends on both the axon membrane 
potential (Δψp) and the mitochondrial proton gradient (Δψm). In theory, the relative 
concentration of TMRM on the two sides of a membrane (e.g. inside the axon relative to 
the extracellular space) can be calculated using the Nernst equation:  
 ∆ψ = 2.3 𝑅𝑇𝑚𝐹 log./ 𝑇𝑀𝑅𝑀 12𝑇𝑀𝑅𝑀 345  ( 1 ) 
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where R is the gas constant, T is the absolute temperature, m is the electric charge on 
the ion, and F is the faraday constant. The factor of 2.3 is due to the use of log10 instead 
of ln. When filling in all constants and rearranging to express the concentration of TMRM 
inside a mitochondrion relative to the outside, this changes to: 
 𝑇𝑀𝑅𝑀 12 = 𝑇𝑀𝑅𝑀 345 ∗ 10∆>/@.AB ( 2 ) 
 
In equilibrium, this equation applies both to the axonal and to the mitochondrial 
membrane (Nicholls & Ferguson 2013 chapter 9). An important difference, however, is 
the time course of equilibration. Since mitochondria have an exceptionally large surface 
to volume ratio, TMRM exchange over their membrane is considered virtually 
instantaneous, whereas exchange over the axonal membrane is orders of magnitude slower 
(Gerencser et al. 2012; Nicholls & Ferguson 2013). 
Since the mitochondrial concentration of TMRM is exponentially larger than the intra-
axonal concentration, and the intra-axonal concentration in turn is exponentially larger 
than the extracellular concentration, it follows that even small differences in TMRM 
concentration in the extracellular space (e.g. between two experiments or due to dilution 
effects over time) lead to vast concentration differences in the mitochondrial matrices. 
This makes mitochondrial brightness by itself an unreliable indicator of Δψm. 
Sophisticated whole cell approaches based on mathematical modelling of dye dynamics 
have been developed, which allow for the absolute quantification of Δψm with high 
precision (Nicholls 2006; Chinopoulos et al. 2010). However, approaches of this kind 
require extensive calibration and a precise loading of dyes which is not feasible in vivo. 
Given high enough resolution, a third approach is to measure the TMRM fluorescence 
within the mitochondrial fraction of an image relative to the surrounding cytosol (Chacon 
et al. 1994; Scaduto & Grotyohann 1999; Diaz et al. 2000; Nicholls & Ward 2000). As 
long as TMRM is used in non-quenching concentration (see below) the ratio of these 
intensities should depend mostly on Δψm and be independent of the extracellular TMRM 
concentration. This approach was used throughout the present study. 
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At low concentrations, TMRM fluorescence intensity is generally assumed to be linearly 
correlated with TMRM concentration (O’Reilly et al. 2003; Gerencser et al. 2012; Nicholls 
& Ferguson 2013). Such concentrations are known as non-quenching (Nicholls & Ward 
2000; Nicholls 2012). If, however, the dye concentration exceeds a certain threshold, the 
photon emissions of the densely packed TMRM particles within mitochondria begin to 
interfere and their cumulative fluorescence relative to their number decreases. In this 
setting, known as quench mode, the ratio of TMRM fluorescence between mitochondrial 
fraction and axoplasm does not correspond to the ratio of concentrations, making the 
estimation of mitochondrial membrane potential impossible. In practice, concentrations 
of TMRM used in vivo tend to be significantly higher than in vitro (e.g. 7.5nM in vitro 
(Gerencser et al. 2012) vs 600nM in vivo (Romanelli et al. 2013)). Hence, it is necessary 
to calibrate carefully the loading of TMRM in order to ensure non-quenching mode. 
Here, I adapted an established in vitro protocol to estimate an appropriate TMRM 
concentration. The H+ ionophore FCCP rapidly depolarizes mitochondria, thus 
provoking the release of TMRM into the axoplasm. In quench mode, this leads to a 
pronounced increase in whole cell fluorescence as previously quenched molecules (i.e. 
particles which did not add to the mitochondrial and cellular brightness) leave the 
mitochondrion and increase the overall fluorescence of the axon (Nicholls & Ward 2000; 
Brand & Nicholls 2011). No such increase can be seen in non-quench mode, since the 
mitochondrial depolarization simply causes a redistribution of unquenched TMRM 
particles. The quenching threshold can thus be established by applying FCCP to 
preparations with different concentrations of TMRM. 
After establishing a candidate TMRM dose, I then verified its suitability for detecting 
changes in mitochondrial membrane potential via the application of Δψm altering drugs. 
The antibiotic oligomycin binds to a subunit of the proton channel of the ATP synthase 
where it inhibits transport of H+ protons from the outside of the mitochondrial inner 
membrane to the inside and thereby ATP synthesis (Symersky et al. 2012). Since 
mitochondria in intact cells usually produce ATP, this leads to a small increase in Δψm 
(Nicholls & Ward 2000). FCCP, on the other hand, rapidly depolarises mitochondria, 
and when used at a sufficiently high dose completely abolishes Δψm. Treating cells with 
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oligomycin followed by FCCP is a well-established protocol to verify Δψm measurements 
in vitro and the same approach was taken here in vivo. 
 
MATERIALS AND METHODS 
ANIMALS 
Animals used in these experiments were either male C57Bl/6 mice acquired from Charles 
River (TMRM dose calibration) or male Mito-S mice bred in-house (all other in vivo 
imaging). Ages commonly ranged from 8 to 12 weeks, never exceeding 16, and care was 
taken to ensure that treatment and control groups were age-matched and wherever 
possible litter mates. 
All animal experiments were carried out according to the 1986 Animals (Scientific 
Procedures) Act, UK, and were approved by the institutional ethics committee. 
 
MICROSCOPES 
Shortly after the conclusion of the pilot study, the LSM Pascal 5.0 microscope was 
replaced by an LSM 710 which yielded significant improvements in our imaging 
capabilities. Most significantly, much improved CFP contrast and reduced photo-
bleaching allowed for simultaneous recording of CFP and TMRM. This chapter marks 
the transition from LSM 5 to LSM 710. Specifically, the experiment comparing different 
doses of TMRM is the last experiment performed on the old microscope. All subsequent 
experiments (including the validation of the chosen TMRM dose using oligomycin and 
FCCP) were conducted using new equipment. 
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TMRM DOSE CALIBRATION 
First, a non-quenching dose of TMRM was determined based on changes in whole cell 
fluorescence. Animals (C57Bl/6J, n=5) were prepared for imaging as described in chapter 
2. Additionally, a thin polypropylene tube was inserted through the skin and placed with 
its end close to the nerve (Figure 3.5). The tube was filled with a mixture of 0.5µM 
fluorescein and 100µM FCCP in sterile saline. Multiple fluorescein doses were tried and 
0.5µM was selected because it allowed for clear monitoring of the FCCP injection but 
did not interfere with the TMRM signal. After the surgery, different doses of TMRM 
(1µM, 0.75µM, 0.5 µM, 0.25 µM; life technologies) diluted in sterile saline were applied 
to the desheathed nerve for 45min. A well made of petroleum jelly was formed around 
the surgical opening and the opening was covered with a glass coverslip. 
Imaging was performed using the LSM Pascal 5.0 confocal microscope (Zeiss) and a Zeiss 
Appochromat 10x objective (NA 0.3). The gain of the photomultiplier tube was adjusted 
at the beginning of each experiment such that the average TMRM signal of the nerve 
was in the middle of the detectable intensity range. Settings for the green (fluorescein) 
channel were kept identical for all animals. A series of images was recoded with one image 
of both the red and the green channel taken every 10 seconds. After 2 minutes, 2-3µl of 
the FCCP containing solution was injected via the tube using a microinjection device. 
This corresponds to approximately 10% of the total liquid volume in the preparation, 
yielding a final FCCP concentration of 10µM. Time lapse recording continued for a total 
of 20min. If the fluorescein signal suggested that the FCCP did not spread throughout 
the field of view reaching all parts of the nerve, the recording was discarded. Furthermore, 
a control animal was treated with 1µM TMRM and a solution containing fluorescein but 
no FCCP was injected to control for potential bleed through of the dyes or any effects of 
the increase in pressure. 
Images were processed using Fiji/ImageJ Version 1.48v. Time lapses were motion 
corrected based on their red (TMRM) channel using the ‘Register Virtual Stack Slices’-
Plugin. Subsequently, the nerve was selected manually and green and red fluorescence 
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averaged over the nerve were measured for every frame. TMRM intensity is presented 
normalized to the first 12 frames (i.e. before injection of the FCCP solution). 
This series of experiments yielded a candidate dose of 0.25µM TMRM. To confirm the 
choice of this dose, animals (Mito-S, n=6) were prepared for imaging as described above. 
After exposing and desheathing of the saphenous nerve, a solution of 0.25µM TMRM in 
ACSF was applied for 45 min in order to allow the dye to equilibrate. Imaging was 
performed using the LSM 710 confocal microscope (Zeiss) and a Zeiss Appochromat Plan 
63x oil objective (NA 1.4) using the same settings as in all subsequent mitochondrial 
imaging (see below). Throughout all experiments, the laser power, and photo multiplier 
gain for the CFP channel remained unchanged, while the laser power for the TMRM 
channel was slightly adjusted (within a range of 0.5% to 2%) in order to avoid over- or 
under-saturation. Axons of interest were located using the CFP channel only (and thus 
independent of their apparent TMRM intensity); then a single image of both CFP and 
TMRM was recorded.  
After taking 10-12 such images, the animal was removed from the microscope stage, the 
coverslip taken off and a solution containing TMRM as well as either 10µg/ml (3 animals) 
or 25µg/ml (3 animals) oligomycin from a 1mg/ml stock in EtOH was applied to the 
nerve. The imaging procedure was repeated. Finally, a third solution containing the same 
dose of TMRM as well as 10µM FCCP was applied to the nerve, followed by a last round 
of imaging. 
Relative mitochondrial TMRM intensity was measured relative to the surrounding 
axoplasm as described below (Image Analysis). Briefly, axons of interest were identified, 
cut out and straightened using Fiji (Schindelin et al. 2012). For every axon, the CFP 
channel was segmented using Squassh to create a binary mask. This mask was used to 
identify the location of mitochondria in the image. Using Matlab scripts, the TMRM 
intensity of every single mitochondrion was measured relative to its local background. 
The final intensity of a particle was defined as the median foreground intensity divided 
by the median background intensity. 
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Conditions were compared on an axon-by-axon basis with every data point corresponding 
to the median relative TMRM intensity of all mitochondria contained in that axon. 
Statistical significance was tested using the statistical software environment R. Using the 
nlme package, a two-level linear model with a fixed slope and random intercepts was 
fitted to the data. Median TMRM intensity per axon was used as the response variable, 
treatment (‘tmrm only’, ‘tmrm + oligomycin’, ‘tmrm + FCCP’) as a fixed effect and 
animal ID as a random effect. See Appendix A for a discussion of this approach.  
 
IN VIVO IMAGING AND IMAGE ANALYSIS 
Naïve animals (male Mito-S, 6-8 weeks, n=6) were anaesthetised with urethane and 
ketamine and prepared for imaging as described in chapter 2. TMRM was applied at a 
concentration of 0.25µM in aCSF for 45 minutes and the imaging site was sealed off with 
a cover slip as described above but without replacing the TMRM solution. Imaging was 
performed using a Zeiss Appochromat Plan 63x oil objective (NA 1.4). For each animal, 
time lapse recordings of at least 15 different axons were taken. The axons were selected 
based on genetically encoded CFP signal only to avoid bias towards particularly bright 
or dim TMRM intensities. If necessary, the laser intensity for TMRM imaging was 
adjusted slightly (within a range of 0.5% to 1.5%) to ensure that the signal fell in the 
middle of the detection range. Then, TMRM and CFP were recorded simultaneously at 
1 frame/sec for 65 seconds. A pinhole size of 1AU was used to ensure a thin optical slice. 
Analysis of mitochondrial movement was performed using the pre-processing method and 
custom cost functions for particle tracking explained above. Briefly, movement artefacts 
were reduced using the Descriptor-based Registration plugin (Preibisch et al. 2010). 
Axons of interest were identified, cut out and straightened using Fiji (Schindelin et al. 
2012). For each axon, the CFP channel was segmented using the Squassh (segmentation 
and quantification of subcellular shapes) algorithm (Paul et al. 2013; Rizk et al. 2014) to 
create a binary mask. Squassh combines image segmentation with deconvolution based 
on the microscope’s point spread function (PSF), which increases segmentation 
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performance near the resolution limit. PSF for both CFP and TMRM-based segmentation 
were determined experimentally from small, fluorescent beads (PS-Speck, Molecular 
Probes) using the same wavelength and pinhole settings as used during time lapse 
recordings (Cole et al. 2011). 
 
Figure 3.4: Squassh segmentation. Example frames from three different animals 
showing raw images of mitochondrial CFP fluorescence above the corresponding image 
segmentations.  
 
Mitochondrial size and shape were measured in Matlab using these binary images. In 
order to extract statistics about mitochondrial dynamics, the segmented videos were 
further processed using a custom algorithm which utilizes pixel changes over time to 
classify particles as either moving or stationary and separate connected particles (see 
above). Particles categorised as moving we linked using the Matlab package uTrack 2.1.3 
(Jaqaman et al. 2008) with custom cost functions (see above). Only tracks with a length 
of at least four frames and a total particle displacement of at least three pixels were used 
for further analysis. 
TMRM intensity was measured separately for every mitochondrion relative to its local 
background as follows. First, the median intensity of all foreground pixels of the particle 
was measured. Then, a local background selection was created containing all pixels within 
a 3px radius around the mitochondrion of interest which were not part of, or immediately 
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adjacent to, another mitochondrion and the median intensity of these particles was 
calculated. The final intensity of a particle was defined as the median foreground intensity 
divided by the median background intensity. 
 
EVALUATION OF PARTICLE TRACKING 
In order to evaluate the performance of the segmentation and tracking solutions described 
above, the results of automatic particle tracking were compared with both manual 
tracking and the Difference Tracker plugin (Andrews et al. 2010). Briefly, videos of 115 
axons from 6 animals and 3 different conditions (2x naïve: 37 axons, 2x day 8 saline 
control: 45 axons, 2x day 8 LPC demyelination: 33 axons) were used for comparison. The 
different conditions were chosen to test the algorithms on both normal axons and axons 
with increased mitochondrial content. Data for the LPC treated and control animals was 
taken from the time series study presented in chapter 4. All time lapses were registered 
using the Register Virtual Stack Slices plugin for Fiji (Arganda-Carreras et al. 2006), 
straightened, and cropped to 30 seconds duration. Subsequently, they were analysed in 
three different ways: 
1. After enhancing contrast for maximal visibility, all particles in all time lapse 
recordings were tracked by hand using the manual tracking capability of the 
TrackMate plugin. 
2. All videos were analysed using DT as described by Andrews et al. (2010) including 
the optional steps “Enhance contrast” (0.4%) and "Despeckle". 
3. All time lapse recordings were analysed using the custom analysis pipeline 
described above. 
For the purpose of this comparison, mitochondrial transport was defined as the average 
number of moving particles per frame times their speed. 
 
 84 
STATISTICS 
As before, the estimation of effect sizes and statistical significance testing was performed 
using a multi-level linear model with a fixed slope and random intercept via the nlme 
package for R. Where axon-specific effects were tested (e.g. when correlating the total 
area of stationary mitochondria with the total axonal transport), animal ID was used as 
a random effect. Correlations on the mitochondrial level (e.g. mitochondrial size vs speed 
or TMRM intensity of anterogradely vs retrogradely moving mitochondria) were 
estimated with both animal ID and axon ID as nested random factors. R2 was estimated 
as the marginal R2 (i.e. the proportion of variance explained by the fixed factors alone) 
using the method developed by Nakagawa and Schielzeth (Nakagawa & Schielzeth 2013) 
as implemented in the piecewiseSEM package in R (Lefcheck 2015). When analysing the 
speed of transport depending on the density of surrounding particles, mitochondria were 
compared with themselves and the effects of animals and axons could be neglected. Hence, 
a simple paired t-test was used to assess statistical significance. 
RESULTS 
TMRM DOSE CALIBRATION 
The injection of FCCP / control solution could be precisely monitored via the fluorescein 
signal (Figure 3.5). In all animals used for the final analysis, this signal increased rapidly 
for 2-3 frames (20-30 seconds) before falling off exponentially to slightly over starting 
level. Injection of fluorescein alone did not increase the TMRM signal but caused a 
gradual decrease of approximately 10% over 15 minutes (Figure 3.5 B). In contrast, when 
FCCP was injected, whole-nerve TMRM fluorescence showed a rapid, dose dependent 
increase for concentrations >= 0.5µM and a steeper-than-control decrease for a TMRM 
concentration of 0.25µM (Figure 3.5 B). After the spike, TMRM fluorescence of all 
concentrations decreased at a similar rate. These results suggest that in this particular 
setup TMRM concentration of 0.5µM and more caused imaging in quench mode while 
concentrations <= 0.25µM should be used for non-quench imaging. While this is a rather 
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high concentration compared with typical in vitro studies, it is nevertheless lower than 
many concentrations used in vivo (Nikić et al. 2011; Romanelli et al. 2013; Sajic et al. 
2013). 
Based on this finding, all subsequent experiments were conducted using a TMRM 
concentration of 0.25µM. 
Next, I measured relative TMRM intensity under regular experimental conditions. 
Results varied considerably between axons, with the median TMRM intensity over 
background of all mitochondria in an axon ranging 1.22 to 5.56 in untreated axons. On 
average and after correcting for animal baseline, the intensity was 2.91 in untreated axons 
(SE: 0.10). Upon the application of oligomycin, TMRM intensity increased by 0.65 (SE: 
0.11, p<0.001). This difference, whilst highly significant, was subtle and impossible to 
see by eye. FCCP treatment, on the other hand, led to a very obvious redistribution of 
TMRM from the mitochondria to the axoplasm and relative mitochondrial intensity fell 
by 1.49 relative to untreated axons (SE: 0.11, p<0.001). This pattern could be observed 
across all five animals, suggesting that a TMRM concentration of 0.25µM is a safe choice 
for detecting both increases and decreases in Δψm. 
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Figure 3.5: TMRM dose calibration in vivo. A: Setup: 10µM FCCP together with 
0.5µM fluorescein (for visualization of the injection) is administered through a thin tube 
in the skin. B: Whole nerve TMRM fluorescence normalised to baseline. Upon application 
of FCCP, a rapid spike in TMRM intensity is visible for 1µM, 0.75µM, and 0.5µM TMRM 
which slowly resolves over time. No such spike is seen when using 0.25µM TMRM. The 
red line indicates a control experiment with 1µM TMRM (the maximum dose used) and 
an injection of fluorescein, but no FCCP, demonstrating that there is no significant bleed 
through between the red and green channel. C: Motion corrected time lapse images at 
the beginning of the experiment, just after injection of FCCP and fluorescein, and after 
20 minutes. 
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Figure 3.6: Drug induced changes in TMRM signal. Top: TMRM intensity over 
background. Each dot indicates the median TMRM intensity of a single axon, each 
coloured line indicates mean intensity ± 95% confidence interval of the mean per animal. 
Bottom: Representative example images (2 per condition). Left: CFP channel, middle: 
TMRM channel, right: merge. A red to white lookup table was applied to the TMRM 
channel in order to amplify differences in signal. Bars indicate 10µm. See text for details. 
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EVALUATION OF PARTICLE TRACKING 
Both Difference Tracker measurements and the analysis method developed here 
correlated significantly with the results obtained through manual tracking. However, DT 
results were noisy, accounting for only 61.4% and 40.2% of the manually observed 
transport for anterograde and retrograde particles, respectively (as indicated by the 
adjusted R2 of a linear fit). In contrast, the analysis routine developed here had a signal 
to noise ratio of roughly 80% for both directions (anterograde: 79.1%, retrograde: 82.4%). 
The performance of both algorithms was worst in case of the LPC-treated axons, with 
the R2 of DT dropping to 0.26 and -0.02 for anterograde and retrograde transport, 
respectively while the custom solution showed R2s of 0.48 and 0.72. It also more 
accurately captured the speed distribution of moving mitochondria, and was able to 
reconstruct a higher percentage of tracks (DT: 58% (95% CI: 43%-73%); custom: 71.3% 
(95% CI: 57%-86%)). Both approaches tended to underestimate mitochondrial transport 
compared with manual analysis. See Figure 3.7 for details. 
The difference between manual tracking and automated tracking was largely due to 
problems with segmentation. Many particles detected in manual tracking were so faint 
as to be unidentifiable in a still image. 
The differences between the performance of DT and the custom solution developed here 
could mostly be explained by one of two sources of error. Firstly, the pixel by pixel 
filtering step used in DT produced a number of artefacts at the edges of large, stationary 
particles which were subsequently linked to form false tracks. This was prevented in the 
custom particle splitting solution by grouping pixels into larger clusters. Secondly, a 
number of tracks produced by DT showed unrealistic, zig-zag-shaped changes in 
direction, linking particles which did clearly not correspond to the same mitochondrion. 
Such links were prevented in the custom made linking algorithm by preventing the 
connection angle between two pixels (see Figure 3.3). 
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Figure 3.7: Correlations between manual and automatic tracking solutions. 
The left column shows results obtained with a custom-made particle tracking solution, 
the right column shows results obtained with the Difference Tracker plugin. Orange lines 
indicate the linear correlation between manually and automatically acquired results as 
well as the expected 95% confidence interval for new measurements. See text for details.  
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MITOCHONDRIAL FUNCTION AND DYNAMICS IN THE NAÏVE 
SAPHENOUS NERVE 
Figure 3.8: Mitochondrial trafficking in naïve animals. The image shows 20 
randomly selected axons with 61 seconds recording time each. Stationary mitochondria 
(median projection) are shown in white, the tracks of anterogradely (left to right) moving 
mitochondria are shown in yellow and retrograde tracks are shown in blue. In order to 
clear up the image, the outlines of the moving mitochondria themselves are not shown. 
 
A total of 110 axons from 6 different naïve animals were recorded, yielding 2432 
individual mitochondrial tracks. Mitochondrial transport could be detected in all axons, 
although the rate of transport varied significantly between axons. While movement of 
mitochondria was observed to stop and start, very few changes of direction were seen. 
More remarkably, not a single fusion or fission event was observed. 
Compared with the pilot study, transport rates measured here were lower in both 
directions (pilot: anterograde transport 1.84 ± 0.12 AU, retrograde transport 0.52 ± 0.08 
AU; here: anterograde transport 1.19 ± 0.07 AU, retrograde transport 0.30 ± 0.03 AU; 
mean ± SE). However, the difference between anterograde and retrograde transport was 
remarkably consistent with anterograde transport on average accounting for 78% of all 
mitochondrial movement vs 79% in the pilot study (see also Figure 3.9 D). A more 
detailed analysis revealed that this difference between directions was almost entirely 
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explained by the number of moving particles; both speed of movement (p = 0.054) and 
size of moving particles (p = 0.051) did not differ between the directions. 
I first tried to understand the relationship between axon width, total area of stationary 
axons, and mitochondrial transport. Axon diameters (defined as the width of the smallest 
rectangle around the straightened axon that could contain 98% of all mitochondrial 
pixels) ranged from 2.11µm to 5.80µm. There was some correlation between axon 
diameter and mitochondrial content of the axon (see Figure 3.9 A), however, the diameter 
only explained about 20% of the variation in total mitochondrial area (marginal R2=0.19, 
p < 0.001). Since mitochondrial dynamics are often thought to maintain and ‘refresh’ 
populations of stationary mitochondria, I next investigated the correlation between each 
axons stationary mitochondrial mass and the total mitochondrial transport observed 
(Figure 3.9 B). Somewhat surprisingly, neither anterograde nor retrograde transport of 
mitochondria were correlated with the total area of stationary mitochondria (p = 0.95 
and p = 0.20) or mitochondrial density of the axon (p=0.16 and p=0.72). Even the 
correlation between anterograde and retrograde transport, whilst statistically significant 
(p < 0.05) was extremely weak (R2 = 0.05, Figure 3.9 C). 
As mentioned in the introduction, one open question is whether mitochondrial transport 
can be inhibited by spatial constrains and the resulting obstruction. The high precision 
particle tracking achieved here enabled an interesting way to tackle this question. Whilst 
there was generally a lot of free space within untreated axons (the maximum intra-axonal 
area occupied by stationary mitochondria in this data set was 21%), many moving 
mitochondria came close to stationary particles at some point during the observation 
period. In order to find out whether this lead them to slow down, I compared the speed 
of every mitochondrion when it was moving freely and away from other particles to when 
it was close to a stationary particle. Close was defined as having no blank pixels between 
the moving and a stationary mitochondrion (i.e. them passing at a distance of < 0.18µm) 
in at least two consecutive frames (see Figure 3.2 for an example). The analysis was 
performed using 525 individual tracks. No difference was found between parts of the track 
where moving mitochondria were close to other particles and parts where they were 
moving freely (p = 0.17, Figure 3.9 E). The average change was estimated to be between 
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-0.006µm/sec and +0.03µm/sec (95% CI) compared with an average speed of about 
0.45µm/sec. Thus, there was no evidence for a slowing down of moving mitochondria due 
to the proximity of other particles. 
Finally, I investigated whether larger mitochondria were moving at a slower speed. The 
analysis revealed the average speed of moving mitochondria to be extremely uniform with 
95% of all mean track speeds between 0.15µm/sec and 0.89µm/sec (2432 tracks) and 
while very large particles were found to move slightly slower, the correlation between size 
and speed was extremely weak (R2 = 0.027, p < 0.001). 
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Figure 3.9: Mitochondrial dynamics in naïve axons. A Axon width explains some, 
but not all of the total mitochondrial content of the axon. B Neither anterograde, nor 
retrograde transport in an axon show a significant correlation to the size of its stationary 
population of mitochondria. C, D Retrograde transport was significantly lower than 
anterograde transport and both were only weakly correlated. E There was no sign of 
slowdown as motile particles passed stationary ones at low distances. F The speed of a 
moving mitochondrion showed virtually no correlation with its size. 
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In addition to mitochondrial trafficking, I also investigated the membrane potential of 
different mitochondrial populations in untreated axons. There was a small but significant 
difference between the relative TMRM intensity of stationary and moving mitochondria 
with stationary mitochondria showing higher intensity (p < 0.05, 108 axons, Figure 3.10 
B). However, the interpretation of this difference was complicated by a weak yet 
significant correlation between mitochondrial size and TMRM intensity (R2 = 0.05, 
p<0.001, Figure 3.10 C). In order to untangle the two factors, I constructed a multilevel 
linear model with TMRM intensity as the outcome variable, mitochondrial size and 
motility (moving vs stationary), as well as their interaction as fixed factors, and animal 
ID as well as axon ID as nested random factors. The data consisted of 5108 mitochondria 
(646 moving, 4462 stationary) from 110 axons. After correcting for animal and axon 
specific differences in this way, both size and motility were found to influence 
independently a mitochondrion’s membrane potential. The baseline intensity over all 
mitochondria was found to be 2.74 ± 0.12 (SE, p < 0.001). Every extra µm2 of 
mitochondrial size increased this value by 0.33 ± 0.02 units (p < 0.001). In addition, 
being mobile reduced TMRM intensity by 0.37 ± 0.09 units on average (p < 0.001). The 
interaction effect of area and motility was not significant (p = 0.85). However, whilst 
size and motility seemed to be contributing factors to a mitochondrion’s membrane 
potential, they only explained a small fraction of the total variance in TMRM intensity 
(marginal R2 = 0.06). 
As mentioned in the introduction, a long standing discussion is whether mitochondria 
which are transported retrogradely are older and destined for mitophagy. One piece of 
evidence for this theory which has been suggested is that retrogradely moving 
mitochondria have a lower membrane potential than anterogradely moving ones (Miller 
& Sheetz 2004). I tested this idea by comparing the relative TMRM intensity of 
anterogradely and retrogradely moving mitochondria whilst correcting for the influence 
of axon and animal. A total of 1702 anterogradely moving mitochondria, and 456 
retrogradely moving mitochondria were measured. I did indeed find a small, yet 
significant difference between the two populations with retrogradely traveling 
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mitochondria showing a 5% lower relative TMRM intensity compared with anterogradely 
moving ones (ant: 2.44 ± 0.07 SE ret: 2.32 ± 0.08 SE, p < 0.01, Figure 3.10 A). 
Importantly, this difference was not explained by size as retrogradely moving particles 
were actually slightly larger than anterogradely moving ones (ant: 0.35µm2 ± 0.04 SE 
ret: 0.40µm2 ± 0.04 SE, p < 0.01, data not shown). 
 
 
Figure 3.10: TMRM intensity in untreated axons. A Small but significant 
difference in the relative TMRM intensity between anterogradely and retrogradely 
moving mitochondria. Grey dots denote individual mitochondria and circles show axon 
means. B, C Stationary mitochondria showed slightly higher membrane potentials than 
moving mitochondria which was partially, though not exclusively, explained by size (see 
text for details). 
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DISCUSSION 
The investigation of mitochondrial function and trafficking in untreated animals yielded 
a couple of encouraging result. Firstly, methods to quantify mitochondrial trafficking and 
membrane potential were developed and verified. I was successfully able to detect the 
relatively small difference in membrane potential caused by the application of oligomycin 
(about 5mV according to Nicholls & Ward 2000) which would likely go undetected with 
a quenching concentration of TMRM. However, it is also apparent that this approach 
does not allow for an absolute quantification of Δψm. Assuming Δψm = 150mV, the 
Nernst equation suggests a [TMRM]mito to [TMRM]axoplasm ratio of approximately 290 
(see above) or 100x the difference in fluorescence intensity observed here. A likely 
explanation for the extreme difference between the theoretical and the observed TMRM 
ratio is that the confocal microscope’s point spread function is significantly taller than 
the diameter of axonal mitochondria, causing a “dilution” of mitochondrial TMRM 
intensity. This effect is further intensified by an accumulation of TMRM in the myelin 
surrounding the axon (see also Romanelli et al. 2013) as well as in Schwann cell 
mitochondria (Gonzalez et al. 2015). Because of this, small shifts in the focus plane may 
also contribute to the large variance in TMRM measurements across axons. While 
computational approaches for approximating the correct TMRM intensity of 
mitochondrial pixels have been suggested (Fink et al. 1998; O’Reilly et al. 2003), they 
require the acquisition of multiple images at different Z planes followed by deconvolution, 
making them incompatible with time lapse recording and particle tracking. 
The performance of the fully automated tracking approach developed here was 
significantly better than suited for my purposes than the previously used 
DifferenceTracker plugin. In fact, it slightly outperformed the comparison to manual 
tracking published by the authors in their original paper, even though the underlying 
data was acquired using much more stable nerve explants (Andrews et al. 2010). 
Importantly, it returned a full set of data with size, movement, and membrane potential 
which enabled some of the most interesting results in this chapter. Like the measurement 
of TMRM intensity, however, it was not without limitations: laser exposure was fairly 
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high and photo bleaching and the occasional depolarisation of single mitochondria was 
sometimes observed when imaging periods were extended to more than 60 seconds. Also, 
while it seemed well-suited to investigate differences in transport between treatment 
conditions, it did not provide an absolute quantification of mitochondrial movement and 
tended to underestimate it when compared with manual tracking. 
Like in the pilot study, mitochondrial transport was observed in virtually all axons. The 
rate of transport observed here, however, was slightly lower. Whilst this might simply be 
a result of noise in the measurement, it is also possible that it is the result of switching 
from saline to aCSF as the medium surrounding the desheathed axons as at least one in 
vitro study suggests that using calcium free media increases mitochondrial transport 
(Zhang et al. 2010). 
Conflicting reports exist about whether spatial constraints can lead to reduced 
mitochondrial transport (e.g. Pilling et al. 2006 vs Janakaloti Narayanareddy et al. 2014). 
Here, mobile mitochondria weren’t found to slow down when passing close to (often 
larger) stationary mitochondria which suggests that the reduction in transport observed 
in the pilot study is likely not explained by a lack of intracellular free space.  
A striking finding when studying mitochondrial dynamics in naïve animals was the 
complete absence of fusion and fission events. Such events are notoriously hard to detect 
automatically, particularly in a noisy in vivo setting where particles appear to change 
their size constantly by a few pixels due to movement artefacts. However, in over a 
thousand recordings of mitochondrial dynamics in axons (both here and in other 
chapters) I cannot point to a single fission/fusion event, which strongly suggests that 
they occur only rarely. I did not find evidence for kiss-and-run fusion, either. Although 
only transient, this kind of fusion is still considered to take a few seconds (Liu et al. 2009; 
Wang et al. 2012). There was no evidence of mobile mitochondria slowing down when 
they get close stationary mitochondria and it seems unlikely that mitochondria have 
enough time to fuse in a kiss-and-run fashion. The absence of fission and fusion may in 
part be explained by the fact the axons imaged in vivo are more mature then those 
imaged in vitro. Mitochondrial motility has been reported to decrease with age (Lewis et 
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al. 2016) and it has been suggested that mitochondrial fission and fusion may decline in 
the same way (Jendrach et al. 2005; Arnold et al. 2011; Figge et al. 2012). 
In line with this absence of interaction between mobile and stationary mitochondria, I 
also did not find a significant correlation between the total area of stationary 
mitochondria and either anterograde or retrograde transport. This is perhaps surprising 
given the prevalent view that mobile mitochondria replenish stationary ones, yet it is 
also in line with findings by Misgeld and colleagues in nerve explants (Misgeld et al. 
2007). Similarly, there was no significant correlation between anterograde and retrograde 
transport within the same axon. 
As in the pilot study, retrograde transport was found to be significantly lower than 
anterograde transport. As mentioned in the discussion of chapter 2, this observation (as 
well as a tendency towards larger retrogradely traveling particles) has been described in 
multiple other studies: in the mouse saphenous nerve (Sajic et al. 2013), in mouse tibial 
nerve explants (Andrews et al. 2010), in excised frog nerve (Zhang et al. 2010), in 
drosophila larvae (Pilling et al. 2006) and in cultured neurons (Kiryu-Seo et al. 2010). 
The most extreme example actually stems from another in vivo study of the mouse 
saphenous nerve in which the authors note that “Retrograde transport was not observed 
in the sciatic nerve of [...] untreated control animals” (Bilsland et al. 2010). The most 
likely explanation for this phenomenon seems to be that a significant proportion of 
mitophagy takes place in the synapses and axon terminals. Alternatively, states of 
predominantly anterograde transport and states of predominantly retrograde transport 
may alternate, for example based on the hosts circadian rhythm (as seems to be the case 
for other mitochondrial processes: Peek et al. 2013; Neufeld-Cohen et al. 2016) although 
this seems far less likely. 
Overall then, a picture emerges whereby mitochondria in the healthy saphenous nerve, 
rather than participating in constant exchange of material, are shuttled mainly from the 
soma towards the axon terminal with relatively few interactions along the way. 
I was, however, able to confirm one finding which is in line with the classical idea of a 
mitochondrial life cycle: Like Miller and Sheetz I found that on average anterogradely 
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moving mitochondria have slightly higher membrane potentials than mitochondria 
moving back towards the soma (Miller & Sheetz 2004). However, whilst Miller & Sheetz 
did not directly measure membrane potential and instead manually categorised 
mitochondria as either high-potential or low-potential, the difference found here was small 
(about 5%) and definitely not visible by eye. The same was true for the difference in 
membrane potential between stationary and moving mitochondria which was found to 
be partially explained by the larger size of stationary particles. It is possible that larger 
mitochondria only appear brighter because the corresponding pixels contain less 
background intensity. However, the fact that movement had an effect on intensity even 
after correcting for size suggests that mitochondria in different states do indeed build up 
different membrane potentials and it seems very possible that larger mitochondria are 
able to build up higher potentials and therefore are more efficient producers of ATP as 
suggested previously (Liesa & Shirihai 2013; Hoitzing et al. 2015). 
In conclusion, this chapter described the successful development and verification of 
methods for simultaneously tracking of mitochondrial movement and estimations of 
mitochondrial membrane potential. Applying these methods to the saphenous nerve of 
untreated mice yielded some interesting insights about mitochondrial dynamics in healthy 
axons, some of which (in particular the fact that mitochondria do not seem to be slowed 
down by nearby stationary particles) are relevant for understanding mitochondrial 
dynamics in demyelination. In the next chapter, the same methods are applied to study 
mitochondria at various time points throughout the course of de- and remyelination. 
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CHAPTER 4: TIME-COURSE OF DE- AND 
REMYELINATION AFTER TOPICAL APPLICATION OF 
LYSOLECITHIN 
INTRODUCTION 
Following the encouraging results of the pilot study I decided to study the relationship 
between demyelination and mitochondrial dynamics more closely. As mentioned 
previously, one of the advantages of the lysolecithin-based model used here is the swift 
progression from demyelination to virtually complete remyelination. Most of what we 
know about this process stems from a set of studies by Smith, Hall and Gregson (Hall & 
Gregson 1971; Gregson & Hall 1973; Hall 1973; Smith & Hall 1980; Smith et al. 1982). 
In the first of these studies, Hall and Gregson investigated the ultrastructural effects of 
lysolecithin injection in the mouse saphenous nerve. They reported an internode-by-
internode swelling and unravelling of myelin, starting almost immediately after injection. 
The foam-like myelin debris was then taken up by macrophages, leaving most affected 
axons free from any surrounding myelin on days 4 and 6. Remyelination with gradually 
increasing myelin thickness was reported to occur from d9 to d25 (“well established in the 
14-day samples”) after injection and debris between axons was reported to be cleared 
fully after about three weeks. Importantly, the authors found that small variations in the 
concentration or amount of LPC solution injected changed the extent of the 
demyelination but not its time course. Two years later, a study by the same authors 
elaborated on these findings, adding that on day 14 every pre-demyelination internode 
seemed to be replaced by on average two new internodes, doubling the number of nodes 
of Ranvier and cutting the distance between them in half (Gregson & Hall 1973). 
Interestingly, this altered density of nodes, together with a significantly higher number 
of axon-associated cells was found to persist up to 90 days after treatment, and probably 
indefinitely. 
A few years later, Smith and Hall investigated the functional consequences of 
demyelination. Similarly to the above studies, the authors report first, single layer 
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remyelination of individual axons at day seven and multi-lamellae remyelination of 70%-
80% of axons at day 14. Whilst they found virtually all axons to be remyelinated after 
four weeks, maximal myelin thickness according to electron microscope images was not 
reached until 8 weeks after treatment (Smith & Hall 1980). When investigating the 
conduction properties of demyelinated axons, the authors report an initial burst of 
activity (seconds) followed by extensive conduction block on days 2-4. Over the period 
from day 6 to day 14, conduction was found to return gradually, albeit with compound 
action potentials with long, irregular tails of up to 5ms. This alternate, slower mode of 
conduction was particularly obvious in the refractory period of the first of a double 
stimulus (see methods) and was found even in nerves showing few signs of remyelination. 
In a subsequent publication using membrane current recordings with high spatial 
accuracy in rats, this new mode of conduction was shown to be facilitated by closely 
spaced, node-like foci which appear to assemble even in the absence of Schwann cells 
(Smith et al. 1982). Finally, at 60 days, remyelinated axons were found to have 
conduction properties indistinguishable from saline treated axons. 
As laid out in the introduction, we thus have three distinct states of conduction (and 
presumably energy demand): early demyelination with total conduction block, early 
remyelination and the gradual return of microsaltatory, putatively more energetically 
expensive, conduction, and later remyelination where gross conduction properties are 
similar to untreated axons. In order to study mitochondrial dynamics and function in all 
of these conditions I decided to investigate mitochondria at days 2, 4 (early 
demyelination), 8, 12 (return of conduction), and 20 (more advanced remyelination). 
First, I investigated the state of myelination at these time points anatomically using 
semi-thin resin sections. In order to test whether the conduction properties reported 
earlier apply, I then recorded compound action potentials on days 8 and 12. Finally and 
most importantly I applied the methods for studying mitochondrial function and 
dynamics developed earlier to study mitochondria at all five time points in demyelinate 
axons compared with control axons. My goal is to combine observations about 
anatomical, electrophysiological, and mitochondrial changes in order to understand what 
might drive the changes in mitochondrial dynamics observed in the pilot study. 
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MATERIALS AND METHODS 
ANIMALS 
Animals used for this section were either male C57Bl/6 mice acquired from Charles River 
(anatomy and electrophysiology) or male Mito-S mice bred in-house (in vivo imaging). 
Ages commonly ranged from 8 to 12 weeks, never exceeding 16, and care was taken to 
ensure that treatment and control groups were age-matched, and wherever possible were 
litter mates. 
All animal experiments were carried out according to the 1986 Animals (Scientific 
Procedures) Act, UK, and were approved by the institutional ethics committee. 
 
SEMI-THIN RESIN SECTIONS 
Animals (C57Bl/6J, n=2 per group (d2, d4, d8, d12, d20) plus n=2 naïve, n=12 total) 
underwent the demyelination procedure described in chapter 2 using 1% LPC on both 
hind legs. At the desired time points after treatment, animals were anaesthetized using 
isoflurane (3%) and euthanized via cardiac perfusion with heparinised buffered saline 
followed by a mixture of 4% paraformaldehyde (PFA) and 2% glutaraldehyde in 
phosphate buffered saline (PBS). The saphenous nerves were harvested and, post-fixed 
and embedded in resin as described in chapter 2. 0.7μm thick transverse sections were 
cut from the middle part of each specimen using an ultramicrotome (Reichert Ultracut 
S, Leica), stained with toluidine blue and examined and photographed using a Zeiss 
Axiophot microscope equipped with a Nikon D300 camera (Nikon, USA). 
Images were processed using Fiji/ImageJ Version 1.48. Photographs of resin sections were 
converted to grayscale and contrast was optimised for each image such that the image’s 
histogram covered the whole range of grey levels. 
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ELECTROPHYSIOLOGY 
Animals (C57Bl/6J; naïve: n=3; d8 saline: n=3; d8 LPC: n=4; d12 LPC: n=4) underwent 
the demyelination procedure described in chapter 2 using 1% LPC on their left hind leg. 
After the desired time period, the saphenous nerve was exposed in the groin and at the 
ankle close to the foot, i.e. on either side of the demyelinated area. In the groin region, 
fat was removed from the surgical opening and the nerve was carefully separated from 
the surrounding tissue. A small piece of Teflon tape was placed between the nerve and 
the surrounding muscle tissue to provide insulation, and the opening was filled with 
mineral oil. A pair of stimulating platinum electrodes with hook-shaped ends was 
carefully placed under the saphenous nerve using micromanipulators. Stimuli were 
produced using a battery powered StimBox (DS2A, Digitimer). At the ankle, a small 
incision was made in the skin and the active recording electrode was placed in between 
the skin and the, in this region, very superficial nerve. A reference needle electrode was 
inserted in one of the toes and a ground electrode in the abdominal muscle. Active, 
reference, and ground electrode were connected to an amplifier (Neurolog System, 
Digitimer) via a headstage (NL100AK, Digitimer). The recorded signal was amplified 
(gain: 2000, NL104 AC preamp, Digitimer), filtered (8-10kHz; 50Hz notch filter; NL125, 
Digitimer), and recorded using a digital oscilloscope (Sigma 60, Nicolette Technologies). 
See Figure 4.1 for a sketch of the setup. 
Two different stimulation protocols were used. Firstly, single CAPs were evoked using 
square, supramaximal stimuli (1.5 to 2.5 V, 50µs) at a rate of 1Hz. 100 traces were 
recorded from 1ms before the stimulus to 9ms post stimulus, at a rate of 5000 samples 
per second. Using custom Matlab scripts, traces containing large artefacts (“glitches”) 
were filtered out and the remaining traces were averaged to yield a single CAP trace with 
a low noise level. 
Secondly, a double stimulation protocol measuring the refractory periods of transmission 
(RPT) similar to the one developed by Ken Smith was employed (Smith & Hall 1980; 
Smith 1980). RPT has been shown to be a sensitive measure of conduction impairment 
which correlates well with the anatomical changes seen in demyelination (Smith & Hall 
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1980). It is less dependent on electrode placement than a comparison of CAPs which is 
particularly helpful given the spatial constrains in the current application. Briefly, instead 
of using a single stimulus, a pair of stimuli is given in short succession. Initially, while 
the first stimulus induces a CAP, the second one does not because of the axons’ refractory 
period. However, as the inter-stimulus-interval (ISI) is increased, a second, smaller and 
partially overlapping CAP appears. The amplitude of this second signal increases with 
increasing ISI, as does the separation between the two response peaks in time. By 
subtracting the first response from the dual response it is possible to obtain a precise and 
visually striking representation of any changes to conduction speed and refractory period 
of the nerve. 
First, 30 single stimuli were given at a frequency of 1Hz and the resulting CAPs recorded 
as described above. Then 30 double stimuli (two square stimuli of 50µs each) were 
recorded at the same rate. The initial delay between the two stimuli was 0.3ms. Blocks 
of single and double stimuli were alternated and the time between the double stimuli was 
increased in steps of approximately 0.1ms up to approximately 2.8ms. Using custom 
Matlab scripts, the resulting traces were filtered, averaged, and aligned at the stimulus 
artefact. In order to reveal the shape of the second CAP, each averaged single stimulus 
trace was subtracted from the corresponding averaged double stimulus trace and the 
resulting lines were stacked vertically (Smith 1980). See Figure 4.1 C. 
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Figure 4.1: Electrophysiology setup. A) Setup: Stimulation in the groin region and 
recording near the foot (A and B indicate the two recording electrodes). The site of 
demyelination in between is undisturbed. B) Example of 100 raw CAP traces (dark grey) 
and the resulting mean trace (blue). C) Isolation of the second CAP after a double 
stimulus. Left: 30 CAPs recorded with a single stimulus and averaged. The red arrow 
head indicates the stimulus artefact. Middle: 30 traces induced by a double stimulus 
with a 0.7ms inter-stimulus interval. Right: Aligning the mean single and double trace 
at the first stimulus artefact and subtracting the first reveals the true shape of the second 
CAP. 
 
IN VIVO IMAGING 
Animals (CFP positive Mito-S; n=3 saline controls + n=3 LPC treated per time point: 
d2, d4, d8, d12, and d20; n=30 total) underwent the demyelination procedure described 
in chapter 2 using 1% LPC on their left hind leg. After the desired time period, they were 
prepared for imaging as described in chapter 3. Whenever possible, two animals (one 
LPC treated plus one saline control) were imaged in the same sitting. 
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Mitochondrial dynamics and membrane potential were recorded as described and verified 
in chapter 3, using 65 frame time lapses with simultaneous recording of CFP and TMRM. 
At least 15 axons were recorded for each animal. In addition, myelination was assessed 
using SCoRe, a recently published label free method which utilises the reflective 
properties of myelin by exciting the tissue with a relatively small number of photons of 
different wavelengths and capturing all reflected light with similar wavelengths (Schain 
et al. 2014). A SCoRe myelin reflection image was taken after recording CFP/TMRM 
time lapses to capture the myelination status of each axon. See Appendix B for a list of 
all excitation and recording wavelengths. 
 
IMAGE ANALYSIS 
Recordings were analysed as described in chapter 3. Data from axons which remained in-
focus for less than 45 subsequent frames or had an axon length of less than 50µm were 
discarded. 
STATISTICS 
As before, the estimation of effect sizes and statistical significance testing was performed 
using a multi-level linear model with a fixed slope and random intercept via the nlme 
package for R. A separate model was constructed for each time point, using treatment 
as a fixed factor and animal ID as a random factor. R2 was estimated as the marginal 
R2 (i.e. the proportion of variance explained by the fixed factors alone) using the method 
developed by Nakagawa and Schielzeth (Nakagawa & Schielzeth 2013) as implemented 
in the piecewiseSEM package in R (Lefcheck 2015). Probability density estimates were 
calculated using Matlab’s ksdensity function with a normal kernel. Corresponding 
confidence intervals were estimated via bootstrapping using 10,000 repeated draws of the 
same sample size as the original distribution. The 95% confidence interval for cumulative 
distribution functions was estimated using Greenwood’s Formula. 
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RESULTS 
 
THE TIMECOURSE OF DE- AND REMYELINATION AFTER 
APPLICATION OF LPC 
The processing of most harvested nerves was successful, although three tissue samples 
ended up unusable. As in the pilot experiment (chapter 2), cross sections of the saphenous 
nerves showed clear signs of demyelination (Figure 4.2). The affected area appeared 
slightly larger in the current experiment, perhaps due to an increased proficiency at 
removing the surrounding tissue, and covered approximately 10 to 70% of the nerve’s 
cross section. Importantly, the time course of de- and remyelination was very similar 
across all samples. Two days after application of LPC, virtually all axons were still 
surrounded by myelin but it appeared swollen and less optically dense than at the caudal 
end of the nerve. On day 4, the surrounding myelin debris was largely removed from the 
axon and affected areas contained completely demyelinated axons. A few axon cross 
sections (fewer than 5%) appeared dark and swollen, likely indicating dying axons. On 
day 8, a number of optically dense cells were found to be associated with the demyelinated 
axons and on day 12, a thin layer of myelin surrounding most axons could be seen. By 
day 20, this layer appeared increased in thickness, though still thinner than the thickly 
myelinated axons towards the deep side of the section. 
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Figure 4.2: Resin cross-sections of saphenous nerves at different time points 
after LPC application. All sections are rotated such that the side of application points 
upwards in the image. Different animals were used for each time point and each row 
contains the left and right saphenous nerve from two animals. Some samples were lost 
during processing. Scale bars indicate 20µM. See text for details. 
 
The time course suggested by the thin resin sections was further confirmed by in vivo 
imaging. From the very first time point (d2), nodes of Ranvier were absent from LPC 
treated nerves and not seen again until day 20. TMRM residue in the myelin surrounding 
the axon (the main in vivo indicator used in the pilot study) could not be seen on days 
2, 4, and 8 and appeared only as a faint line on days 12 and 20. In addition to this 
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indirect marker, SCoRe reflection images were used to judge the state of myelination 
(See Figure 4.3). Unfortunately, in my hands at least, this technique was strongly 
dependent on the distance of the axon from the cover slip. Axons which were too far 
away from the glass showed only faint reflection signals whilst for the very top axons 
reflection from the glass itself saturated the detectors and masked the underlying tissue. 
Nevertheless, where images were available, they mirrored the resin sections shown above. 
On day 2, axons still showed myelin reflection, albeit with a smoother appearance and 
fewer details compared with control treated axons. No such reflections were seen on days 
4 and 8 and only rarely on day 12. On day 20, however, most axons presented with 
SCoRe images similar to control axons. Apart from the limitations described above, the 
appearance of most axons at any given time point were uniform within and across 
animals. 
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Figure 4.3: SCoRe reflection imaging over the time course of de- and 
remyelination. Arrows indicate nodes of Ranvier, arrow heads point to potential 
Schmidt-Lanterman incisures. See (Schain et al. 2014) for comparison. 
 
ELECTROPHYSIOLOGY OF THE DEMYELINATED SAPHENOUS NERVE 
Compound action potentials were successfully recorded from animals at all four time 
points / conditions. CAP amplitude differed significantly between animals in the same 
condition, likely as a function of electrode placement and hence taken by itself proved to 
be an unreliable indicator of conduction. Similarly, there was no clear pattern in the 
minimum inter stimulus interval necessary to produce a second CAP which ranged from 
0.3ms to about 0.8ms. However, there was a clear difference in the shape of the second 
CAP, particularly when stacked up into a “3D array” (Smith 1980). While differing in 
amplitude, CAP stacks from both naïve animals and saline treated animals on day 8 
after treatment showed a sharp rise and fall leading into a flat line within less than 1.5ms 
across all inter-stimulus intervals. On day 8 after LPC treatment, in contrast, CAPs 
showed multiple peaks with very small amplitudes stretched out over more than 2.5ms. 
By day 12, these had increased significantly in amplitude but the sharp rise of the CAP 
was still followed by a prolonged return phase with multiple peaks. Taken together, these 
measurements suggest that conduction in the treated nerves was still largely blocked on 
day 8 but returned in the form of micro-saltatory conduction with prolonged refractory 
periods after the first CAP by day 12. 
 
 112 
Figure 4.4: Electrophysiological time course. Each line shows the second compound 
action potential (2CAP) following a double stimulus. The time between the two stimuli 
increases from the bottom to the top in increments of approximately 0.1ms. Blue lines 
indicate similar stimulus intervals for comparison. Top two rows: 2CAPs rise and fall 
sharply in both naïve animals and saline controls. Third row: Conduction appears 
severely limited in LPC treated animals on day 8. 2CAPs are significantly smaller and 
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longer and show multiple peaks. Bottom row: By day 12, 2CAPs have increased in size 
but still appear abnormally long and with multiple peaks. 
 
MITOCHONDRIAL FUNCTION AND DYNAMICS 
After discarding unstable recordings and axons of less than 50µm length, the total 
number of recordings analysed in this experiment was 650 (saline control: 330, LPC: 320). 
In common with the pilot study and chapter 3, axons with CFP positive mitochondria 
were reliably expressed in the nerve and damaged / dying axons were clearly 
distinguishable from healthy axons. Although the penetration depth of LPC appeared 
increased compared with the pilot study, the total number of damaged axons was smaller, 
suggesting that at least some of the damage seen in the pilot study was caused by surgery 
rather than the application of LPC. 
 
Axon width (defined as the width of the smallest rectangle around the straightened axon 
that could contain 98% of all mitochondrial pixels) was similar across all time points 
except for day 8 where it was found to be significantly increased compared with controls 
(ctrl: 4.24µm ± 0.16µm vs. LPC: 5.36µm ± 0.28µm, mean ± SE, p<0.01; Figure 4.5 A). 
However, as in the pilot study, this apparent increase in diameter co-occurred with an 
increase in the density of stationary mitochondria - on both day 4 and day 8, 
demyelinated axons contained an increased amount of stationary particles (d4: ctrl 
13.30% ± 0.83% vs LPC 17.36% ± 1.41%, p<0.05; d8: ctrl 12.39% ± 0.40% vs LPC 
19.85% ± 0.72%, p< 0.001; mean ± SE, Figure 4.5 B). This increase was also reflected 
in the size of stationary particles which was increased on day 4 and even more so on day 
8 (Figure 4.5 C). The size of moving mitochondria, in contrast, remained stable except 
for a potential increase on day 2 (note however the very small number of day 2 
observations, see below). 
 
 
 114 
 
Figure 4.5: Mitochondrial size and density. A: Axon width. B: Mitochondrial 
density. Grey dots indicate individual axons; circles indicate animal means. Naïve data 
are taken from chapter 3 and replicated for comparison. C, D: Cumulative density plots 
showing the size of stationary and moving mitochondria, respectively. Shadows indicate 
95% CI of the mean. 
 
I next analysed the effect of demyelination on mitochondrial transport. Transport was 
significantly reduced in the early stages of demyelination, particularly on days 2, 4, and 
8 with both anterograde and retrograde transport affected and on day 12, on which 
retrograde transport was found to be significantly different to controls (see Figure 4.6 A 
and Table 4.1). This reduction in transport was particularly striking on day 2, in part 
because mitochondrial size and density was still very similar to control axons, leaving 
large intra-axonal spaces with no mitochondria passing them. This experiment thus 
replicated the reduction in transport seen in the pilot study. There were, however, a few 
differences. The reduction seen here on day 8 was 58.5% and 48.2% for anterograde and 
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retrograde transport, respectively, which was lower than the 74.3% and 76.7% reductions 
observed on day 7 in the pilot study. Moreover, the reduction in transport speed seen on 
day 7 in the pilot study was not found here: Instead, particles moving in either direction 
showed a narrow range of speeds with the possible exception of anterogradely moving 
particles on day 2 which were found to move slower on average (Figure 4.6 C). Instead, 
the difference in transport was mostly explained by a smaller number of moving particles 
and shorter track lengths, indicating more frequent stopping (Figure 4.6 B). 
 
Day Direction Saline control [AU] LPC [AU] p 
d2 anterograde 1.04 ± 0.06 0.19 ± 0.11 < 0.0001 
retrograde 0.29 ± 0.04 0.12 ± 0.07 < 0.05 
d4 anterograde 1.80 ± 0.19 0.73 ± 0.33 < 0.05 
retrograde 0.47 ± 0.07 0.19 ± 0.13 < 0.05 
d8 anterograde 1.72 ± 0.14 0.71 ± 0.24 < 0.01 
retrograde 0.56 ± 0.05 0.29 ± 0.10 < 0.05 
d12 anterograde 1.65 ± 0.41 1.28 ± 0.70 n.s. 
retrograde 0.69 ± 0.07 0.42 ± 0.12 < 0.05 
d20 anterograde 1.66 ± 0.33 1.11 ± 0.57 n.s. 
retrograde 0.34 ± 0.05 0.45 ± 0.08 n.s. 
Table 4.1: Measurements of total transport Total transport is defined as the 
average number of mitochondrial tracks seen at any given time point multiplied with 
their respective speeds. Values are mean estimates and SE according to a multilevel linear 
model with LPC treatment as the fixed effect and animal ID as a random effect. 
 
A caveat of this result is that, in contrast to e.g. mitochondrial density or membrane 
potential, mitochondrial dynamics in saline treated axons varied markedly over time. 
This result is discussed further below. 
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Figure 4.6: Mitochondrial transport throughout the time course of 
demyelination. A: Total anterograde and retrograde transport over time, defined as 
the average number of moving particles in any given frame multiplied with their 
respective speeds. B: Number of moving particles per frame. Grey dots indicate individual 
axons; circles indicate animal means. Naïve data are taken from chapter 3 and replicated 
for comparison. C: Distribution of transport speeds for untreated as well as LPC treated 
axons at different time points. Shadows indicate bootstrapped 95% confidence intervals 
of the mean.  
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One particularly interesting result of this set of experiments was the change in 
mitochondrial membrane potential: Stationary mitochondria in demyelinated axons 
presented with significantly higher TMRM ratios compared with controls on days 2 and 
4 (d2: 4.74 ± 0.60 vs. 2.96 ± 0.34, p<0.05; d4: 3.57 ± 0.24 vs. 2.68 ± 0.15, p<0.05; mean 
± SE). On day 2, this increase was strong enough to be obvious by eye. On day 8, the 
ratio was virtually identical to controls (2.85 ± 0.17 vs. 3.01 ± 0.10, n.s.) only to fall to 
below-control levels on day 12 (2.30 ± 0.17 vs. 2.91 ± 0.10, p<0.05). This trend was 
mirrored by moving mitochondria, although the difference on day 2 was not significant 
in this case. Importantly, the effect could not only be seen in measurements of TMRM 
intensity relative to the axoplasm, but also in the TMRM intensity of mitochondrial 
pixels alone (without background normalisation), suggesting that the change was driven 
by a true increase in mitochondrial membrane potential rather than just a decrease in 
background intensity due to the removal of TMRM. 
 
 
Figure 4.7: Mitochondrial membrane potential over the time course of 
demyelination. Grey dots indicate individual axons; circles indicate animal means. 
Naïve data are taken from chapter 3 and replicated for comparison. 
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Figure 4.8: Representative images of axons taken at various time points 
throughout the time course study. Genetically encoded CFP in cyan and TMRM in 
red. TMRM images were normalised to the background (defined as the 25th percentile of 
all pixels in the image) and the Fiji look-up table Red Hot was applied to emphasize 
differences in TMRM foreground intensity. Note the apparent increase in membrane 
potential on days 2 and 4 as well as the striking increase in mitochondrial density on day 
8. Scale bars indicate 10µm. 
 
DISCUSSION 
Before investigating the role of mitochondria I first set out to map out the anatomical 
and functional time course of lysolecithin-induced de- and re-myelination. Overall, my 
findings were in good agreement with previous literature. Anatomically, the finding that 
most affected axons were not surrounded by any myelin on day 4, the first signs of early 
remyelination on day 8 and the more advanced remyelination seen on day 12 and 
particularly 20 were in good agreement with the findings of Smith, Hall, and Gregson 
laid out above. There was, however, a difference in the spread of demyelination. Despite 
using a comparatively low dose of LPC, axons were found to be demyelinated over much 
longer stretches and myelinated and demyelinated axons were rarely seen in the same 
image. This is in stark contrast to Gregson and Hall’s finding that most axons only 
showed loss of myelin along the length of 2 to 3 internodes (Gregson & Hall 1973) and is 
likely a function of the difference in application. Whilst all papers cited in the 
introduction relied on microinjections of LPC in the nerve or white matter tract of 
interest, I opted for topical application (Griffin et al. 1990; Wallace et al. 2003), causing 
a much wider spread of lysolecithin along the nerve. Arguably, a lesion which allows for 
comparing myelinated and demyelinated sections of the same axon would have been more 
desirable, however, I found the small diameter of the saphenous nerve incompatible with 
injections. Nevertheless, the proportion of degenerating axons seen in the resin sections 
was very low, suggesting that whilst extending the lesion my choice of LPC application 
did not cause additional damage to the axons. 
The extent of demyelination over the nerve’s cross section seen here was comparable to 
previous reports based on topical application of LPC (Wallace et al. 2003 (40% of axons)) 
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and, in fact, not too dissimilar from the numbers reported by Smith and Hall (Smith & 
Hall 1980 (53% of axons on average)) although no nerve was seen which came close to 
the reported maximum of 95% from the latter study. 
My studies also suggest that the recently published SCoRe imaging procedure is useful 
for confirming demyelination in vivo, at least on an animal by animal basis. 
In order to find the onset of return of conduction, a previously published double stimulus 
electrophysiology protocol was employed. However, CAPs recorded by me were wider 
than in the original study by Smith and Hall and the inter stimulus interval necessary to 
evoke a second CAP was noticeably larger, even in naïve axons. In part, the slower 
dynamics might be explained by the different fibre composition of the two nerves: whilst 
the sciatic nerve investigated by Smith and Hall is a mixed nerve with many fast motor 
axons, the saphenous nerve is purely sensory, including a large number of slowly 
conducting C fibres. More likely, however, it was also influence by suboptimal recording 
conditions. Smith and Hall went to great lengths to ensure a constant temperature of the 
nerve and all surrounding tissues, going so far as to submerge the whole animal in a 
temperature controlled bath of mineral oil. In the setup used here, in contrast, the leg 
was warmed only with a heating lamp controlled according to the animal’s rectal 
temperature rather than a more precise probe measurement next to the nerve. Hence it 
is possible that the final temperature of the nerve, whilst fairly stable over time, was 
below the 37C. As both conduction speed and refractory period are very dependent on 
temperature (personal communication, Ken Smith) this might explain the slower speeds 
measured here. 
Nevertheless, the time of return of conduction seen here was largely in agreement with 
previous findings, if perhaps slightly delayed. While conduction in the majority of axons 
was still be conduction blocked on day 8, elongated second CAPs with multiple peaks 
were observed in recordings from LPC based axons on both day 8 and 12. This suggests 
the onset of micro-saltatory conduction somewhere around this time, i.e. slightly later 
than originally reported (i.e. from day 6). However, this difference could easily be 
explained by the significantly longer lesions compared with the injection based study), 
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since conduction is restored to axons with short lesions before those with long lesions 
(personal communication, Ken Smith). 
Taken together, the anatomical and electrophysiological findings suggest that the axons 
imaged on day 2 and 4 were electrically inactive. By day 8, a few of them had probably 
regained the ability to conduct action potentials, although their number was likely still 
low. On day 12, on the other hand, a substantial number of remyelinated axons seemed 
to be conducting in a slower, most likely micro-saltatory fashion. Conduction on day 20 
is more difficult to predict as no electrophysiological recordings were conducted in this 
study and few data about similar time points can be found in the publications cited 
above. However, myelin thickness appeared significantly increased compared with day 12 
suggesting that conduction might also be more similar to the axon’s natural state. In 
terms of putative energy demand (or at least its conduction dependent component), one 
would thus expect a slightly decreased ATP consumption on days 2 and 4 and increased 
ATP demand in at least some axons on day 12 and perhaps day 8. 
Given this background, it is striking that the observed decrease in transport was strongest 
not at the return of conduction, which is generally thought to cause an increase in energy 
demand, but, rather, early on in the course of demyelination, preceding the accumulation 
of stationary mitochondria. This is of methodological relevance as well, since it shows 
that the reduced transport found in demyelinated axons is not just an artefact of moving 
mitochondria being hidden by a larger number of stationary ones. One caveat of this 
finding is that the transport rates in controls varied significantly. Furthermore, they were 
found to be higher than in untreated axons. One possibility is that because experiments 
on naïve animals were conducted before the time series, followed by most d2 and d4 
experiments, there may have been a training effect whereby later surgeries were more 
skilled and less disruptive to the axon. Alternatively, the control surgery and the resulting 
local environment around the nerve might stimulate increased mitochondrial transport, 
perhaps through damage to branches supplying the skin (compare e.g. Mar et al. 2014).  
Alternatively, there might have been slight differences for example in temperature control 
across experiments, leading to slightly different mitochondrial dynamics. However, one 
 123 
LPC treated and one control animal each were imaged on the same day, meaning that 
many of the potential biases should apply to both groups. 
In any case, there is little doubt that LPC treatment led to significantly compromised 
mitochondrial transport. Interestingly, the reduction in transport happened at a time 
when conduction in the axons was almost certainly blocked and was largely resolved by 
the likely time of return of conduction. Similarly, both density and size of stationary 
mitochondria peaked at time points when the axons most likely did not conduct action 
potentials. This calls into question the common assumption that mitochondrial changes 
in demyelinated axons are driven by increased ATP demand due to continuous 
conduction of action potentials (van Horssen et al. 2012). Other processes may drive up 
energy consumption in early demyelination. As mentioned in the introduction, upkeep of 
the axon’s membrane potential is believed to account for a large proportion of white 
matter energy consumption even in healthy axons (Howarth et al. 2012). It is possible, 
that its cost increases further after demyelination due to increased leakiness of the 
membrane. Similarly, the cells “housekeeping” cost which is estimated to be similar in 
magnitude to the cost of membrane potential upkeep may be increased due to repair 
processes. Ultimately, direct measurement of the axon’s ATP/ADP ratio (Imamura et 
al. 2009; Berg et al. 2009) would be necessary to conclusively rule out low ATP as the 
reason for the observed effects. 
Alternatively, two other mechanisms seem well-suited to explain the time line observed 
here. The most obvious one is an increase in intracellular calcium. Ca2+ has long been 
recognized as one of the main influences on mitochondrial transport (see introduction). 
If intra-axonal Ca2+ is increased – either because the demyelinated axon is unable to 
effectively regulate calcium influx or due to a direct effect of lysolecithin – this would 
almost certainly lead to a reduction in mitochondrial movement (see introduction). 
Intracellular calcium levels are measured and discussed further in chapter 6. 
Another possibility is that the reduction in mitochondrial transport is a direct 
consequence of conduction block. Work from our lab has shown that stimulation of the 
saphenous nerve leads to an increase in mitochondrial transport speed as well as an 
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increase in the number of moving mitochondria through fission of larger, stationary ones 
(Sajic et al. 2013). This suggests that perhaps decreasing neuronal activity might have 
the opposite effect, leading to a shift towards fusion as well as a decrease in mitochondrial 
transport. This theory is explored further in chapter 5. 
The time course revealed here also raises interesting questions about the link between 
mitochondrial transport and the observed hyperfusion of mitochondria. Traditionally, 
calcium overload is associated with mitochondrial fission rather than fusion (Hom et al. 
2007; Hom et al. 2012; discussion of Drp1 regulation in van der Bliek et al. 2013). 
However, in many cases this is in the context of a catastrophic event, so the putative 
Ca2+ increase here would likely be less extreme compared with the cited studies. 
Mitochondrial fission and fusion are often seen as stochastic events, with selective fusion 
controlled by membrane potential (Twig et al. 2008; Mouli et al. 2009; Tam et al. 2013). 
If moving mitochondria stop more often (as is clearly the case here) it is conceivable that 
the hyper-fusion observed on days 4 and 8 seen here is a direct consequence of them 
having more opportunities to merge. This mechanism might be boosted further by the 
observed increased membrane potential (see below). Alternatively, increased fusion has 
been shown to downregulate mitochondrial transport in dendrites as larger clusters of 
mitochondria fail to enter the small dendrites (Fukumitsu et al. 2016). However, many 
of the stationary mitochondria on day 2 were well within the normal size range of mobile 
mitochondria. Hence it seems more likely that hyperfusion is either a consequence of the 
decrease in mitochondrial transport or an independent event than the cause of reduced 
transaport. One possible transport-independent mechanism is cellular stress (Tondera et 
al. 2009; Gomes et al. 2011) and oxidative stress in particular (Shutt et al. 2012; Redpath 
et al. 2013), both of which have been shown to cause mitochondrial hyperfusion. LPC-
mediated demyelination was shown to cause upregulation of the stress-induced 
transcription factor ATF3 (Kiryu-Seo et al. 2010) and an increase in reactive oxygen 
species due to changes in Δψm might further drive fusion. Interestingly, Kiryu-Seo et al. 
suggest that ATF3 causes an increase in mitochondrial size as well as transport within 
48h after LPC treatment. While my observations on day 2 seem to strongly contradict 
this finding it is conceivable that the stress response in the peripheral nerve is simply 
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delayed. Thus, even though I never observed the increase in transport reported by the 
authors, stress may support the return of mitochondrial transport which seems to coincide 
with the increase in mitochondrial density. 
A particularly interesting finding was the sharp increase in TMRM signal observed on 
days 2 and 4. This finding has to be treated with some caution as lack of a myelin sheath 
surrounding the axon might lead to a reduction in background TMRM signal and hence 
an apparent increase in relative mitochondrial TMRM brightness (see also discussion of 
chapter 3). However, in semi-thin resin sections axon were still surrounded by a swollen 
layer of myelin on day 2 when relative TMRM intensity was highest. Furthermore, a 
change in background signal cannot explain the reduced membrane potential observed 
on day 12. One theory which fits well with the observed timeline is that increased Δψm 
might simply be a function of reduced energy demand and hence mirror the increased 
membrane potential seen in conditions of excessive nutrient supply (Liesa & Shirihai 
2013). This theory is explored further in chapter 5. However, it is worth noting that the 
increase seen here was significantly higher than the increase in Δψm caused by oligomycin 
which suggests that something else must influence the membrane potential. As with 
hyperfusion, the potential influence of calcium is complicated. Larger increases in 
intracellular Ca2+ are known to cause a reduction of Δψm (e.g. Abramov & Duchen 
2008). However, as an important indicator of cellular activity, e.g. in synapses or muscle 
cells, calcium would also be well suited to cause dynamic upregulation of ATP production 
and over the last years a series of publications have emerged showing that moderate 
increases in calcium do indeed upregulate mitochondrial metabolism (Glancy & Balaban 
2012; Rangaraju et al. 2014; Llorente-Folch et al. 2015). Using perhaps the most 
sophisticated methods to quantify Δψm published so far, Gerencser et al. reported a 14% 
hyperpolarisation of mitochondria in cultured rat cortical neurons due to physiologically 
elevated levels of intracellular calcium (Gerencser et al. 2012) – a bigger difference than 
can be induced through blocking of the ATP synthase using oligomycin. It seems possible 
that a combination of moderately increased calcium levels and decreased ATP 
consumption might cause the observed increase in membrane potential. 
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Another factor which has been shown to boost Δψm is the presence of neurotrophic 
factors (Huang et al. 2005). Schwann cells are known to produce large quantities of 
neurotrophic factors such as NGF, BDNF, NT-3 and NT-4/5 in reaction to axon injury 
(Frostick et al. 1998) which could in theory influence mitochondrial membrane potential 
in the nearby axons. However, the increase in neurotrophic factors usually lasts for weeks 
which seems incompatible with the brief increase and subsequent fall in membrane 
potential observed here. 
Finally, a few potential caveats of this study need to be addressed. Firstly, the fact that 
some of the most extreme changes occurred at the earliest time point raises the obvious 
questions whether LPC itself might cause the reduction in mitochondrial transport. Two 
observations argue against this: firstly, as discussed in the introduction of chapter 2, LPC 
is quickly deactivated in vivo whereas the effects on mitochondrial transport lasted for 
days. Secondly, Kiryu-Seo et al. showed that LPC does not have an effect on 
mitochondrial transport or size when applied to unmyelinated axons in vitro (Kiryu-Seo 
et al. 2010). I furthermore tried to address these concerns in a control experiment using 
a different demyelinating agent (see Appendix C). Secondly, the reduction in 
mitochondrial transport could be caused by inflammation. In other contexts such an 
animal model of multiple sclerosis (EAE), inflammation has been shown to arrest 
mitochondrial movement (Sorbara et al. 2014) and the peak of reactive oxygen species 
production by microglia / macrophages in the CNS after injection of lipopolysaccharides 
is also on day 2 (A L Davies et al. 2013). However, other observations are not consistent 
with the inflammation hypothesis. Firstly, the number of inflammatory cells in LPC 
lesions seen by me and others is very low. And secondly, the by-products of inflammation 
such as NO which impair mitochondrial trafficking also significantly reduce Δψm (Nikić 
et al. 2011) which stands in contrast to the strong early increase in membrane potential 
observed here. 
In summary, studying mitochondrial dynamics and function at different time points 
during demyelination helped further to illuminate the underlying processes. I was able to 
confirm the transport deficit discovered in the pilot experiments and the increase in 
mitochondrial mass reported elsewhere. However, both occurred at a time when axonal 
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conduction was very likely still blocked, suggesting that an increase in axonal energy 
demand due to alternate forms of conduction was not the underlying cause. Furthermore, 
I found a striking early increase in mitochondrial membrane potential. Potential 
mechanisms explaining these findings include elevated intracellular calcium, conduction 
block, and cellular stress. I test the first two in chapters 5 and 6.  
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CHAPTER 5: CHANGES IN MITOCHONDRIAL 
FUNCTION DUE TO DRUG-INDUCED CONDUCTION 
BLOCK 
INTRODUCTION 
The link between mitochondrial transport in axons and neuronal activity is only poorly 
understood. As mentioned in the introduction, calcium is generally excepted as the main 
signal causing mitochondria to stop at energetically demanding locations such as synapses 
(e.g. MacAskill et al. 2010). Calcium also enters axons during action potential 
propagation through voltage-gated Ca2+ channels at the nodes of Ranvier (Jackson et al. 
2001) but reports on whether this leads to mitochondrial arrest are conflicting. Using 
cultured mouse hippocampal neurons, Obashi and Okabe report that field stimulation 
increases mitochondrial stopping while treatment with the sodium channel blocker 
tetrodotoxin (TTX) reduces it (Obashi & Okabe 2013). Similarly, Ohno et al report a 
reduction in the speed of mitochondrial transport at nodes during resting state, an overall 
decrease in transport during stimulation, and an increase in the number of mobile 
mitochondria after TTX application (Ohno et al. 2011); Chen and Sheng report a 
syntaphilin-dependent decrease in transport during KCl stimulation of cultured 
hippocampal neurons (Chen & Sheng 2013); and Zhang et al. describe calcium dependent 
recruitment of mitochondria to nodes of Ranvier during tetanic stimulation of excised 
frog nerves (Zhang et al. 2010). In contrast, research from our own lab suggests that 
physiological stimulation of the saphenous nerve leads to increased mitochondrial 
transport both in terms of speed and number of particles (Sajic et al. 2013). Finally, 
Beltran-Parrazal et al. report based on cultured rat cortical neurons that neither action 
potential firing (spontaneous or chemically induced), nor TTX treatment or removal of 
extracellular calcium have any effect on mitochondrial transport (Beltran-Parrazal et al. 
2006). I do not have a conclusive explanation for the difference between these findings 
but potential candidates include the difference between in vivo and in vitro settings (e.g. 
the difference in age of the neurons mentioned in the introduction), different stimulation 
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protocols (see also discussion of Sajic et al. 2013), or the difference between central and 
peripheral axons. The last point seems particularly interesting given other differences in 
mitochondrial transport between the two populations. For example, injuring peripheral 
axons has been shown to upregulate mitochondrial transport in vivo whereas injury to 
central axons does not have the same effect (Mar et al. 2014; Smit-Rigter et al. 2016). 
This example also highlights that there are regulators of mitochondrial transport beyond 
calcium, many of which we do not fully understand. 
Given the upregulation in mitochondrial fission and transport observed by Sajic et al. I 
decided to investigate whether blocking axonal conduction might have the opposite effect. 
Since the normalisation of mitochondrial transport coincided with the putative return of 
conduction in my time course experiment (Chapter 4), I reasoned that conduction block 
might cause some of the changes which occur in demyelination. 
Experimental conduction block is commonly achieved using the pufferfish toxin 
tetrodotoxin (TTX) or through local anaesthetics such as lidocaine or bupivacaine. All 
three substances have in common that they block voltage gated sodium channels. 
However, TTX is highly toxic with an LD-50 of only 334 μg/kg in mice (Fisher Science 
Material Safety Datasheet) which makes it difficult to control, particularly close to the 
saphenous vein. Hence I chose lidocaine and bupivacaine to induce conduction block.  
Both drugs act mainly by blocking voltage gated sodium channels in a use-dependent 
manner – that is, the first action potential after drug application is usually unchanged 
but subsequent ones that follow closely in time are significantly diminished (Scholz 2002). 
To a lesser extent, they also block potassium and calcium channels. Although their 
mechanisms of action are similar, bupivacaine has a 4-10x stronger affinity to its target 
channels. Both drugs are usually given in combination with ephedrine in order to 
minimise absorption into the blood stream and prolong their duration of action. However, 
I decided not to add this drug in order to avoid the effects of decreased blood flow on 
mitochondria. 
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MATERIALS AND METHODS 
ANIMALS 
Animals used for this section were either male C57Bl/6 mice acquired from Charles River 
(electrophysiology) or male Mito-S mice bred in-house (in vivo imaging). Ages commonly 
ranged from 8 to 12 weeks, never exceeding 16, and care was taken to ensure that 
treatment and control groups were age-matched and wherever possible litter mates. 
All animal experiments were carried out according to the 1986 Animals (Scientific 
Procedures) Act, UK, and were approved by the institutional ethics committee. 
 
ELECTROPHYSIOLOGY 
Different combinations of local anaesthetics and means of application were tested in order 
to achieve a reliable, prolonged conduction block. Initially, animals were prepared for 
surgery similarly to the demyelination procedure and had a small pad of sterile Gelfoam 
(Pfizer) soaked in a local anaesthetic implanted under the skin just above the saphenous 
nerve. After the desired time period, they were terminally anaesthetised and prepared for 
electrophysiological measurements as described in chapter 4. Multiple combinations of 
drugs and time periods were tried (see Table 5.1), however, none led to prolonged 
conduction block. 
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drug 
time between 
implant and CAP 
recordings 
result 
2% lidocaine 48h normal conduction 
2% lidocaine 24h normal conduction 
5% lidocaine 24h normal conduction 
10% lidocaine 24h terminated, cardiovascular side effects 
1% bupivacaine 24h normal conduction 
1% bupivacaine 8h reduced CAP amplitude 
Table 5.1: Different doses of local anaesthetics delivered through a Gelfoam 
implant in the leg. 
 
Since in my hands Gelfoam implants were not sufficient to cause a reliable medium-term 
conduction block, I investigated the duration of action of sub cutaneous bupivacaine 
injections instead. C57Bl/6 mice (n=3) were anaesthetised using isoflurane (5% 
induction, 1.5% maintenance). The hair was removed from their left leg using electronic 
hair clippers and hair removal cream and the underlying skin was sterilized using ethanol 
wipes. Then, an injection of 30µl of 1% w/Vol bupivacaine hydrochloride (Sigma Aldrich) 
in sterile saline was placed under the skin in the same area that was usually used for 
demyelination. The animal was left to recover for approximately 30 minutes after which 
it was re-anaesthetised and prepared for electrophysiological examination as described in 
chapter 5. 50 single stimuli at a frequency of 1Hz were given every 10 minutes starting 
approximately 80 minutes after injection and up to 190 minutes. Traces were filtered and 
averaged in Matlab. 
  
IN VIVO IMAGING AND IMAGE ANALYSIS 
Based on the measured electrophysiological effects of bupivacaine injection, I decided to 
investigate a conduction block of six hours induced by four injections in 90 minute 
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intervals. Animals (Mito-S, n=5 per condition) were anaesthetised with isoflurane (5% 
induction, 1.5% maintenance) and the inside of their left legs was shaved and sterilised. 
Then, 30µl of either 1% w/Vol bupivacaine hydrochloride (Sigma Aldrich) in sterile 
saline, or saline only, were injected s.c. above the saphenous nerve in the location used 
for the demyelination procedure in previous experiments. Subsequently, they were 
allowed to recover. The injection was repeated three more times in 90min intervals under 
light isoflurane anaesthesia. After the fourth time, the animals were terminally 
anaesthetised using urethane / ketamine and prepared for imaging as described before. 
Just before desheathing the nerve, bupivacaine was applied one last time. TMRM was 
applied at a concentration of 0.25µM in aCSF for 45 minutes and imaging was performed 
using the LSM 710 microscope and a Zeiss Appochromat Plan 63x oil objective (NA 1.4). 
Simultaneous CFP / TMRM time lapses were recorded as described above (at least 15 
different axons per animal) and the resulting data were analysed as described in chapters 
3 and 4. 
STATISTICS 
As before, the estimation of effect sizes and statistical significance testing was performed 
using a multi-level linear model with a fixed slope and random intercept via the nlme 
package for R, using bupivacaine treatment as a fixed factor and animal ID as a random 
factor. 
 
RESULTS 
RETURN OF CONDUCTION AFTER INJECTION OF BUPIVACAINE 
The total time between the injection of bupivacaine and recording of the first CAP was 
about 80 minutes, including a 30 min recovery period after injection. At this time point, 
there was no sign of conduction in any of the three animals investigated. The first CAPs 
(defined as the first averaged recording with more than 4 standard deviations difference 
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from the baseline at any point) occurred after about two hours and CAPs didn’t reach 
their full amplitude until at least 2.5h after injection (see Figure 5.1). Encouragingly, this 
time course was very similar across different animals. Based on these findings, I decided 
to use four injections of bupivacaine at 90min intervals to produce a conduction block of 
six hours. 
 
 
Figure 5.1: Return of conduction. Compound action potentials recorded from three 
different animals after subcutaneous injection of bupivacaine. The first detectable signal 
is indicated in blue (>4 standard deviations over baseline, 2500 samples). In all cases, 
conduction was blocked for at least 120 minutes. 
 
MITOCHONDRIAL DYNAMICS AND FUNCTION IN CONDUCTION 
BLOCKED AXONS 
When investigated under the microscope after 6h of conduction block, saphenous nerves 
appeared normal with no signs of mitochondrial or axonal changes compared with saline 
injected controls. This first impression was confirmed by subsequent data analysis. 
Mitochondria in bupivacaine-treated axons were virtually identical to those in saline-
treated axons in all of the aspects measured in the previous chapters: mitochondrial size, 
density (saline 11.97% ± 0.26%, bupivacaine 12.68% ± 0.49%, p > 0.12), anterograde 
(saline 1.82 ± 0.31, bupivacaine 1.71 ± 0.57, p > 0.81) and retrograde (saline 0.38 ± 
0.08, bupivacaine 0.39 ± 0.15, p > 0.94) transport, and relative TMRM intensity (saline 
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3.12 ± 0.10, bupivacaine 2.83 ± 0.18, p > 0.10). These values were similar to naïve and 
control values observed in chapters 3 and 4. 
 
 
Figure 5.2: Effects of 6h conduction block on mitochondria. There was no 
significant difference between bupivacaine-treated and control axons for any of the 
properties investigated. Grey dots indicate individual axons; circles indicate animal 
means. 
 
DISCUSSION 
Conduction block over 6 hours using bupivacaine had no discernible effect on 
mitochondrial density, dynamics, or membrane potential. While the duration achieved 
here was significantly below the 48 hours of conduction block at the earliest time point 
investigated in chapter 4, it nevertheless provides evidence that the mitochondrial 
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changes observed early on in demyelination are unlikely to be caused by conduction block 
itself. Changes in mitochondrial transport and distribution due to TTX, for example, 
were reported as early as 15min (Ohno et al. 2011) or 30min (Obashi & Okabe 2013) 
after the application of the sodium channel blocker in vitro. Similarly, depolarisation of 
Δψm due to stimulation and subsequent hyperpolarisation have both been reported to 
happen on the scale of tens of seconds (Gerencser et al. 2012). While the possibility 
cannot be excluded that a prolonged conduction block would induce changes similar to 
those seen in demyelination cannot be excluded, the results presented here suggest that 
conduction block is not the driver of the observed mitochondrial changes. 
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CHAPTER 6: CHANGES IN INTRA-AXONAL CALCIUM 
CAUSED BY THE APPLICATION OF LYSOLECITHIN 
INTRODUCTION 
As elucidated above, calcium is one of the most potent regulators of mitochondrial 
function and dynamics and elevated calcium levels could explain many of the phenomena 
seen so far from decreased mitochondrial transport to increased membrane potentials. 
Thus investigating intra-axonal calcium was a logical next step in trying to understand 
the chain of events linking demyelination and mitochondria. 
Imaging-based measurement of Ca2+ has seen great advances in the last years. Today, 
calcium sensors are available both as injectable dyes such as Fura2 (Barreto-Chang & 
Dolmetsch 2009; Grienberger & Konnerth 2012) or OGB1 (Agronskaia et al. 2004; Lee 
et al. 2007), or as a variety of protein-based genetically encoded calcium indicators 
(GECIs) which can be delivered via viral constructs or inserted into the genome of mouse 
lines. GECIs can be further divided into single-fluorophore indicators such as GCaMP 
and dual-fluorophore indicators like Yellow-Cameleon or Tn-XXL (Grienberger & 
Konnerth 2012). When choosing an appropriate calcium indicator, the first important 
consideration is whether one desires to measure acute changes or compare baseline 
calcium levels in two different conditions. GCaMPs have been engineered to produce 
strong increases in fluorescence within fractions of a second upon calcium entry into a 
cell, allowing the detection of single action potentials in dendrites (Tian et al. 2009; Chen 
et al. 2013). However, since they only emit a single wavelength they do not provide a 
good way of quantifying resting state cytosolic Ca2+. Tn-XXL in contrast is less bright 
and takes longer to change its emission in reaction to changes in calcium but since its 
readout is the ratio of two wavelengths rather than a change in brightness of one, it 
allows for the quantification of intra-axonal calcium “as is” without inducing a change. A 
second important attribute of calcium indicators is their Ca2+ affinity. Ca2+ affinity is 
the strength with which the indicator binds free calcium and is usually expressed through 
its dissociation constant Kd. Kd measures the likelihood that a calcium molecule will 
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separate from the indicator - hence low affinity indicators have a high Kd and vice versa. 
In theory, low affinity indicators are preferred as they buffer less calcium and therefore 
interfere less with the cell’s physiology. In practise, however, higher affinity may 
sometimes be necessary to enable fast changes in the fluorescence signal (Grienberger & 
Konnerth 2012). 
For this study, Tn-XXL was identified as the most suitable calcium indicator. As a dual-
fluorophore indicator with a comparatively low affinity (Kd = 830nM), it is appropriate 
for measuring changes in resting state cytosolic Ca2+ (Williams et al. 2014; Siffrin et al. 
2015; Luchtman et al. 2016). Importantly, a mouse line expressing Tn-XXL under the 
Thy1.2 promoter has been developed and extensively tested for behavioural and 
neurophysiological abnormalities (Direnberger 2011; Direnberger et al. 2012) giving us 
the opportunity to investigate intracellular calcium in a strain of mice and a subset of 
axons similar to those expressing mitochondrially targeted CFP. We received the mice 
as a kind gift from Oliver Griesbeck in Munich and bred them in house. 
The Tn-XXL construct is made up of the fluorophores eCFP and Citrine cp174 which 
are connected via a modified version of the calcium binding protein troponinC (TnC) 
(Mank et al. 2008). TnC is a muscle protein and does not interfere with neuronal proteins, 
hence avoiding some of the long term physiological side effects and inactivation of 
indicator proteins reported for calmodulin-based GECIs (Hasan et al. 2004; Tian et al. 
2009). Upon binding of Ca2+, troponinC undergoes a conformational change which brings 
the two fluorophores closer together (see Geiger et al. 2012 for a rather impressive 3D 
rendering of the conformational change). This causes an effect known as fluorescence (or 
Förster) resonance energy transfer (FRET). FRET is a special form of quenching whereby 
energy is transferred non-radiatively from one excited fluorophore to another. Two 
conditions for FRET are a) that the emission spectrum of the first fluorophore and the 
excitation spectrum of the second fluorophore overlap and b) that they are within very 
close proximity of one another (1-10nm range). In fact, the rate of energy transferred 
falls with the 6th power of the donor-acceptor distance (Jares-Erijman & Jovin 2003). 
When using Tn-XXL for the quantification of intracellular calcium, only the CFP 
fluorophore is excited. As Ca2+ causes a conformational change of TnC that brings CFP 
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and Citrine closer together, a larger proportion of energy is transferred from CFP to 
Citrine, causing a shift in their emission ratio. This ratio can serve as semi-quantitative 
readout of axonal Ca2+. 
In order to better understand the effects of demyelination on intracellular calcium, I first 
optimized the imaging settings and analysis methodology for single photon measurements 
of Tn-XXL on our microscope. Axons were flooded with extracellular calcium using the 
Ca2+ ionophore ionomycin to gage the detection range (Siffrin et al. 2015). Then, I 
performed the demyelination procedure established above on Tn-XXL mice and compared 
intra-axonal calcium levels at an early (d2) and an intermediate (d8) time point. 
 
MATERIALS AND METHODS 
ANIMALS 
Calcium imaging was performed using male, C57Bl/6J based Thy1-TN-XXL mice 
(Direnberger et al. 2012) which were kindly gifted by Oliver Griesbeck and bred in-house. 
Thy1-TN-XXL mice homozygously express the calcium sensor Tn-XXL (Mank et al. 
2008; Geiger et al. 2012) in a broad range of neurons and were shown to have a healthy 
phenotype up to an age of at least six months (Direnberger 2011; Direnberger et al. 2012). 
The expression pattern in the saphenous nerve was similar to that of Mito-S mice with 
expression in myelinated axons but not in C-fibres. However, the level of expression was 
much more variable and Tn-XXL was seen in approximately 0-80% of all axons of a given 
animal with no obvious heritability pattern. See results for details. 
All animal experiments were carried out according to the 1986 Animals (Scientific 
Procedures) Act, UK, and were approved by the institutional ethics committee. 
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IN VIVO IMAGING 
For initial proof of concept, animals (Tn-XXL, n=5), were prepared for imaging as 
described above. No dyes were applied to the nerve and image acquisition was performed 
using a Zeiss Appochromat Plan 63x oil objective (NA 1.4). Axons of interest were 
identified by exciting the Citrine fluorophore of Tn-XXL directly via a 514nm laser, 
producing a crisp image with little background fluorescence and low laser power. Then, 
two 512x512px images were taken for every axon: a ratiometric two-channel image with 
an excitation of 405nm and detection ranges of 460nm - 510nm and 520nm - 570nm for 
CFP and Citrine, respectively, and an ‘anatomical’ image with 514nm excitation and a 
broad detection range of 515nm - 650nm (see Figure 6.1). Laser settings were left constant 
across all animals. Since a laser with the optimal excitation wavelength for Tn-XXL 
(around 432nm) was not available, some of the initial calibration experiments were 
conducted using both a 405nm laser and a 458nm laser for comparison. After all visible 
axons were imaged, the animal was removed from the microscope stage and ionomycin 
(100µM in aCSF) was applied to the nerve for 10 minutes. A new coverslip was placed 
on the leg and imaging was repeated. 
To assess axonal calcium in demyelination, animals (Tn-XXL, nd2 = 7, nd8 = 6) 
underwent demyelination as described above with one change: since no dyes were used, 
the time from induction of anaesthesia to image acquisition was significantly reduced, 
making it possible to image both hind legs of any give animal. Hence, each subject served 
as its own control: one hind leg was treated with LPC and one with sterile saline. The 
treatment side was alternated. After the desired time period, animals were prepared for 
imaging as described in chapter 2. The left leg was imaged first. After all visible axons 
were recorded, the animal was removed from the microscope stage, the surgical opening 
in the leg was closed with 2-4 sutures of 6-0 polypropylene thread (Ethicon) and the cast 
of dental impression material carefully detached from the stage. Subsequently, the 
procedure was repeated for the right leg. 
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Figure 6.1: Calcium imaging and analysis. See text for details. 
 
IMAGE ANALYSIS 
Image analysis was performed using Matlab. First, all images were filtered using a 3x3px 
median filter to reduce noise. Individual axons were extracted by manually selecting a 
rough axon outline. Then, all pixels of interest were selected by thresholding the 
anatomical (Citrine-only) image. For each pixel of interest, the ratio of Citrine to CFP 
in the ratiometric image was calculated. A number of publications stress the importance 
of background subtraction in the analysis of calcium imaging data (Helmchen 2011; 
Niesner et al. 2013; Siffrin et al. 2015). However, in my hands, background subtraction 
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did not further enhance the detection range. Results are presented as the median pixel 
ratio per axon. 
Conditions were compared on an axon-by-axon basis. Statistical significance was tested 
using the statistical software environment R. Using the nlme package, a two-level linear 
model with a fixed slope and random intercepts was fit to the data. The median pixel 
ratio per axon was used as the response variable, treatment/day as a fixed effect and 
animal ID as a random effect. See Appendix A for a discussion of this approach. 
 
RESULTS 
Tn-XXL expression in the saphenous nerve differed widely across animals (see Figure 
6.2). It ranged from virtually every myelinated axon in the nerve expressing the indicator 
to less than a handful of axons, and even total lack of expression in the PNS (investigation 
of one zero expression animal revealed strong Tn-XXL signal in the hippocampus). Whilst 
the expression was similar between two legs of the same animal, it varied across 
littermates with no obvious correlation to the expression seen in their parents. However, 
peripheral Tn-XXL was more reliably seen in females than in males. Despite these 
differences, the level of expression (as indicated by fluorescence intensity) seemed uniform 
across all expressing axons, even across different animals. 
 142 
 
Figure 6.2: Different expression patterns of Tn-XXL in the saphenous nerve. 
Expression ranged from virtually every axon in the nerve to none. C fibres did not show 
expression. All images taken from naïve animals. Scale bars indicate 250µm. 
 
In experiments using both a 405nm and the 458nm excitation wavelength for comparison, 
background fluorescence was significantly lower when using the latter. However, this 
wavelength also seemed to excite the Citrine fluorophore directly, leading to a reduced 
detection range. Thus, all subsequent experiments were conducted using 405nm 
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excitation. While the indicator’s signal was strongest in the axoplasm of nerve fibres, 
many myelin sheaths were clearly visible, too (most obvious after ionomycin application, 
see Figure 6.4). This was surprising since this expression pattern had not been described 
(Mank et al. 2008; Direnberger 2011; Direnberger et al. 2012). However, reports of Thy1.2 
promoted transgene expression in Schwann cells have been published (Livet et al. 2007) 
and since the sheaths were visible in Tn-XXL mice even when excited with 514nm light 
(a wavelength which typically does not produce autofluorescence) but never in Mito-S 
mice, it seems that Schwann cells do indeed express Tn-XXL. 
In naïve animals, the Citrine to CFP ratio of axons was remarkably consistent across 
animals (mean: 0.267 ± 0.007 SE, n = 5 animals, 257 axons; see Figure 6.3 A). Upon 
application of ionomycin, it increased significantly by 0.176 ± 0.004 (mean and SE, p < 
0.001), enough to be visible by eye. At the same time, the treated axons changed shape 
to a bead-like appearance with swellings and constrictions. The effects of demyelination 
were less strong but still highly significant (Figure 6.3 B and D) and occurred in every 
animal. At day 2 after treatment, the fluorescence ratio in demyelinated axons was 
increased by 0.02 ± 0.004 (mean and SE, n=7 animals, 219 vs 172 axons, p<0.001) and 
at day 8 by 0.04 ± 0.005 (mean and SE, n=6 animals, 125 vs 140 axons, p<0.001). 
Differences between the control treatments on days 2 and 8, between control treatments 
and untreated axons, or between LPC treated axons on days 2 and 8 were not significant. 
Some of the demyelinated axons showed calcium indicator ratios similar to those seen 
after ionomycin application. In order to make sure that the observed effects were not 
caused by axons with catastrophic levels of intracellular calcium, I removed all axons 
with fluorescence ratios within two standard deviations of the mean of ionomycin treated 
axons from the analysis (Figure 6.3 D). Importantly, the differences between myelinated 
and demyelinated axons remained significant with p<0.001. 
In order to determine whether the increase in calcium and / or the measurement thereof 
was influenced by axon diameter, the correlation between fluorescence ratio and axon 
width was determined for demyelinated axons on both days. No correlation was found 
between putative calcium levels and axon diameter (Figure 6.3 C) and axon diameters 
seemed virtually identical for naïve, saline treated, and demyelinated axons (4.10µM, 
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4.26µM, and 4.10µM, respectively; differences not significant). Myelin in LPC treated 
nerves appeared disrupted but mostly still in proximity to the axons on day 2. On day 
8, axons appeared virtually free from myelin and obvious clusters of debris could be seen 
between them. No nodes of Ranvier were seen on either day in demyelinated axons and 
no beading as seen after ionomycin treatment was observed. 
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Figure 6.3: Changes in Tn-XXL ratio following ionomycin treatment and 
demyelination. A: Citrine/CFP ratio in five animals before and after ionomycin 
application. Markers indicate median pixel ratios for individual axons. Error bars indicate 
mean and 95% confidence interval. B: Significant change in fluorescence ratio due to 
demyelination. Markers indicate individual axons, connected circles show average ratios 
for the LPC and saline treated leg of the same animal. C: No correlation between axon 
width and fluorescence ratio. D: Kernel density plots of fluorescence ratio distributions. 
The grey rectangle indicated two standard deviations above and below the mean ratio 
for ionomycin treated axons. The difference between myelinated and demyelinated axons 
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remained significant even when all axons within this range were removed from the 
analysis. 
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Figure 6.4: Representative examples of Tn-XXL expressing axons before and 
after application of ionomycin. The first three columns contain raw data. Images on 
the right show processed data with false colours indicating the Citrine / CFP ratio 
(“hotter” = higher). Scale bars indicate 10µm. 
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Figure 6.5: Representative examples of demyelinated and control treated 
Tn-XXL expressing axons. The first three columns contain raw data. Images on the 
right show processed data with false colours indicating the Citrine / CFP ratio 
(“hotter” = higher). Note the difference in myelin debris on days 2 and 8. Scale bars 
indicate 10µm. 
 
 
DISCUSSION 
Originally planned as a more comprehensive series of experiments covering all time points 
investigated in chapter 4, the investigation of intra-axonal calcium was significantly 
hampered by the spotty expression of the indicator. More than one in three animals 
showed little to no expression of Tn-XXL. Thy1.2, the promotor under which the 
transgene is expressed, is known to cause mosaic expression in a varying number of cells 
(Caroni 1997; Feng et al. 2000), however, there was a significant difference from the 
much more reliable Thy1.2 controlled expression of CFP in Mito-S mice. 
Regardless, it was possible to successfully image calcium in peripheral axons. The 
proportion of fluorescence ratios measured in untreated axons and axons flooded with 
extracellular calcium was found to be about 1.65x or 65%. This is significantly lower than 
the difference of 2.7x which the creators of Tn-XXL reported under optimal conditions 
(in vitro, cultured kidney fibroblasts) (Direnberger 2011) and also lower than the ratio 
of approximately 2 found by Siffrin and colleagues in the cerebellum in vivo (Siffrin et 
al. 2015)8. This difference in performance can potentially be explained by the fact that 
the 405nm laser (the most suitable wavelength available to us) is suboptimal for the 
excitation of Tn-XXL and may lead to a lower signal to background ratio compared with 
excitation with a wavelength of 430nm or 850nm in a two photon system as used by 
Siffrin et al. Nevertheless, significant increases in calcium signal were found in 
demyelinated axons both on day 2 and day 8 after treatment, even after potentially dead 
                                         
8 Somewhat peculiarly, both (Siffrin et al. 2015) and (Luchtman et al. 2016) calculate ∆R/R 
based on an intensity modulated ratio image. It is not addressed what implications this has for 
the interpretation of their results.  
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axons were removed from the analysis. No significant difference was found between the 
two days suggesting a consistently increased calcium level during the first week of 
demyelination. 
In order to further interpret these changes, it would be desirable to translate the change 
in fluorescence to a change in intracellular calcium. However, such a conversion is difficult 
to achieve in practise. The median increase in fluorescence ratio due to demyelination 
(regardless of time point) was 7% absolute or 10% of the total range between a control 
axon and an axon flooded with extracellular Ca2+. Calibration curves for Tn-XXL 
obtained in both drosophila and mice in vivo suggest that the relative change in 
fluorescence over baseline ∆R/R and the actual concentration of free calcium are 
approximately linearly related over the physiological range (Mank et al. 2008; Geiger et 
al. 2012). This suggests that the increase in calcium may be around 135nM or 1/10th of 
the concentration difference between the intracellular and extracellular space (assuming 
1.4mM extracellular Ca2+ and 50nM intracellular Ca2+). While a rather rough estimate, 
this value is below the transient 250nM increase due to a single action potential reported 
in the dendrites of hippocampal pyramidal cells (Maravall et al. 2000). 
A different approach is to compare the changes observed here to other publications using 
Tn-XXL. Birkenstock, Siffrin et al investigated the effects of glutamate excitotoxicity on 
axonal Ca2+ by applying 100mM of glutamate directly to cerebellar axons (Luchtman et 
al. 2016). They report a mean increase in fluorescence ratio of 21% at a max change of 
about 100% induced by ionomycin (Siffrin et al. 2015). Williams et al used Tn-XXL mice 
to investigate axonal Ca2+ in spinal cord injury (Williams et al. 2014). They classified 
axons as injured if they showed an increase in ∆R/R of >50% after spinal cord contusion 
and while the total range is not stated, data from dying axons suggest that the maximum 
increase may be around 200%. Finally, Mank et al used Tn-XXL to measure physiological 
stimuli in the mouse optical cortex and reported a peak increase of 7.4 ± 5.6% at a 
maximum increase of about 150% (Mank et al. 2008). While difficult to interpret due to 
differences in image acquisition and analysis, taken together these publications may 
suggest that the increase in calcium observed here may be in the high physiological range, 
below the ones observed in spinal cord injury or excitotoxicity but significantly above 
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baseline levels. This seems realistic considering that calcium is a strong cell death signal 
and axons would not be expected to survive long under conditions of very high calcium 
(Coleman 2005; Stirling & Stys 2010). On the other hand, the elevated calcium may be 
sufficient to explain some of the mitochondrial effects. The Ca2+ level necessary to anchor 
mitochondria near synapses, for example, is believed to be somewhere above 100µM and 
below 600µM (MacAskill et al. 2010). Similarly, the disruption of mitochondrial transport 
in a model of ALS has been explained by elevated levels of axonal Ca2+ (Mórotz et al. 
2012).  
No difference in intra-axonal calcium was observed between demyelinated axons on day 
2 and day 8. While the mitochondrial transport deficit was observed at both time points, 
the increase in membrane potential was only seen on days 2 and 4. This could indicate 
that the increase in Δψm is caused by something other than calcium. Alternatively, it is 
possible that even if the levels of Ca2+ in the axoplasm are similar, the ones inside the 
mitochondria might not be. There is no published data about whether the Tn-XXL sensor 
can enter mitochondria - the original publication just indicates that it does not seem to 
enter neuronal nuclei (Direnberger 2011). However, whereas a publication describing 
mitochondrial calcium in muscle fibres using the Ca2+ indicator yellow cameleon 2 showed 
mitochondria which clearly stood out from the intracellular space (Rudolf et al. 2004) 
due to their increased fluorescence, no such pattern could be seen here even though the 
level of magnification used was the same as in the mitochondrial experiments. Hence it 
seems reasonable to assume that Tn-XXL based estimations of Ca2+ are dominated by 
intra-axonal but extra-mitochondrial calcium. The influence of calcium of mitochondrial 
respiration is mediated by receptors both inside and outside the mitochondrial matrix 
(Bhosale et al. 2015). If larger mitochondria are indeed better at buffering calcium (see 
Chapter 1) it is possible that the increase in mitochondrial size may counteract the 
increase in membrane potential. 
Ultimately, it would be desirable to measure intracellular calcium at a point in time when 
mitochondrial transport is restored (e.g. day 20) – an experiment which I was not able 
to conduct due to time constraints. Nevertheless, the data presented above strongly 
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suggests that calcium is elevated during early demyelination, and therefore likely to 
contribute to the observed reduction in mitochondrial transport. 
This leaves the question how exactly demyelination might cause the increase in 
intracellular calcium. As mentioned in the introduction, the accumulation of calcium 
channel subunits has been reported in demyelinated axons in EAE (Kornek et al. 2001). 
The subunits were fully integrated into the cell membrane and analysis of immunostained 
sections suggested that their number was greatest in early demyelination (day 11) and 
reduced to near-normal levels after remyelination. The authors also reported an increase 
in β-amyloid precursor protein in the affected axons which is a widely used marker of 
disturbed axonal transport. Similarly, the acid sensing Ca2+ channel ASIC1 was found to 
be upregulated in EAE 15 days after immunisation (Vergo et al. 2011). The caveat in 
both cases is that EAE is highly inflammatory which makes it difficult to conclude 
whether the inclusion of said channels is a consequence of demyelination or inflammation. 
Furthermore, it seems unlikely that the inclusion of ion channels into the cell membrane 
could occur quickly enough to explain the increased calcium levels observed on day 2. 
The increase in intra-axonal calcium could also be secondary to an increase in 
intracellular sodium. Calcium is usually removed from the axon via the sodium-calcium 
exchanger. In situations of high intracellular Na+, however, this ion transporter has been 
shown to operate in reverse, shuttling Ca2+ into the axon (Lehning et al. 1996). In 
myelinated axons, regions of sodium entry and the Na+/Ca2+ exchanger are mostly 
separated with sodium channels located at the nodes and Na+/Ca2+ exchangers at the 
internodes and the paranode. In demyelination, however, sodium channels redistribute 
along the axon, bringing Na+ channels and Na+/Ca2+ exchangers closer together 
(Waxman et al. 2004). Close proximity of NaV1.6 channels and Na+/Ca2+ exchangers in 
particular has been suggested to cause calcium entry into the axon, without requiring a 
reduction in ATP levels (Craner et al. 2004). Furthermore, redistribution of sodium 
channels was shown to occur in the first days after lysolecithin-mediated demyelination 
in the PNS (Novakovic et al. 1996). However, whilst this redistribution likely puts axons 
at risk of higher calcium entry upon return of conduction, it is less clear whether 
redistribution without conduction would be sufficient to disturb calcium homeostasis. 
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A third potential pathway for calcium entry into demyelinated axons are ion channels 
and signalling machinery which are normally protected underneath the myelin sheath. 
Zhang et al recently described L-type calcium channels underneath the myelin sheath of 
murine peripheral motor axons which are usually silent but can be exposed through acute 
LPC application or stretch-based myelin injury (Zhang & David 2016). Furthermore, a 
series of nano-complexes including receptors for glutamate and potentially other 
transmitters have been described in the internodal axon membrane of central and 
peripheral axons (Ouardouz et al. 2009; Stirling & Stys 2010; Christensen et al. 2016). In 
contrast to the ion channels mentioned above, these complexes do not cause calcium 
influx from outside the axon but rather provoke calcium release from internal calcium 
stores (notably the axoplasmic reticulum). Usually shielded by the myelin sheath, these 
complexes could get activated as they are exposed in demyelination, causing an almost 
immediate increase in intracellular calcium (see Stirling & Stys 2010 for a review). 
In summary, even though the precise mechanism by which demyelination causes an 
increase in intracellular calcium is not known, several candidates have been identified. 
Overall, a moderate increase in intra-axonal calcium seems like the most likely 
explanation for the mitochondrial effects described in chapter 4. 
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CHAPTER 7: CONCLUSION 
KEY FINDINGS 
The aim of this thesis has been to understand more clearly the changes to mitochondrial 
function and dynamics caused by demyelination. In particular, I set out to add to the 
already substantial body of research by shining a light on mitochondrial dynamics and 
function at multiple time points during the development of the demyelinating lesion, 
covering different states of myelination, activity, and axonal energy demand. 
The research presented here confirms many of the previously published findings such as 
the increase in mitochondrial size and density in demyelinated axons (Mutsaers & Carroll 
1998; Hogan et al. 2009; Zambonin et al. 2011; Campbell & Mahad 2011), or the initial 
conduction block in demyelinated axons followed by a period of altered (and likely micro-
saltatory) conduction (Smith & Hall 1980; Felts et al. 1997). I add to these findings by 
showing that mitochondrial transport is significantly reduced during early demyelination 
while mitochondrial membrane potential is increased. Furthermore, I show that these 
effects are unlikely to be explained by continuous conduction of action potentials, spatial 
constraints, or conduction block and instead may be a consequence of impaired 
mitochondrial Ca2+ homeostasis. 
A central assumption which motivated this investigation is that mitochondrial transport 
is essential for a neuron’s function and survival (e.g. Rugarli & Langer 2012). As 
mentioned in chapters 1 and 3, there is ample evidence for this, both from studies of 
models of neurological diseases and from knockout models in which mitochondrial 
transport is directly impaired. The findings presented here also support this idea: despite 
its high cost, bi-directional transport of dozens of mitochondria per minute was observed 
in virtually all naïve or sham-treated axons. I also found a slight difference in membrane 
potential between anterogradely and retrogradely moving mitochondria which is in line 
with the theory that mitochondrial transport helps to rejuvenate the mitochondrial pool 
by facilitating exchange of mitochondrial proteins and DNA (e.g. Miller & Sheetz 2004; 
Twig et al. 2008). 
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The reduction in mitochondrial transport observed here is thus an important, and 
currently unreported, consequence of demyelination. During the short period between 
lysolecithin-mediated demyelination and subsequent remyelination, this reduction did not 
appear to have any negative consequences for the axon: damaged axons were rare and 
their number did not increase with time. In fact, it seems likely that the accumulation of 
mitochondria helps protect the axon from the observed increase in Ca2+, which is in line 
with a study by Ohno et al. showing that knock-out of the mitochondrial anchoring 
protein syntaphilin increases axonal loss in demyelination (Ohno et al. 2014). It is, 
however, interesting to speculate what the long-term consequences of this change might 
be. In diseases such as multiple sclerosis or Charcot-Marie-Tooth disease, demyelination 
is known to last for long periods of time and sometimes becomes chronic. Often, it is 
followed by axonal demise long after the initial demyelinating attack (reviewed in Trapp 
& Nave 2008). Similarly, mice treated with cuprizone, a copper chelator which causes 
slightly longer-lasting demyelination than lysolecithin, were found to recover initially and 
undergo successful remyelination but then experience a second phase of axonal loss 
(Manrique-Hoyos et al. 2012). In contrast to multiple sclerosis, which is a strongly 
inflammatory disease, the authors of the cuprizone study report only low levels of 
inflammation, suggesting that the observed degeneration is a direct consequence of 
demyelination. But the strongest evidence for detrimental consequences of mitochondrial 
accumulation caused by demyelination comes from a study by Joshi et al. (Joshi et al. 
2015). Like Ohno and colleagues, Joshi et al. knocked out the calcium-controlled 
mitochondrial anchoring protein syntaphilin, likely ameliorating the impairment of 
mitochondrial transport observed here. However, instead of inducting strong but short-
lived demyelination the authors tested the effects of syntaphilin knockout in chronically 
dysmyelinating Shiverer mice. In this model, preventing the accumulation of 
mitochondria prolonged the animal’s lifespans. While they did not investigate 
mitochondrial movement directly, the authors speculated that demyelination might 
reduce mitochondrial exchange and renewal which, in the long run, causes the demise of 
axons. Recently, a similar detrimental effect of syntaphilin was also shown in axotomy 
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in vitro, and increasing anterograde transport through enhanced expression of Miro-1 
was demonstrated to facilitate regeneration (Zhou et al. 2016). 
In summary, there is reason to believe that the reduction of mitochondrial transport 
caused by demyelination is detrimental to the axon’s health in the long term. This could 
be the case because limited transport leads to limited exchange of mitochondrial proteins 
and DNA which in turn permits the spread of mitochondrial dysfunction. Alternatively, 
the axon might simply run out of mitochondria. As discussed above, mitophagy likely 
occurs locally in the axon. This means that in order to keep their total number stable, 
new mitochondria have to be supplied from the soma at a constant rate. If the supply of 
new mitochondria is restricted by demyelination, the axon could become depleted of 
mitochondria downstream of the demyelinating lesion. Such depletion has been 
demonstrated in a chronic form of EAE after three weeks of impaired mitochondrial 
transport (Sorbara et al. 2014, supplementary materials). It also may be increased by 
axonal activity. Axons in sensory nerves such as the saphenous nerve investigated here 
are innervated at the distal end so that the distal part of the axon might still be active, 
even if axonal conduction is blocked more proximally. Work from our lab suggests that 
in response to high workload, saphenous nerve axons upregulate mitochondrial supply to 
their terminals (Sajic et al. 2013) – a physiological response which may fail if 
mitochondrial transport is disrupted by demyelination. 
Any detrimental effects of demyelination on mitochondria may be further amplified by 
the increase in mitochondrial membrane potential observed here. Both the production of 
ATP and superoxide increase with mitochondrial membrane potential and in their resting 
state are balanced such that mitochondria only reach a small fraction of their maximal 
ROS production (Nicholls & Ferguson 2013, chapter 9). However, the rate of superoxide 
production increases significantly if mitochondria sit idle (Murphy 2009). Since 
mitochondria were found to exhibit increased membrane potentials at an early time point 
during demyelination at which conduction was almost certainly blocked, it seems possible 
that they were also producing superoxide at a higher than usual rate, damaging 
mitochondrial proteins and DNA in the process. 
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The second half of this thesis has been dedicated to investigating a number of potential 
mechanisms through which demyelination might lead to the observed decrease in 
mitochondrial transport and increase in membrane potential. The accumulation of 
mitochondria in demyelinated axons is often explained through a putative increase in 
energy demand caused by a continuous form of conduction (e.g. Campbell et al. 2012). 
However, at least in the particular model studied here the time course of events does not 
agree with this theory as both the decrease in mitochondrial transport and the peak of 
mitochondrial density preceded the likely return of conduction. Similarly, conduction 
block itself had no discernible effect on mitochondrial function and whilst it has been 
suggested that spatial constraints can limit mitochondrial trafficking, data from both 
naïve animals and early demyelination suggest that spatial constraints do not play a 
significant role here. 
Instead, I found axonal calcium to be elevated during the first week of demyelination. 
Importantly, the observed increase was significant but not so extreme as to be 
catastrophic. As laid out in chapters 1 and 6, calcium is a powerful regulator of 
mitochondrial dynamics and in some conditions can also cause increases in mitochondrial 
membrane potential. It also directly controls the activity of the anchoring protein 
syntaphilin, tying the study at hand to the work by Ohno and Joshi (Ohno et al. 2014; 
Joshi et al. 2015). The mechanism by which demyelination might lead to an increase in 
intra-cellular calcium is not clear, but several promising candidates have been identified, 
including the addition and redistribution of ion channels and the exposure of signalling 
complexes previously protected under the myelin sheath (see discussion of chapter 6). 
Overall, the findings presented here suggest a new interpretation of the well-known 
accumulation of mitochondria in demyelinated axons. They suggest that rather than 
respond to increased energy demand due to continuous conduction of action potentials 
along the membrane of the demyelinated axon, mitochondria may react to an early and 
pathological increase in intracellular calcium. Note that this is fully compatible with the 
idea that mitochondrial accumulation and hyperfusion protect the axon, at least in the 
short term. However, it suggests that this initial protection comes at a price, namely, 
decreased availability of mitochondria and impaired mitochondrial maintenance. It seems 
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feasible that this mechanism contributes to the axonal degeneration following long-term 
demyelination in diseases such as Charcot-Marie-Tooth disease and multiple sclerosis, 
even in the absence of inflammation. Importantly, however, if mitochondrial 
accumulation is caused by a change in axonal calcium rather than axonal energy demand, 
this also may open up new treatment opportunities: if the source of calcium entry into 
the axon can be identified, it may be possible to block it pharmacologically, thereby 
eliminating most of the need for increasing mitochondrial density in the affected parts of 
the axon.  
 
LIMITATIONS AND FUTURE DIRECTIONS 
Like any scientific endeavour, the work presented here leaves many questions 
unanswered. Perhaps the most glaring omission is the lack of a control experiment using 
a different way to induce demyelination. Whilst it seems unlikely to me that effects on 
intra-axonal calcium and mitochondrial dynamics which last for more than a week should 
be artefacts of lysolecithin treatment rather than consequences of demyelination, I feel 
that replicating these changes in a different model would significantly strengthen my 
conclusions. I unsuccessfully attempted to use ethidium bromide as demyelinating toxin 
(see Appendix C), but because of its effect on mitochondrial DNA the interpretation of 
this approach would have been difficult even if the experiment had been successful. An 
interesting alternative would be to apply the tools developed here to one of the many 
available animal models of Charcot-Marie-Tooth disease (Fledrich et al. 2012). 
Secondly, it cannot be ruled out that axons experience a transitory increase in energy 
demand early in demyelination, for example due to repair processes or increased difficulty 
to keep up their membrane potential. Over the last years, new tools have been developed 
which allow measurement of the ATP/ADP ratio in intact cells, either indirectly via 
magnesium (Leyssens et al. 1996) or directly using novel FRET based sensors (Imamura 
et al. 2009). These tools could be very useful for understanding the relationship between 
demyelination, energy demand, and mitochondrial dynamics.  
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Furthermore, time restrictions and limited transgene expression meant that some 
interesting experiments around intra-axonal calcium were left undone. For example, I 
would have liked to obtain calcium measurements from axons after successful 
remyelination to see if the return to normal mitochondrial transport coincides with a 
return to baseline levels of Ca2+. Furthermore, if calcium is indeed responsible for the 
changes in mitochondrial function and dynamics, applying a membrane-permeable 
calcium chelator such as EGTA to the lesion should reverse them (Ohno et al. 2011). I 
believe that this experiment would be particularly useful to address the caveats of 
measuring TMRM given the varying thickness of myelin surrounding the axons of interest 
(see discussion of chapter 4). 
As discussed in chapter 6, it is not clear how calcium enters the axon after demyelination. 
Measuring axonal calcium during the application of lysolecithin might provide a first clue 
as it would allow to distinguish between calcium entry mechanisms which are immediate 
(e.g. the exposure of channels and receptors usually protected by the myelin sheats, see 
Zhang & David 2016) and mechanisms which take more time such as the integration of 
calcium channels into the axon membrane or the redistribution of sodium channels. 
Finally, I believe that some of the most interesting questions raised by this piece of work 
concern not demyelination but rather the mitochondrial life cycle in healthy neurons. As 
discussed in chapter 3, I found very little evidence of mitochondrial fission and fusion in 
the adult mouse in vivo. Given the length of the saphenous nerve, a low rate of exchange 
between mitochondria might be necessary to ensure that “fresh” material reaches the axon 
terminals at all. However, given that much of our theory of mitochondrial maintenance 
is based on the assumption that the mitochondrial pool is frequently replenished through 
fission and fusion (e.g. Mouli et al. 2009; Liesa & Shirihai 2013) and since it is becoming 
apparent both here and elsewhere that in vitro experiments overestimate both 
mitochondrial transport and fission / fusion (e.g. Takihara et al. 2015) it seems vital to 
better understand mitochondrial interactions in neurons. One fruitful experiment might 
be to label the mitochondrial population at one point of the nerve (e.g. with a permanent 
MitoTracker dye or via light activate-able gene constructs) and observe the interaction 
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of moving anterogradely and retrogradely moving mitochondria with stationary 
mitochondria on either side of the treatment site. 
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APPENDIX 
 
APPENDIX A: PERFORMING STATISTICAL TESTS ON NESTED 
DATA 
This thesis is concerned with biological entities at fundamentally different levels.   On 
the lowest level, properties of individual mitochondria such as size or membrane potential 
are measured. On the next level above this, properties of individual axons such as 
mitochondria transported per unit time or mitochondrial density are measured. Finally, 
every axon belongs to an animal and multiple axons (and their mitochondria) therefore 
share the same confounding factors such as variations in treatment, quality of surgery, 
depth of anaesthesia or body temperature of the animal. This raises the question how to 
perform statistical analysis on the results of experiments properly. 
Historically, two major approaches have been used to tackle similar problems. Perhaps 
most common is the so called naïve (Snijders & Bosker 2011) or pooled (Kreft & de 
Leeuw 1998) approach in which each cell or axon is treated as an independent 
observation, irrespective of which  animal / cell culture it stems from. Perhaps because 
of its simplicity, the naive approach is common in the mitochondrial literature (Nikić et 
al. 2011; Sajic et al. 2013; Sorbara et al. 2014; Ohno et al. 2014). Underlying it is the 
assumption that the macro level (e.g. the animal) has no significant effect on the micro 
level (the axon). This assumption, while rarely tested explicitly, is critical since even 
small intra-class correlations can lead to drastic underestimation of Type 1 errors 
(Dorman 2008). 
Alternatively, data are sometimes aggregated to a single value per macro unit (e.g. mean 
transport per animal). Whilst certainly more conservative, this kind of analysis also leads 
to a shift of meaning the micro level (axons) to the macro level (the animal). This shift 
can have important consequences when trying to make observations about the micro level 
as demonstrated by the so called Robinson Effect or Ecological Fallacy (Robinson 1950). 
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Robinson showed that a correlation between two factors on the macro level can be very 
different from the equivalent correlation on the micro level. As an example of this, 
consider the hypothetical case of measuring axonal mitochondrial transport in two mice 
of very different age. Suppose that the axons in the younger mouse show significantly 
more transport compared with the older animal (Milde et al. 2015), and that the axon 
diameter in the older mouse is larger than in the younger animal. It is possible to 
construct a scenario in which the correlation between axon diameter and transport is 
reversed depending on the level of observation. Because of cases like these it is generally 
accepted that aggregation should not be used to make conclusions about micro level 
effects (Kreft & de Leeuw 1998 for further discussion; see also Snijders & Bosker 2011). 
A third option is to choose a multilevel approach which considers differences on both the 
micro and the macro level. Such analyses are increasingly common in the social sciences 
(Field et al. 2012) and in clinical studies (Twisk 2006) and generally fall in one of two 
categories: random effects ANOVAs (Sahai & Ageel 2012; Krzywinski et al. 2014) and 
hierarchical linear models (HLM) (Kreft & de Leeuw 1998; Twisk 2006; Snijders & Bosker 
2011). Both approaches have in common that they take the variation on the macro level 
(e.g. between animals with the same treatment) into account when comparing micro level 
instances. In many cases, random effects ANOVAs and HLMs can be applied to the same 
problems (Logan 2010)9. However, the use of random effects ANOVA usually requires 
balanced group designs, whereas HLM do not, making the latter a more versatile tool. 
Hierarchical linear models can be seen as an extension of general multiple regression 
models in that they contain multiple error terms (and optionally varying slopes) for 
different levels of the model. In its simplest form, the random intercept model, the general 
equation for linear models 
𝑌1 = 𝛽/ + 𝛽.𝑋.,1 + 𝜀1 
becomes 
                                         
9 In fact, using hierarchical linear models with residual maximum likelihood (REML) methods for 
equal group sizes is equivalent to using ANOVA estimators (Snijders & Bosker 2011, chapter 
3.2.1). 
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𝑌1I = 𝛽/ + 𝜇/I + 𝛽.𝑋1I + 𝜀1I 
with j indicating the level over which the intercept varies. This way, the model can 
capture the offsets which apply to the axons of a particular animal, for example due 
variations in anaesthesia, as well as the effect of a treatment which applies to axons 
across multiple animals. The parameters β and μ of an HLM are determined using either 
maximum likelihood (ML) or restricted maximum likelihood (REML) estimation. There 
appears to be no consensus about which method is superior. Snijders and Bosker 
recommend the use of REML when dealing with <50 groups (Snijders & Bosker 2011, 
chapters 4.7 and 6.1) while Twisk suggests that ML may be a superior tool for estimating 
fixed effects (Twisk 2006). Both, however, agree that in practise the differences between 
the two tend to be small. 
What makes HLM particularly powerful is that in estimating the parameters of the 
model, the information of a single group is combined with the information of all other 
groups; a process which is sometimes described as “borrowing strength”. For example, in 
order to untangle how much of the difference between treated and untreated axons on 
day 8 post treatment is due to the treatment and how much is due to differences in 
animal baseline, HLM can borrow strength by using the variance between animals at 
other time points to assign an individual intercept to every animal and thereafter arrive 
at an estimate of the treatment effect. Multilevel models thus present a good way to deal 
with nested, partially dependent observations (Field et al. 2012). 
In order to find out whether the multilevel linear modelling approach is applicable in this 
study, I followed the approach laid out in (Field et al. 2012) and constructed both a 
naïve linear model using the generalized least squares method (gls) in R and a 
hierarchical linear model with a random intercept dependent on the animal using nlme. 
I then compared the fit of both models using the Akaike Information Criterion (AIC) 
and -2log-likelihood. HLM proved the superior approach to modelling most effects studied 
in this thesis and hence is used to determine significance throughout this study. Maximum 
likelihood estimation is used to estimate the model parameters since it offers the option 
to compare the fit of the HLM to that of a naive model (Field et al. 2012) and since it 
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was used in most of the text books available to me. I believe that this is a more honest 
approach to significance testing which avoids the inflation of Type 1 error rates that 
occurs when dependent observations are assumed to be independent (Dorman 2008). 
Unfortunately, multiple experiments in this study (particularly those described in 
chapters 2, 3 and 4) were originally designed with the naïve approach in mind and thus 
assuming a larger statistical power than I would attribute to them now. While many of 
the observed effects are still statistically significant, I would prefer to have conducted the 
experiments described in these chapters using a larger number of animals. 
 
 
Figure A.1: Three ways of analysing nested results. See text for details 
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APPENDIX B: OVERVIEW OF EXCITATION AND DETECTION 
SETTINGS 
 
Microscope Dye Excitation Detection 
LSM Pascal 5.0 TMRM 543nm > 585nm 
CFP 458nm 475nm - 525nm 
Fluoromyelin Green 488nm 505nm - 550nm 
LSM 710 TMRM 561nm 565nm - 730nm 
CFP 458nm 465nm - 550nm 
Myelin reflection 488nm, 
561nm, 
633nm 
485nm - 491nm, 
558nm - 564nm, 
630nm - 636nm 
TnXXL (ratiometric) 405nm 460nm - 510nm, 
520nm - 570nm 
TnXXL (citrine) 514nm 515nm - 650nm 
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APPENDIX C: ETHIDIUM BROMIDE CONTROLS 
All mitochondrial and axonal changes described in chapters 2, 4, and 6 followed the 
application of lysolecithin (LPC). There are reasons to believe that they were caused by 
demyelination rather than direct action of LPC such as the long duration of the effects 
(days) compared to the estimated time it takes for LPC to be broken down in vivo 
(minutes), or studies showing that LPC applied to unmyelinated axons in vitro does not 
affect mitochondrial dynamics (see introduction and discussion of chapter 2 and 
discussion of chapter 4). Nevertheless, it would be desirable to confirm these findings 
using other means of demyelination. As mentioned in chapter 2, ethidium bromide (EB) 
is another demyelinating toxin with a well-understood time-course and physiology (Black 
et al. 1991; Felts & Smith 1996; Felts et al. 1997). The major drawback of EB is that it 
drastically reduces the amount of mitochondrial DNA through DNA chelation (Leibowitz 
1971; Desjardins et al. 1985; Hayashi et al. 1990) which makes it less suitable for the 
study of mitochondria. On the other hand, axons in EB lesions in rats have been reported 
to survive at even higher rates than axons in LPC lesions (Woodruff & Franklin 1999), 
suggesting that the loss of mtDNA is not catastrophic. Thus I decided to repeat some of 
the experiments presented earlier with EB as the demyelinating agent. I argued that 
while EB would likely have a direct effect on mitochondrial function, replicating the 
increase in intracellular calcium or the decrease in mitochondrial transport in EB treated, 
demyelinated axons would nevertheless provide evidence that these effects were direct 
consequences of demyelination. 
In order to induce demyelination using EB a similar procedure as described in chapter2 
was used. However, instead of applying the compound directly, a sterile piece of flexible 
tubing was lowered onto the nerve and held in place using light pressure. The inside of 
the tube was filled with EB solution while sterile saline was applied outside. This way, 
the exposure of surrounding tissue and particularly the skin to EB was minimized. In 
total, 19 male Mito-S mice were treated with different doses of EB (ranging from 0.05% 
to 1% in sterile saline) over either 20 or 45 minutes. In addition, the perineureum of the 
saphenous nerve of three animals was pierced with a fine tungsten needle to facilitate the 
 168 
uptake of EB into the nerve. Since EB takes longer to induce demyelination than LPC 
(Felts et al. 1997; Woodruff & Franklin 1999), animals were imaged between 3 and 13 
days after application. 
Ethidium bromide is a yellow fluorescent molecule which made it possible to confirm that 
the compound was successfully taken up into the nerve and into cell nuclei in particular 
(see Figure C.1 A). However, even though all 19 animals showed signs of EB having 
entered through the perineureum, the resulting demyelination was, in my hands at least, 
unpredictable (see Table C.1). The nerves of some animals showed little or no signs of 
demyelination even at high doses while in others virtually all visible axons appeared dead 
and filled with fragmented and depolarised mitochondria (see Figure C.1). Additionally, 
the saphenous nerve and the tissues surrounding it showed signs of severe inflammation 
including clusters of mobile macrophages. While this observation disagrees with earlier 
reports based on rats, there is at least one report of severe and chronic inflammation 
cause by EB injection into the spinal cord of mice (Kuypers et al. 2013). 
Even though mitochondria in some demyelinated axons increased in density and showed 
signs of hyperfusion similar to those observed after LPC treatment, I ultimately decided 
to abort this series of experiments. It seems that topical application of EB, while it causes 
some of the toxin to enter the nerve, is not suitable for consistent induction of 
demyelination. 
As discussed in chapter 2, other means of causing demyelination such as the targeted 
expression of diphtheria toxin receptors in myelinating cells followed by the injection of 
small doses of the toxin (Buch et al. 2005; Locatelli et al. 2012) could be used to instead 
of ethidium bromide and would likely be more suitable for the control experiment 
attempted here. 
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Figure C.1: Saphenous nerves from different mice after the application of 
ethidium bromide. A: After topical application, EB fluorescence can be seen in cell 
nuclei in the saphenous nerve. B: Consequences of EB application ranged from no obvious 
signs of demyelination and fragmented mitochondria in axons with only slightly disturbed 
myelin through demyelinated axons with increased mitochondrial content and 
hyperfusion to destruction of all visible axons. Genetically encoded, mitochondrially-
targeted CFP in blue; Fluoromyelin Red in red; scale bars indicate 10µm. 
 
animal dose 
[%] 
application 
time 
perineureum 
punctures 
day of 
imaging 
outcome 
1 0.05 20 no 3 no signs of demyelination 
2 0.02 20 no 3 no signs of demyelination 
3 0.02 20 no 7 no signs of demyelination 
4 0.05 20 no 7 no signs of demyelination 
5 0.05 20 yes 7 little demyelination, a lot of axonal damage 
6 0.02 20 yes 7 some demyelination, a lot of axon damage 
7 0.1 20 no 7 no signs of demyelination 
8 0.1 45 no 7 little demyelination 
9 1 20 no 7 deformed myelin, no full demyelination, axon 
damage 
10 0.1 20 yes 7 little demyelination, a lot of axon damage 
11 1 45 no 7 unacceptable inflammation - animal culled 
12 1 45 no 13 widespread demyelination and destruction of 
axons 
13 0.1 45 no 13 little demyelination 
14 0.2 20 no 13 no signs of demyelination 
15 0.5 20 no 13 virtually complete demyelination 
16 0.4 20 no 13 virtually no demyelination 
17 0.3 20 no 13 no signs of demyelination 
18 0.5 20 no 10 widespread axon damage 
19 0.5 20 no 10 some myelin disruption, little demyelination, a lot 
of axonal damage 
Table C.1: Different doses and application times of ethidium bromide and 
their effects on myelin and axons. 
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